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ABSTRACT 
 DNA is constantly damaged by a variety of exogenous and endogenous sources. To 
maintain the integrity of the genome, different DNA repair mechanisms have evolved, 
which deal with different kinds of DNA damage. One of the DNA repair pathways, 
Nucleotide Excision Repair (NER), is highly conserved throughout the three kingdoms of 
life and deals mainly with lesions arising in the DNA duplex after exposure to UV-light. 
The NER pathway in archaea is more closely related to that of eukarya, although the 
overall process is not yet well understood. This thesis describes the isolation and 
characterisation of one of the repair factors, XPD, from the crenarchaeon Sulfolobus 
acidocaldarius (SacXPD).  
 SacXPD was first identified due to its homology with the eukaryal XPD protein. In 
eukarya XPD is the 5’ 3’ helicase involved in opening the DNA duplex around a 
damaged site. In eukarya, XPD is part of a 10-subunit complex, where it fulfils important 
structural roles and takes part in NER, transcription initiation from RNA polymerase II 
promoters and cell cycle regulation. The archaeal protein on the contrary is a monomer 
and a 5’ 3’ SF2 DNA helicase as its eukaryal counterpart. Its cellular functions, 
however, are unclear. 
 Upon purification of SacXPD, it was discovered that the protein binds an iron-
sulphur cluster (FeS), which is essential for its helicase activity, but not for any other 
enzymatic functions, such as the ATP hydrolysing activity. The FeS cluster domain was 
not only identified in archaeal XPD, but also in eukaryal XPD and other related eukaryal 
helicases, such as FancJ. The presence of the FeS cluster was confirmed in the eukaryotic 
XPD homologue Rad3 from Saccharomyces cerevisiae. Mutagenesis studies were used to 
investigate a possible function of the FeS cluster, which may be used to engage ssDNA 
during the duplex unwinding process. This would actively distort the ss/ ds DNA 
junction. In addition, the resulting bending of the clamped single DNA strand could be 
used to avoid reannealing. The consequences of some human mutations introduced into 
the SacXPD gene were investigated and could contribute to our understanding of the 
development of human diseases.  
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1.1 ARCHAEA-THE THIRD DOMAIN OF LIFE 
 Life as we know it is divided into the prokaryotic (life forms without nucleus) and 
the eukaryotic (life forms with nucleus) world. When Fox and Woese reformed the 
taxonomy of the bacteria on the basis of similarities of their 16S-rRNA, rather than 
physical markers, it led to the discovery of the third domain of life, which they named 
“Archaebacteria” (Woese & Fox (1977)). Archaea share many similarities with bacteria. 
They are single celled organisms, possess no real nucleus and usually have a single 
circular chromosome. On the other hand archaeal DNA processing pathways are more 
related to the eukarya. This includes the DNA repair machineries, gene transcription, 
DNA replication and recombination and the mRNA translation process. These pathways 
in archaea tend to be stripped down versions of the eukaryal equivalents. Understanding 
fundamental features in archaea is helpful to unravel the complexity of the eukaryal 
pathways. Archaea are also easier to handle and provide useful insights into gene and 
protein evolution.  
 The domain of the archaea is divided into two kingdoms: the crenarchaea and the 
euryarchaea. The latter consists mainly of methanogenes, extreme halophiles, 
(hyper)thermophiles and marine mesophiles. They are thought to be the closer relatives 
of the eukarya (White (2003)). The crenarchaea include many (hyper)thermophiles as 
well as marine and terrestric mesophiles. Spontaneous mutations that could drive 
evolution are less tolerable under extreme environmental conditions. Hence, the evolution 
of extremophiles is slower than evolution of organisms living under mesophile 
conditions. Therefore, the archaea are thought to be the closest living relatives to the last 
universal common ancestor (LUCA) of life on earth.  
 It is worth mentioning, that there may be another kingdom: The korarchaea. The 
existence of the korarchaea was only suggested on the basis of 16S-rRNA analysis of 
samples from a hyperthermophile biocoenosis (Barns et al. (1996)). However, their 
existence was never proved nor disproved, but it is likely that the identified 16S-rRNA 
was an artifact. The Nanoarchaea were first thought to represent a separate kingdom as 
well, on the basis of the isolation of Nanoarchaeum equitans, a parasite of another 
archaeon, which also possesses the smallest genome of any known organism (Huber et al. 
(2002); Waters et al. (2003)). Later phylogenetic studies, however, suggested that N. 
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equitans may be a member of a fast-evolving euryarchaeal lineage (Brochier et al. 
(2005)). 
 In this project, proteins from the two crenarchaeal hyperthermophiles Sulfolobus 
acidocaldarius DSM639 (XPD) and S. solfataricus P2 (XPF) are described. Both 
organisms grow aerobically in acidic (pH 2-4), sulphur-rich environments at around 80 
˚C. Genomes of S. solfataricus and S. acidocaldarius have been fully sequenced (She et 
al. (2001), Chen et al. (2005)). Recombinant proteins were expressed and purified using 
Escherichia coli as a heterologous expression host. Sulfolobus proteins are generally 
thermostable and easily amenable to biochemical and structural studies. XPD 
(Saci_0192) was first identified on the basis of its sequence similarity to its eukaryotic 
counterpart; XPF (Sso0729) was already extensively studied by J. Roberts, a former PhD 
student. 
 
1.2 DNA DAMAGE AND REPAIR 
 DNA is constantly damaged by exogenous (e.g. UV-light, ionizing radiation) and 
endogenous (e.g. reactive oxygen species produced in metabolic processes) agents. In 
humans, the number of damages occurring per cell per day was estimated to be around 
104-106 (Lindahl (1993)). If modifications persist, they can give rise to mutations, cancer 
and cell death.  
 The simplest reaction leading to DNA damage is hydrolysis. Hydrolysis of the N-
glycosylic bond between a purine and its deoxyribose sugar leads to depurination. The 
generated abasic site can be further fragmented to single strand breaks. Hydrolysis can 
also cause deamination of bases and can alter the genome sequence. For example, the 
deamination of cytosine leads to uracil, which base pairs with adenine. If not repaired, 
replication of this mispair will cause a C-G to T-A transversion, permanently altering a 
genetic sequence. 
 Oxidation is a major threat to DNA. Reactive oxygen species (ROS) are frequent 
by-products of the aerobic metabolism. Oxidised bases (e.g. 8-oxoguanine, thymine 
glycol) block transcription and replication and are highly mutagenic. Other metabolic 
CHAPTER 1: INTRODUCTION 
 4 
hazards can be found in form of enzyme cofactors such as S-adenosylmethionine, which 
methylates bases accidentally.  
 Environmental factors, like UV radiation, ionizing radiation, cigarette smoke or 
anticancer drugs are potentially mutagenic. They cause bulky helix-distorting lesions or 
damage to the DNA sugar phosphate backbone. This can provoke single strand breaks, 
and eventually double strand breaks during replication. Double strand breaks also occur 
at replication fork collapses, but also during meiosis and recombination. Rare incidences 
of interstrand crosslinks are also highly cytotoxic. (reviewed in Scharer (2003)) 
 To cope with such a variety of DNA damages, cells have developed several DNA 
repair systems, most of which are highly conserved throughout evolution. An overview is 
given in Figure 1.1. 
 XPD and XPF are part of the Nucleotide Excision Repair (NER) machinery, a 
highly versatile and conserved repair pathway. It deals with a variety of bulky helix-
distorting lesions mainly arising from exposure to UV light. The most common adducts 
are cyclobutane pyrimidine dimers (CPD) and (6-4) photoproducts (6-4-PP). 
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Figure 1.1: Overview of DNA damaging factors, lesions and repair mechanisms 
DNA is constantly damaged by exogenous and endogenous agents. Different repair 
pathways have evolved, which deal with different types of lesions. Figure adapted from 
Hoeijmakers (2001). 
 
1.2.1 Nucleotide excision repair in the three domains of life 
 The overall mechanism of NER is highly conserved among all organisms, although 
the participating factors are not. In bacteria the process basically involves three proteins 
(UvrA, UvrB and UvrC), while in eukarya circa 15 proteins constitute the core repair 
process. It is thought that the NER system in archaea could resemble a simplified version 
of the eukaryal NER pathway, because homologues of some of the eukaryal NER factors 
were identified in archaea. Other archaea also possess the UvrABC system or use a 
combination of both NER systems (White (2003)). It was suggested, that some archaea 
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acquired the bacterial NER factors through lateral gene transfer (Aravind et al (1999)). 
Two distinct NER pathways have evolved: Global Genome Repair (GGR) and 
Transcription Coupled Repair (TCR). As the names indicate, the GGR system repairs 
lesions occurring throughout the genome, while TCR repairs damage arising in the 
actively transcribed DNA strand (van Hoffen et al. (2003)). 
 Most organisms, apart from placental mammals, encode a photolyase, an enzyme 
that directly reverses CPD (the most common lesion arising following UV-exposure) in a 
light dependent reaction. In human cells NER is the only way to deal with DNA 
photoproducts, since no photolyase homologue has been identified in the genome (Yasui 
et al. (1994); Sancar (2003)).  
 
1.2.1.1 GGR 
 In bacteria, UvrA binds specifically to damaged DNA (Seeberg & Steinum (1982)), 
although the damage signalling factor is UvrB (Theis et al. (2000)). UvrA dimerises upon 
binding to DNA and binds one or two molecules of UvrB (Orren & Sancar (1989); 
Verhoeven et al. (2002b)). UvrA delivers UvrB to the damaged site (Orren et al. (1992)), 
where UvrB unwinds the DNA around the lesion, locks itself using a β-hairpin structure 
and actively kinks the DNA around 130 ˚ (Theis et al. (2000); Shi et al. (1992)). UvrA 
leaves the complex in an ATP-dependent manner and the endonuclease UvrC, which has 
high affinity for the UvrB-DNA complex, binds UvrB and performs a dual incision. The 
3’ incision is first made at the 4th to 6th phosphodiester bond before the lesion and the 
following 5’ incision occurs at the 8th phosphodiester bond (Sancar & Rupp (1983)). The 
12-13 nt long excised oligonucleotide together with the bound UvrC are removed by the 
helicase UvrD. UvrB, which is bound to the strand opposite the damage, remains at the 
damaged site until DNA polymerase I fills in the gap and removes it at the same time 
(Orren et al. (1992)). Finally, the gaps between old and new strands are sealed by a DNA 
ligase.  
 E. coli harbours another 3’ endonuclease, called Cho (UvrC homologue), which is 
able to act in combination with UvrA and UvrB to make the 3’ incision at the 9th 
phosphodiester bond. Cho is not essential for bacterial NER, but it is thought to make 
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some contribution to DNA repair within this pathway (Moolenaar et al. (2002); van 
Houten (2002)). 
 
 In eukarya, NER is carried out by six repair factors called RPA, XPA, XPC, TFIIH 
(Transcription Factor II H), XPG and XPF-ERCC1. Three factors appear first at the 
damaged site (RPA, XPA, XPC), although it is unclear in which order. Another dilemma 
is that none of the three are specific for CPDs, the major substrate for human NER. XPC 
prefers to bind undamaged DNA over CPDs, while RPA and XPA have a non-
physiologically relevant preference for CPDs (Reardon & Sancar (2003)). Another DNA 
damage binding protein, DDB, was proposed to initiate excision of CPDs (Wagasugi et 
al. (2001)), but it was found that DDB-knockout Chinese hamster cell extracts still 
efficiently repaired CPD lesions (Reardon et al. (1997)). Therefore, it was suggested that 
any of these repair initiation factors, which have affinities for each other, could appear 
first at the damaged site and assemble in a random order (Figure 1.2). Eventually, 
protein-protein interactions and cooperativity would lead to the assembly of the NER 
machinery. The interaction of XPC with TFIIH leads to formation of a rather unstable 
closed complex (Uchida et al. (2002)). The two helicases of TFIIH, XPB and XPD, 
unwind the DNA around the lesion in 3’5’ and 5’3’ direction, respectively. This 
leads to conformational changes within all bound proteins and the resulting stable open 
complex is called preincision complex 1 (PIC1). XPC recruits XPG to the 3’ incision site 
and leaves the complex (PIC2), similar to how UvrA swaps with UvrC in bacteria. XPF-
ERCC1 is recruited and strongly bound by XPA (PIC3) and XPG facilitates the 3’ 
incision at the 6th ± 3 phosphodiester bond from the damage, followed by the 5’ incision 
by XPF-ERCC1 at the 20th ± 5 phophodiester bond. The excised oligonucleotide has a 
typical length of 24-32 nt. Subsequently, all repair factors except RPA leave and the 
remaining gap becomes subject to repair synthesis carried out by repair factor C (RFC)-
PCNA and polymerase δ/ε which fills the gap. DNA ligase 1 finally seals the repair patch 
(Huang et al. (1992); Mu et al. (1997); Evans et al. (1997); Reardon & Sancar (2005)).  
 Little is known about the overall process of NER in archaea. Although homologues 
of RPA, XPB, XPD, XPF and XPG have been identified, the damage recognition factors 
XPA and XPC have not been detected in archaeal genomes (White (2002)). Interestingly, 
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lower eukaryotes and plants do not possess homologues of XPA either, and it is thought 
that this gene was added later to the repair pathway. The single stranded DNA binding 
(SSB) protein (RPA in eukarya) is a potential candidate for damage recognition and NER 
initiation (Cubeddu & White (2005)). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Model of nucleotide excision repair in human cells 
The damage recognition factors XPA, XPC and RPA assemble in a random but 
cooperative manner at the damaged site (black triangle). XPC recruits TFIIH whose two 
helicases  (XPB and XPD) unwind the DNA around the damage in opposite directions 
leading to formation of presincision complex 1 (PIC1). XPC recruits XPG to PIC1 in a 
process called molecular matchmaking and leaves PIC1. The resulting complex (PIC2) is 
recognised by XPF-ERCC1 leading to formation of PIC3. Dual incision takes place and a 
damage containing oligonucleotide of a typical length of 24-32 nt is released. Steps 
leading to the formation of the three PIC complexes may be aborted at any time (kinetic 
proofreading). The gap is filled in by polymerase δ/ε and the repair patch sealed by ligase 
(figure adapted from Reardon & Sancar (2005)). 
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1.2.1.2 TCR 
 Damages in the transcribed strand during transcription stall the RNA polymerase 
(RNAP) in E. coli. Stalled RNAP complexes are recognised by a transcription repair 
coupling factor (TRCF), also known as Mfd. TRCF functions as a translocase and release 
factor for RNAP at blocking lesions and is also thought to recruit the NER factors, which 
remove the damage from the transcribed strand (Selby & Sancar (1993)).  
 The mechanism in eukarya is not very clear. NER of transcription blockages does 
not require XPC, while the transcription coupling factors involved are CSA and CSB. 
The latter seems to be the orthologue of bacterial TRCF and is involved in recruitment of 
the NER machinery, but does not lead to release of RNAPII once it is stalled at a lesion. 
The release of RNAPII may be facilitated by transcription termination factor 2 (TTF2). 
(reviewed in Reardon & Sancar (2005)). 
 There are no published data on TCR in archaea and a mfd homologue has not yet 
been identified in archaeal genomes. 
 
1.3 HELICASES 
Helicases are powerful motor proteins which transfer the free energy derived from 
NTP hydrolysis onto translocation along nucleic acid (NA). This results in unwinding of 
duplex NA and provides single stranded DNA or RNA. Helicases are found in all DNA 
processing pathways and their general function is to provide access to genomic 
information. 
On the basis of conserved residues, helicases are categorised into three 
superfamilies (SF1-3) and one family (F4) (Gorbalenya & Koonin (1993)). These 
(super)families are characterised by seven (SF1 and 2), three (SF3) and five (F4) 
conserved motifs, respectively. Two motifs are common to all helicases (motifs I and II/ 
A and B) and they are called Walker A and B motifs (Walker et al. (1982)). Generally, 
lysine and glycine residues of the Walker A box bind the NTP and coordinate the β-γ 
phosphoanhydride bond, while acidic residues in the Walker B box direct a divalent 
cation (mostly a Mg2+ or Mn2+) to activate water for hydrolysis of the terminal 
phosphoanhydride bond (Velankar et al. (1999)). The other motifs are specific for each 
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family and were thought to facilitate specific functions in respective helicases, such as 
substrate binding and unwinding. However, crystal structures and biochemical studies 
revealed that all motifs are somehow involved in NTP binding and hydrolysis. They 
come together in the three dimensional structure of the protein to form the NTP binding 
and hydrolysing pocket within the two RecA-like motordomains (Korolev et al. (1997); 
Velankar et al. (1999)). It is worth mentioning that for the majority of putative helicases, 
helicase activity has not been shown. It is generally accepted that the so-called helicase 
motifs are actually characteristic for NTPases, rather than helicases. Hence, specific 
properties of a helicase are encoded outside the conserved motifs (reviewed in Hall & 
Matson (1999); Singleton& Wigley (2002)). 
Superfamily 1 and 2 are the largest families and are thought to derive from a 
common ancestor. They harbour most of the eukaryotic, prokaryotic and viral DNA or 
RNA helicases and NTPases. With a few exceptions, all members of these superfamilies 
are ATPases. In addition to the seven conserved motifs, another motif was recently 
discovered in DEAD-box RNA helicases, called the Q-motif. It is located prior to motif I 
and is involved in the coordination of the β-γ phosphoanhydride bond of the NTP (Cordin 
et al. (2004)).  
XPD, both in archaea and eukarya, is a SF2 DNA-helicase. It contains the seven 
conserved motifs and the conserved sequence Asp-Glu-Ala-His (DEAH) in the Walker B 
box, typical for SF2 helicases (Gorbalenya & Koonin (1993); see also Chapter 3, section 
1.3.5). 
 
1.3.1 Models of nucleic acid unwinding 
Helicases unwind duplex nucleic acid to produce single stranded DNA/ RNA. 
Duplex unwinding mostly occurs with a specific polarity, either in 3’ to 5’ or 5’ to 3’ 
direction. How directionality is facilitated is still unclear, but how the enzymes manage to 
unwind nucleic acid became much clearer in recent years. There are three different 
models of nucleic acid unwinding, which depend on the oligomeric state of the helicase. 
They are called the Inchworm Model, the Active Rolling Model and the Model for 
hexameric Helicases. 
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1.3.1.1 The Inchworm Model 
The inchworm model was first proposed for the Rep helicase (Yarranton & 
Genfter (1979)) before it was discovered that the active form of Rep was a dimer. Since 
then the model has been thoroughly refined, especially with studies on the PcrA helicase. 
The inchworm model (Figure 1.3A) describes an unwinding mechanism for monomeric 
helicases assuming two sites of DNA binding per monomer. The first site contacts single 
stranded DNA, which induces conformational changes, leading to contact of the second 
motor domain with dsDNA. Binding of ATP increases the affinity for dsDNA and 
decreases that for ssDNA. When ATP is hydrolysed another large domain movement is 
induced, which can be imagined as a contraction. Since the enzyme is still tightly bound 
to the dsDNA region, this contraction leads to a movement of the ssDNA binding domain 
one step size in the direction of the ss/ ds fork. Bound ADP increases the affinity for 
ssDNA and decreases that for dsDNA. When ADP and Pi is released, the enzyme “snaps” 
open, which leads to a movement of one step size of the dsDNA binding domain away 
from the ss/ ds fork. Overall, this would look like the enzyme inches along the DNA 
strand (Velankar et al. (1999)).  
 
Step sizes 
 The step size of a helicase per hydrolysed ATP can be defined as the step size of 
translocation or the step size of duplex unwinding. Duplex unwinding requires more 
energy and therefore step sizes are smaller. For monomeric helicases the number of base 
pairs unwound per hydrolysed ATP varies from one for the PcrA helicase (Dillingham et 
al. (2000)) to up to six for the NPH-II helicase (Jankowsky et al. (2000)). 
 
Modifications of the general Inchworm Model 
 A few modifications of the general inchworm model are described: the Mexican 
wave model (Figure 1.3B) and the cooperative inchworm model. For the SF1 helicase 
PcrA it was found that the enzyme flips out one base for every hydrolysed ATP near the 
ss/ ds fork and releases another base on the opposite end. This would simulate a Mexican 
wave, while the enzyme translocates along the single DNA strand (Velankar et al. 
(1999)). Other helicases, such as the SF2 RNA-helicase NPH-II, do not interact with the 
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bases, they only bind the ribose phosphate backbone of one strand and “strip off” the 
opposite strand during translocation (Kawaoka et al. (2004)). The cooperative inchworm 
model was proposed for the Dda-helicase, because it was found that the rate of duplex 
unwinding increases with increasing concentrations of protein (Byrd & Raney (2004)).  
 
 
 
 
 
 
 
 
 
 
Figure 1.3: DNA unwinding mechanism for monomeric helicases 
(A) The inchworm model proposes two DNA binding sites per monomer, a single 
stranded and a double stranded DNA binding site. Cyclic changes of ATP binding, 
hydrolysis and ADP + Pi release induce conformational changes in the enzyme and 
alternating changes in affinities for ssDNA and dsDNA. The movement resembles that of 
a moving inchworm and leads to duplex unwinding (adapted from Eoff & Raney (2005)). 
(B) The Mexican Wave model was proposed for the SF1 helicase PcrA and presumes a 
direct interaction of the ssDNA binding domain with the bases of the DNA strand. For 
each hydrolysed ATP a base near the ss/ ds fork is flipped out and released on the other 
end of the bound DNA strand (adapted from Soultanas & Wigley (2000)). 
 
1.3.1.2 The Active Rolling Model 
 This model, although debatable, was proposed for dimeric helicases with two sites 
of nucleic acid binding, one per monomer (Figure 1.4). The mechanism suggested for the 
E. coli Rep helicase is as follows (Lohman (1993)): one or both monomers are bound to 
ssDNA with a specific polarity. Binding of ATP induces a negative cooperativity and 
increases the affinity of one monomer to ssDNA, while it decreases the affinity of the 
other one. The latter has now an increased affinity for dsDNA and binds the DNA duplex 
ahead of the ss/ ds fork. ATP hydrolysis induces duplex melting, leading to strand 
A 
B 
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displacement with the result that both subunits are bound to ssDNA. Exchange of ATP 
for ADP completes the cycle.  
 
 
 
 
 
 
 
 
 
 
Figure 1.4: DNA unwinding mechanism for dimeric helicases 
The active rolling model for dimeric helicases assumes one DNA binding site per 
monomer. Conformational changes and changes in affinities to ss/ dsDNA are induced by 
ATP hydrolysis. The emerging protein–DNA complexes are shown in the lower panel: P, 
protein monomer; S, ssDNA; D, dsDNA (adapted from Korolev et al. (1997)). 
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1.3.1.3 Hexameric Helicases 
 Hexameric helicases are complicated and can either consist of identical monomers, 
trimers of dimers or dimers of trimers. They form a ring-like structure through whose 
central hole single stranded nucleic acid can pass, while the helicase translocates along its 
nucleic acid substrate. NTP hydrolysis is carried out in a sequential manner. Allosteric 
effects induced by NTP hydrolysis cycles change the conformations of the enzyme 
subunits and the affinity to nucleic acid (reviewed in Soultanas & Wigley (2000); Eoff & 
Raney (2005)).  
 The crystal structure of the E1 protein from papillomavirus suggested a general 
mechanism for translocation of hexameric helicases (Figure 1.5; Enemark & Joshua-Tor 
(2006)). The subunits bind the ssDNA backbone in a helical right-handed staircase-like 
manner. Alternating states of ATP binding, hydrolysis and ADP release change the 
conformation of the central hairpins interacting with the DNA. Each subunit tracks one 
nucleotide per hydrolysed ATP. The subunit on the bottom of the staircase releases ADP 
and upon binding of ATP moves to the top of the staircase. Subunits in intermediate 
positions obtain varying states of ATP-hydrolysis and product formation (ADP+Pi). The 
ring structure and interdomain interactions avoid early dissociation from the nucleic acid 
and ensures completion of events like replication.  
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Figure 1.5: Model of nucleic acid unwinding by hexameric helicases  
(A) The crystal structure of hexamer 1 of the E1 protein from papillomavirus is shown. 
The six subunits are colour-coded. The DNA in the central hole and the ADP molecules 
at the subunit interfaces are depicted as stick representations. (B) The mechanism of 
staircasing for translocation along ssDNA is illustrated. The six individual subunits are 
represented as wagons with the same colour code as in (A). Each wagon transports one 
DNA nucleotide from the right to the left. The wagon couplers depict staircasing 
interactions. The left wagon (red) releases its DNA nucleotide. Upon ATP binding it 
moves to the right, where it picks up the next DNA nucleotide, couples to the purple 
wagon and moves with the DNA nucleotide to the left again (Figure adapted from 
Enemark & Joshua-Tor (2006)). 
A 
B 
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1.3.2 Human XPD 
 In humans, XPD (ERCC2) is the 5’3’ helicase (Weber et al. (1988)) and as a 
component of TFIIH it takes part in NER, transcription initiation of genes regulated by 
RNA polymerase II (RNPII) promoters and cell cycle regulation (Orphanides et al. 
(1996); Lehmann (2001)). The orthologues and aliases are known as Rad3 
(Saccharomyces cerevisiae) and rad15 (Schizosaccharomyces pombe). XPD is an SF2 
helicase and it contains the seven conserved helicase motifs and a highly conserved D-E-
A-H signature sequence in motif II (Gorbalenya & Koonin (1993)). It bridges the two 
subcomplexes of TFIIH by binding to the p44 subunit of the TFIIH core with its C-
terminus, and with its N-terminus it contacts the MAT1 subunit of the CAK subcomplex 
(Coin et al. (1998); Tirode et al. (1999)).  
 
1.3.2.1 Functions of human XPD and its role in TFIIH 
 The core TFIIH complex comprises the five subunits XPB, p34, p44, p52 and p62 
(Figure 1.6). As part of this complex, hXPD is the major helicase in NER (Coin et al. 
(1998)).  
 The C-terminus of hXPD tethers the p44 subunit, which stimulates its helicase 
activity up to 10-fold during NER (Coin et al. (1998)). The amino terminal region 
interacts with MAT1 (Busso et al. (2000); Feaver et al. (2000)), a subunit of the Cdk 
Activating Kinase (CAK) complex, which consists of three subunits (MAT1, cyclin-H, 
cdk-7; Figure 1.6). The remaining factor is called TTD-A (p8), a 8 kDa protein, that is 
not as strongly associated with the complex as the other five proteins. It targets XPD and 
plays an essential role in stabilising TFIIH (Cleaver (2005)). CAK and the TFIIH core in 
concert with XPD and TTD-A represent the TFIIH holocomplex.  
 XPD is catalytically active during NER and plays an important structural role 
during transcription initiation, by bridging the TFIIH core and the CAK subcomplex 
(Tirode et al. (1999)). The cdk-7 subunit of the CAK complex phosphorylates the C-
terminus of the large subunit of RNPII, thereby facilitating promoter escape and the 
recruitment of mRNA processing enzymes (Winkler et al. (2000)). Furthermore, as part 
of the CAK complex, XPD regulates cdk-7, which in turn regulates cell cycle through 
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phosphorylation of other downstream CDKs. Excess XPD was found to inhibit mitosis, 
while low levels of XPD lead to cell over-proliferation (Chen et al. (2003)). XPD 
probably releases the CAK complex during interphase and is degraded to allow cellular 
redistribution of cdk-7 during the cell cycle. High levels of XPD also have dramatic 
effects on viability in Drosophila melanogaster embryos. Hence, expression levels of 
XPD need to be tightly regulated during cell cycle. Accordingly, downregulation of 
expression levels of XPD during prophase coincides with repression of basal 
transcription of genes regulated by RNPII promoters (Chen et al. (2003)). Thus, the 
importance of XPD in eukaryotic cells is obvious. It acts not only as a helicase in NER, 
but has also very important structural and regulatory functions during transcription and 
cell cycle.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Subunit arrangement of TFIIH 
Electron microscopic studies revealed a circular form of the human TFIIH holocomplex, 
which can accommodate dsDNA in its central hole. The CAK complex protrudes from 
the top of the complex. The two helicases are located on opposite sites. The exact 
positions of p34, p52 and p62 are not yet clear and are assumed on the basis of 
biochemical data (Schultz et al (2000)). TTD-A stabilizes the TFIIH complex by binding 
to p44 and XPD. The TFIIH core is not connected to the CAK subcomplex during NER 
and XPD is enzymatically active. 
 
XPD 
XPB 
3’5’ 
helicase 
(5’3’ 
helicase) 
p34 
p44 
p52 
p62 
TTD-A 
cdk7 
MAT1 
cyclinH 
CAK 
XPD 
XPB 
3’5’ 
helicase 
5’3’ 
helicase 
p34 
p44 
p52 
p62 
TTD-A 
TFIIH in transcription 
initiation 
TFIIH in NER 
CHAPTER 1: INTRODUCTION 
 18 
1.3.2.2 Mutations of human XPD and diseases 
 The enzymatic activity of XPD is only required for DNA repair. It is dispensable 
for transcription, but has a stimulatory effect probably because it brings both the TFIIH 
core and the CAK complex in close proximity (Reardon et al. (1996)). Therefore, the 
XPD gene is rather tolerant to mutations.  
 Most of the human mutations are located in the C-terminal region (Lehmann 
(2001)). The reasons for this could be that either mutations on the N-terminus are more 
devastating, and lead to early abortion of the human embryo or they are not clinically 
significant, so that respective patients are not registered. The C-terminus of XPD interacts 
with the p44 subunit of TFIIH and stimulates the helicase activity of XPD 10-fold (Coin 
et al. (1998)). Without stimulation by p44, XPD still exhibits a reduced helicase activity 
in analogy to the stimulation of UvrB by UvrA in E. coli (Seeley & Grossman (1990)). 
Furthermore, three of the conserved motifs are found in the C-terminus and mutations 
most likely lead to reduced or abolished ATPase activities. Mutations in the xpd gene can 
cause trichothiodystrophy (TTD) or xeroderma pigmentosum (XP) (Lehmann (2001)).  
 
xeroderma pigmentosum (XP) 
 XP is generally characterised by increased photosensitivity with pigmentation 
anomalies and predisposition to skin cancer, as well as varying grades of neurological 
abnormalities induced by primary neuronal degeneration. Certain mutations in XPD 
induce one of the most severe XP phenotypes found in the XP complementation group, 
with the exception of XP-A. XP-D has an early onset from the age of 12 to the early 
twenties. Cells also show surprisingly high unscheduled repair synthesis with 20-45 % 
increase over normal cells (reviewed in Lehmann (2001)). 
 
Trichothiodystrophy (TTD) 
 TTD is characterised by sulphur-deficient brittle hair, arising from a reduced 
number of cysteine-rich matrix proteins in the hair shaft. Varying grades of mental 
retardation, skeletal abnormalities and ichthyotic skin are described (Itin & Pittelkow 
(1990)). Some patients also show increased UV-sensitivity, but no pigmentation changes 
or skin cancers have been reported. Repair defects are very heterogeneous varying from 
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severe (10 % of normal repair) to no repair defect at all. The majority of patients have 
low levels of TFIIH (reviewed in Lehmann (2001)). It was first thought that this was due 
to a decreased stability of the multisubunit complex caused by an abolished or reduced 
interaction of XPD with p44. However, mutagenesis studies revealed that although most 
TTD cell lines showed reduced levels of TFIIH, one mutation that abolishes p44 
interaction (R683W) led to nearly normal TFIIH levels. In addition, the mutation R112H 
does not affect p44 interaction but still showed reduced levels of the transcription factor 
(Dubaele et al. (2003)).  
 Another interesting discovery was made with mice harbouring a TTD mutation in 
the XPD gene. They exhibited a phenotype similar to humans with the characteristic 
brittle hair, but also showed premature aging with all the typical symptoms, such as 
reduced life span, osteoporosis, cutaneous aging and early greying (de Boer et al. (2002)). 
This was thought to be an effect of accumulation of DNA damage in TTD cells. 
 
Cockayne syndrome (CS) 
 CS, another disease associated with XP genes, has not yet been described for XPD 
patients. There are only some rare cases of combined XP/CS phenotypes. CS is a disease, 
which affects transcription but, as was stated before, XPD is dispensable for 
transcription. It is likely that there may be CS mutations in XPD, which lead to clinically 
not relevant phenotypes and hence are not recognised. CS is a multisystem disorder with 
severe dwarfism, skeletal abnormalities, microcephaly and progressive neuronal 
dysfunctions arising from demyelination (Nance & Berry (1992)). Unlike XP, CS does 
not lead to pigmentation changes in the skin or skin cancer. Interestingly, although cells 
are sensitive to UV-killing, they are proficient in removing photoproducts (van Hoffen et 
al. (1993)). 
 
 Apart from inherited disorders like XP or TTD, XPD gene polymorphisms seem to 
be involved in the development of almost every kind of cancer. Specific polymorphisms 
have frequently been found for example in patients with lung (Benhamou & Sarasin 
(2005)), bladder (Schabath et al. (2005)) and breast (Debniak et al. (2006)) cancers. 
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1.3.3 Other related helicases and pathways 
1.3.3.1 Human FancJ and the Fanconi anemia DNA repair pathway 
 Fanconi anemia (FA) is named after the Swiss paediatrician Guido Fanconi, who 
described the disease for the first time in 1927. It is a rare (1-5/ million) autosomal (apart 
from FancB: X-chromosomal) recessive inherited disorder, leading to bone marrow 
failure, increased cancer susceptibility and cellular hypersensitivity to DNA cross-linking 
agents with accumulation of chromosomal breakages (Taniguchi & D’Andrea (2006)). 
The disease shows an early onset between the ages of six and eight with an average 
survival age of 30 years. FA shows clinical heterogeneity and 25 - 40 % of the patients 
appear phenotypically normal (Auerbach et al. (2001)). 
 The FA pathway is a DNA repair mechanism involved in the maintenance of 
chromosomal stability and is induced after treatment with DNA damaging agents such as 
ionizing radiation, UV-light, DNA cross-linking agents or hydroxyurea (Auerbach et al. 
(2001)). Twelve complementation groups (Figure 1.7) have been described, eight of 
which form the FA-core complex (Fanc: A, B, C, E, F, G, L and M). This multisubunit 
complex is required for mono-ubiquitination of FancD2 (FancD2-Ub), which is the 
critical step for induction of the FA DNA repair pathway. FancD2-Ub moves to the 
chromatin fraction and accumulates at damaged sites. FancD2 has no known conserved 
motifs and its exact function is unknown. The FA DNA repair pathway becomes more 
important, as proteins involved in other inherited disorders were found to colocalise with 
Fanc-proteins. This includes ATM (Ataxia telangiectasia), BLM (Bloom syndrome), 
NBS1 (Nijmegen breakage syndrome) or ATR (Seckel syndrome) (reviewed in: 
Taniguchi & D’Andrea (2006)).  
 The Fanconi anemia pathway itself is not yet well understood, and scientists are 
busy adding missing pieces to the puzzle. One missing piece was discovered only 
recently, the helicase FancJ. FancJ was found to be identical to the gene product of the 
helicase called BRIP1 or BACH1 (BRCA1 interacting protein 1/ BRCA1 associated C-
terminal helicase) (Litman et al. (2005); Levitus et al. (2005)). FancJ binds the C-terminal 
BRCT-domains of BRCA1. Phosphorylation of FancJ at serine 990 is critical for a stable 
BRCA1-FancJ interaction, which leads to binding of FancJ to the phosphopeptide 
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binding motif located at the interface between BRCTs (Cantor et al. (2001); Yu et al. 
(2003)). Germline mutations in BRCA1 and BRCA2 (FancD1; Howlett et al. (2002)) are 
associated with early onset of breast and ovary cancer (Yoshida & Miki (2004)). BRCA1 
takes part in homologous recombination (HR) and the repair of DNA double stranded 
breaks. Subsequently, FancJ deficient cell lines are defective in HR, hypersensitive to 
mitomycin C (MMC) induced chromosomal instability and patients show early onset of 
breast cancer (similar to BRCA1). Furthermore, FancJ is not required for FancD2 mono-
ubiquitination and it was suggested that it functions further downstream of the pathway 
(Litman et al. (2005)).  
 Like XPD, FancJ is a 5’3’ SF2 helicase with a conserved DEAH signature motif 
in the Walker B box (Cantor et al. (2004)). It is 25 % identical and shows 43 % similarity 
to hXPD. The mutation of K52 to arginine in the Walker A box led to a loss of ATPase 
and helicase activity and mutant cell lines exhibited a FA deficiency phenotype (Cantor 
et al. (2001); Bridge et al. (2005)). FancJ prefers to unwind forked duplexes and can also 
resolve D-Loop structures, which regularly occur during HR. No helicase activity was 
observed on holiday junctions (Gupta et al. (2005)). 
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Figure 1.7: Current model of the Fanconi anemia DNA repair pathway 
Upon DNA damage or during normal S-phase progression FancD2 is mono-ubiquitinated 
at K561 (FancD2-Ub). Several proteins are necessary for efficient mono-ubiquitination 
including ATR, RPA and the FA-core complex. FancD2 then localises in the nuclear foci 
where it interacts with FancD1 (BRCA2). The overall process of FA damage repair is not 
yet fully understood. USP1 is a negative regulator and deubiquitinates FancD2 (adapted 
from Taniguchi & D’Andrea (2006)). 
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1.3.3.2 Bacterial DinG 
 The damage-inducible helicase DinG is the closest bacterial homologue of 
eukaryotic and archaeal XPD helicases (Figure 1.8), although not participating in the 
same DNA repair pathway (Koonin (1993)). DinG is repressed by LexA, which 
suggested its involvement in the bacterial SOS response mechanism (Lewis et al. (1992)). 
Upregulation of dinG was observed after treatment with mitomycin C and nalidixic acid 
(Lewis et al. (1992), van Dyk et al. (2001)). Experiments using the cold-sensitive mutant 
DinD68 suggested DinG may be a negative regulator of the bacterial SOS-response 
system (Yasuda et al. (1998)).  
 Similar to XPD, DinG is a SF2 helicase with 5’3’ directionality. The ATPase 
activity is stimulated by single stranded DNA and a kcat of 24 sec-1 makes it one of the 
most efficient ATPases (Voloshin et al. (1993)).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: Sequence alignment of archaeal XPD and bacterial DinG helicases 
The figure shows a sequence alignment of the related helicases XPD from archaea and 
DinG from bacteria. Eco, E. coli DinG; Sty, Salmonella typhimurium DinG; Sac, S. 
acidocaldarius XPD; Pto, Pyrococcus tokodaii XPD. Highly conserved residues are 
white on black and similar residues are white on grey. The motifs are indicated on the top 
of the respective sequence. The cysteines which are involved in FeS cluster coordination 
are highlighted in yellow (for a better alignment of the FeS cluster domain in DinG 
helicases see supplementary figure 6 in Rudolf et al. (2006)). The C-terminal 21 (E. coli) 
and 19 residues (S. typhimurium), respectively, are omitted. 
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                                                                      motif I 
Eco   1 -MALTAALKAQIAAWYKALQEQIPDFIPRAPQRQMIADVAKTLAGEEGRHLAIEAPTGVG 
Sty   1 -MALTAALKAQIAAWYKALQDQIPDFIPRAPQRQMIADVARTLAGEEGRHLAIEAPTGVG 
Sac   1 --------MLKLRDWQEKLKDKVIEGLRNN------------------FLVALNAPTGSG 
Pto   1 MHRYLYVEGFRPRGWQDGITSTILSNLNNN------------------GKIALEAPTGSG 
 
Eco  60 KTLSYLIPGIAIAREEQKTLVVSTANVALQDQIYSKDLPLLKKIIPDLKFTAAFGRGRYV 
Sty  60 KTLSYLIPGIAIAREEQKTLVVSTANVALQDQIFSKDLPLLRKIIPDLRFTAAFGRGRYV 
Sac  35 KTLFSLLVSLEVKP--KVLFVVRTHNEFYP---IYRDLTKIREKR-NITFSFLVGKP--- 
Pto  43 KTSFILYLAFLSGK--KFIYSVRTHNEFTR---IYEDN----KRFFNLDIAYMFGKK--- 
 
Eco 120 CPRNLTALASTEPTQQDLLAFLDDELTPNNQEEQ---KRCAKLKGDLDTYKWDGLRDHTD 
Sty 120 CPRNLAALASSEPTQQDLLAFLDDELTPNNQEEQ---KRCARLKGDLDGYKWDGLRDHTD 
Sac  86 ------------------SSCLYAEKGAESEDIP---CKYCELKGSIVEVKTD------- 
Pto  91 ------------------SLCPLPDRWLENDDSDRDICTGCFLKDKTIDVKFDMDPEELC 
 
Eco 177 IAIDDDLWRRLSTDKAS-----------CLNRNCYYYRECPFFVARREIQEAEVVVANHA 
Sty 177 IAIDDDLWRRLSTDKAS-----------CLNRNCHYYRECPFFVARREIQEAEVVVANHA 
Sac 118 ---------DSPLSLVK-----------KLKKDGLQDKFCPYYSLLNSLYKADVIALTYP 
Pto 133 NFLLRESMENINIDIKNRSLVKNERGDYYYKREKKSLGFCPYYSVRLSALSHNIIVMTYN 
 
motif II 
Eco 226 LVMAA--MESEAVLPDPKNLLLVLDEGHHLPDVARDALEMSAEITAPWYRLQLDLFTKLV 
Sty 226 LVMAA--MESEAVLPEPKHLLLVLDEGHHLPDVARDALEMSAEITASWYRLQLDLFSKLV 
Sac 158 YFFID--RYREFIDIDLREYMIVIDEAHNLDKVN-----------------------ELE 
Pto 193 YLLNPGIRYRTFGIENFNDYCIVFDEAHNIDDFVEN--------------LGRSLRPKTV 
 
Eco 284 ATCMEQFRPKTIPPLAIPERLNAHCEELYELIASLNNILNLYMPAGQEAEHRFAMGELPD 
Sty 284 ATCMEQFRPKTTPPLANPERLNAHCEEVYELIASLNAILNLYMPAAQEAEHRFAMGELPD 
Sac 193 ERSLSEITIQMAIKQSKSE----------ESRRILSKLLNQLREVVLPDEKYIKVENVPK 
Pto 239 ERAIEQSMNYFPVKEYKCN----------DRTRLGIMLERLLSELDLNESGTLKRFSFSK 
 
Eco 344 EVLE--ICQRLAKLTEMLRGLAELFLNDLSEKTGSHDIVRLHRLILQMNRALGMFEAQSK 
Sty 344 EVME--ICQRLAKLTETLRGLAESFLNDLSEKTGSHDIVRLHRVILQMNRALGMFEAQSK 
Sac 243 LSKE--ELEILADDYEDIR--KDSLKQGKVNKIHIGSILRFFSLLS-----IGSFIPFSY 
Pto 289 DFIDNLDIDIIKRFSDMFNDINEKNPAGQRHRNYLESLYNFLYDVFNSENSGLYYYSDKN 
 
                                                                      motif III 
Eco 402 LWRLASLAQSSGAPVTKWATREEREGQLHLWFHCVGIRVSDQLERLLWRSIPHIIVTSAT 
Sty 402 LWRLASMAQSSGAPVSKWATREIREGQLHVWFHCVGIRVSDQLERLLWRSVPHIIVTSAT 
Sac 294 SKRLVIKN-----PE-----------------------ISYYL-NLLNDNELSIILMSGT 
Pto 349 GILLKIMY-----YD-----------------------VSSFL-RFLNSS-P-VIFMSGT 
 
Eco 462 LRSLNSFSRLQEMSG-LKEKAGDRFVALDSPFNHCEQGKIVIPRMRVEPSIDNEEQHIAE 
Sty 462 LRSLNSFSRLQEMSG-LKEKAGDRFVALDSPFNHVEQGKLVIPQMRYEPTIDNEEQHIAE 
Sac 378 LPPREYMEKVWGIKRNMLYLDVEREIQKRVSG-SYECYIGVDVTSKYDMRSD---NMWKR 
Pto 325 MPSPEHISLVWGFEN-IIYISVEKIFKNAGGEKKYHIVTGFTTLNKYRLKSDTWEPMLKK 
 
                                    motif IV 
Eco 521 MAAFFRKQVESKKHLGMLVLFASGRAMQRFLDYVTDLRLMLLVQGDQPRYRLVELHRKRV 
Sty 521 MAAYFREQLESKKHHGMLVLFASGRAMQRFLEHVADVRLLLLVQGDQPRYRLVELHRKRV 
Sac 434 YADYLLKIYFQAKAN-VLVVFPSYEIMDRVMSRISLPKYVESEDSSVEDLYSAISANN-- 
Pto 384 YMDFIKERYNSASGS-VLVAVPAYSILSGDKSISSFIDDDIKPHVIIETRKLSFSYIKGR 
 
                              ---------motif V------ 
Eco 581 ANGERSVLVGLQS--FAEGLDLKG---DLLSQVHIHKIAFPPIDSPVVITEGEWLKSLNR 
Sty 581 ESGERSVLVGLQS--FAEGLDLKG---ELLTQVHIHKIAFPPIDSPVVITEGEWLKSLNR 
Sac 491 ----KVLIGSVGKGKLAEGIELRNNDRSLISDVVIVGIPYPPPDDYLKILAQRVSLKMNR 
Pto 443 ALREKLLIFSVHGGKLLEGVQLVNKNRSLISDVIIMGLPLIPMDDYRTDKIKFIERQSKR 
 
                                    motif VI 
Eco 636 YPFEVQSLPSASFNLIQQVGRLIRSHGCWGEVVIYDKRLLTKNYGKRLLDALPVFPIEQP 
Sty 636 YPFEVQSLPSASFNLIQQVGRLIRSHACRGEVVIYDKRLLTKNYGQRLLNALPVFPIEQP 
Sac 547 ENEEFLFKIPALVTIKQAIGRAIRDVNDKCNVWLLDKRFES-LYWKKNLKCLNANKMKL- 
Pto 503 NMQDNLYYENAMIKVKQAAGRSTRSENDVADIWLCDDRFSS-AYWRDIFQN--------- 
 
 
 
Figure 1.8 
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1.4 IRON-SULPHUR CLUSTER PROTEINS 
 Iron-sulphur (FeS) clusters are survivors of an anaerobic world, when reduced iron 
and sulphide were available en masse and FeS clusters could assemble spontaneously. 
With the creation of photosynthesis and the presence of oxygen, evolving aerobic 
organisms faced a new problem. The major problem with oxygen is that it readily 
oxidises transition metals, because they are excellent univalent electron donors. Ferric 
iron precipitates and it is no longer available for biological uptake. Furthermore, reactive 
oxygen species (NO•, O2-, OH•, H2O2) inside the cell are dangerous. In this context, free 
iron represents a specific problem for cells by reacting with H2O2 thus creating hydroxyl 
radicals (OH•), which in turn damage proteins and DNA (Fenton Reaction). FeS cluster 
proteins are particularly sensitive to oxygen, as in most of the cases, oxidation leads to 
cluster destruction and subsequent enzyme inactivation.  
 The accumulation of oxygen in the atmosphere is assumed to have happened 
slowly, giving organisms the time to adapt. The general metabolism needed little de novo 
synthesis, the problem was the large number of FeS proteins, which took part in almost 
every metabolic pathway. The adjustments needed included acquisition of siderophores 
and other systems to capture free iron, iron transport and storage systems, regulatory 
systems that adjust the metabolism in response to the availability of iron and the presence 
of reactive oxygen species, repair systems and FeS cluster assembly machineries. FeS 
clusters present a particular problem in an aerobic world and cells have gone to a lot of 
effort to maintain them. Although, it seems that evolution is driving especially aerobic 
organisms to replace their FeS cluster proteins by more resistant or clusterfree isozymes; 
examples include the isozymes fumarase C or aconitase A. [reviewed in Imlay (2006)] 
 
1.4.1 Structure of FeS clusters 
 The simplest form of a FeS cluster consists of one iron coordinated by four protein 
ligands. The most common ligand is cysteine, due to the fact that iron has a high affinity 
for thiolate groups, followed by histidines and aspartates. The most frequently found 
clusters in nature are [2Fe-2S], [3Fe-4S] and [4Fe-4S] (Figure 1.9). More complex 
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clusters derive from metal substitutions and fusions between the simpler clusters (Rees 
(2002)).   
 FeS clusters can exist in different oxidation states, which are calculated from the 
overall oxidation state of all irons (Fe2+ or Fe3+) and all sulphurs (S2-) involved, without 
the coordinating ligands. They are referred to as the oxidised or the reduced form of the 
FeS cluster. Apart from a few exceptions, the all-ferrous and all-ferric state of an FeS 
cluster does not occur in nature. In general, only two oxidation states have been observed 
for [2Fe-2S] (2+/ 1+), [4Fe-4S] low potential (2+/ 1+) and [4Fe-4S] high potential (3+/ 
2+) FeS clusters. For some of the [3Fe-4S]1+/ 0 clusters a third all-ferrous state is naturally 
occurring (2-) (Duff et al. (1996); Beinert et al. (1997)).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9: Structure of the most common FeS clusters 
The most common FeS clusters found in nature are: (A) [1Fe-0S]3+/2+, (B) [2Fe-2S]2+/1+, 
(C) [3Fe-4S]1+/0 and (D) [4Fe-4S]2+/1+ or [4Fe-4S]3+/2+. The irons (red) are coordinated by 
protein ligands, mostly cysteines (black) and bridged by inorganic sulphide (blue). Figure 
adapted from Imlay (2006).  
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1.4.2 Functions of FeS cluster proteins 
 FeS clusters cover a wide range of redox potentials from around -0.6 to +0.45 V 
(Capozzi et al (1998)). This makes them excellent electron donors or acceptors. 
Therefore, FeS clusters are used as a bridge between redox couples which are physically 
separated. Some enzymes even contain several FeS clusters, which serve as an “electric 
wire” through the enzyme. One example is fumarate reductase, which contains three FeS 
clusters with a typical spacing of 10-14 Å. The electrons are transferred from the 
membrane bound menaquinone to cytosolic fumarate by electron hopping between the 
clusters (Iverson et al. (1999); Page et al. (2003)).  
 
FeS clusters of nitrogenase – An example for electron transfer 
 Another example is nitrogenase, a large protein complex used by diazotrophic 
microorganisms to transform atmospheric dinitrogen into ammonia. Microorganisms fix 
up to 2 x 1011 kg N2/ year and they are highly important for the maintenance of the 
natural nitrogen cycle. The nitrogenase contains 19 iron and 20 sulphurs and under 
nitrogen limiting conditions it makes up to 10 % of the total soluble protein of 
Azotobacter vinelandii (Zheng et al. (1998)). To satisfy this high demand of iron and 
sulphur, the nitrogenase has a specialised FeS cluster assembly machinery (see section 
1.4.3). To split the dinitrogen triple bond (960 kJ/ mol) microorganisms require 16 ATP 
molecules. The homodimeric Fe-protein of the nitrogenase binds a [4Fe-4S] cluster 
between its interfaces. Upon binding of 2 ATPs, it forms a complex with the MoFe-
protein of nitrogenase and delivers 2 electrons at once to the P-cluster of the MoFe-
protein. This double electron transfer is unique and changes the oxidation state of the 
[4Fe-4S] cluster of the Fe-protein from +2 to 0. Subsequently ATP is hydrolysed, which 
refills the electron “lack” of the Fe-protein. The P-cluster (8 Fe:7 S) transfers the 2 
electrons to the M-cluster. The M-cluster (7 Fe:9 S:1 Mo) transfers the electrons in the 
final step to split the dinitrogen bond (Muhlenhoff & Lill (2000); Seefeld et al. (2004)) 
 There are a huge number of FeS proteins with electron transfer functions. Most 
famous are the FeS proteins, which participate in the electron transfer during 
photosynthesis or respiration. But FeS cluster proteins also fulfil other roles, which do 
not involve an electron transfer step. 
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FeS clusters in sensing and regulation of gene expression 
 One of these enzymes is aconitase. There are three forms of aconitase ([4Fe-4S], 
[3Fe-4S] and the apoprotein) in two different locations (cytosol: c-aconitase; 
mitochondria: m-aconitase). C- and m-aconitase have 30 % identity in their amino acid 
sequence. Depending on how many irons are bound to the enzyme, the function changes. 
The m-aconitase in the [4Fe-4S] form takes part in the tricarbolic acid cycle (TCC) and 
one of the 4 Fe is probably directly coordinated by the substrate citrate, which is 
converted into isocitrate. The enzyme is only active in the 4 Fe state, the 3 Fe protein 
represents an inactive enzyme. Citrate is a strong iron chelator, so it is possible that the 
fourth iron is delivered to the enzyme by the substrate itself. C-aconitase in its 4 Fe form 
also takes part in the TCC, the 3 Fe form is inactive and the apoprotein is generated under 
iron-limiting conditions. As apoprotein this enzyme is known as iron regulatory protein 1 
(IRP1) and it binds to iron responsible elements (IREs) in the untranslated region of 
several m-RNAs. IREs are m-RNA secondary loop structures, which are highly 
conserved. Depending on whether IRP1 binds to an IRE in the 3’ or 5’ untranslated 
region, it stabilises or destabilises transcripts and is involved in cellular iron homeostasis, 
which leads for example to an increased iron uptake. This is one example where the 
presence or absence of a FeS cluster is used for sensing intracellular iron levels and for 
the regulation of protein expression (reviewed in: Beinert et al. (1996); Beinert & Kiley 
(1999)). 
 In other proteins, such as SoxR, the oxidation state of the cluster is used to sense 
reactive oxygen species (ROS) and induces the transcription of respective genes (only in 
the oxidised form of the FeS cluster), whose products are necessary for the defence 
against ROS (Gaudu & Weiss (1996)).  
 
Structural roles of FeS clusters 
 In DNA repair enzymes like MutY and EndoIII - both contain a [4Fe-4S] cluster - 
the cluster stabilises a loop structure known as the iron-sulphur-cluster loop (FCL), which 
interacts with DNA. In the absence of the FeS cluster, these enzymes are inactive due to 
an inability to bind DNA (Thayer et al. (1995); Chepanoske et al. (2000)). In addition to 
its structural function, the FeS cluster in these glycosylases was also suggested to have a 
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catalytical role, by facilitating electron charge transport on the DNA, leading to local 
accumulation of these repair enzymes near to damaged sites (Boal et al. (2005)). 
 
1.4.3 The FeS cluster assembly machinery 
 Under anaerobic conditions and in the presence of reduced iron and sulphide, FeS 
clusters assemble spontaneously. In a biological system spontaneous assembly does not 
occur and three distinct biogenesis systems have been described for bacteria. The Nif 
(nitrogen-fixation) system is responsible for formation and assembly of the FeS clusters 
in the enzyme nitrogenase (section 1.4.2). All nitrogen-fixing bacteria possess the Nif 
system (Rees & Howard (2000)). The Isc (iron-sulphur cluster assembly) system is more 
a general machinery for FeS cluster assembly and is responsible for biosynthesis of the 
majority of FeS clusters of cellular FeS proteins (Zheng et al. (1998)). The third system 
Suf (sulfur-mobilisation) is active under iron-limiting and oxidative stress conditions. The 
genes of the respective systems are coexpressed and arranged in clusters. All systems are 
essential and deletions are lethal or lead to severe growth defects. In general these 
systems are interchangeable and highly conserved throughout the three domains of life.  
[reviewed in: Muhlenhoff & Lill (2000)] 
 
The general mechanism of action of FeS cluster assembly 
 The general mechanism of action for all three systems is as follows: A pyridoxal-
phosphate dependent enzyme activates sulphur from L-cysteine. The resulting enzyme 
bound cysteine-persulphide is the ultimate sulphur source for FeS cluster formation. The 
sulphur is delivered to a protein, which serves as a molecular scaffold for the formation 
of the FeS cluster precursor. The delivery of sulphur is followed by iron incorporation. 
The correct mechanism is not yet fully understood. For most of the factors found to be 
essential for FeS cluster formation and assembly, an exact function has not yet been 
described. It is also unclear how the FeS cluster precursor is transferred to the respective 
apoproteins.  
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Peculiarities of FeS cluster assembly in eukaryotes 
 In eukaryotes, the location of the FeS cluster assembly machinery is in the 
mitochondria, yet FeS cluster proteins are also abundant in the cytosol. It is still unclear, 
how cytosolic FeS cluster proteins are assembled in eukarya. It was suggested that a FeS 
cluster precursor is somehow transferred from the mitochondrial matrix into the cytosol. 
The yeast ATM1 (human: hABC7) ABC transporter seems to be involved in this process, 
however, the modality of the transfer and how the FeS cluster is incorporated into the 
apoprotein in the cytosol is still unknown (Kispal et al. (1999)). 
 
1.4.4 Iron metabolism and human diseases 
 Iron is an essential element and the majority of the iron in humans is used for 
incorporation in erythrocytes and FeS cluster containing proteins. Due to the toxicity of 
iron for the aerobic metabolism, tight regulation of iron homeostasis is necessary. Most 
common diseases in human are caused by mutations in factors that regulate iron uptake 
(e.g. defective hepcidin or transferring receptors). This leads to iron accumulation in 
specific tissues (Fe-overload) and causes hemachromatosis. Atransferrinemia, a rare 
inherited disease, is caused by the absence of the Fe-transport protein transferrin in the 
patients blood. This leads to anemia and iron deposition in the heart and liver, causing 
heart and liver failures. Aceruloplasminemia is caused by defective ceruloplasmin, a 
ferroxidase, and leads to accumulation of iron especially in neural tissue. Following lipid 
peroxidation, patients suffer from progressive neurodegeneration (reviewed in: Hentze et 
al. (2004)). The most common inherited iron-related disorder is Friedreich’s ataxia, 
caused by a triplet expansion in intron 1 of the frataxin gene. The severity of the 
phenotype caused by Friedreich’s ataxia correlates with the length of this triplet 
expansion. Frataxin is located in the mitochondria and the related disorder is 
characterised by accumulation of iron within the mitochondria and FeS cluster protein 
deficiency. The disease causes slow progressive degeneration of the nervous system 
leading to an inability of voluntary muscle movement (ataxia) and heart conditions 
(Rouault & Tong (2005)). The exact function of frataxin, however, is not yet clear. 
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 This thesis will describe the characterisation of the archaeal homologue of human 
XPD. The protein was isolated from the crenarchaeon S. acidocaldarius and is shown to 
be a monomeric SF2 ATP dependent 5’ 3’ DNA helicase. S. acidocaldarius XPD was 
found to coordinate an essential FeS cluster. Bioinformatic analysis showed that the FeS 
cluster domain was also present in human XPD and other related human helicases such as 
FancJ and the bacterial homologue DinG. 
2 MATERIALS AND METHODS 
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2.1 ISOLATION OF GENOMIC DNA FROM SULFOLOBUS 
 The isolation of genomic DNA from Sulfolobus solfataricus (Sso) and Sulfolobus 
acidocaldarius (Sac) cells (frozen cell pellet, stored at -80 ˚C) was carried out using the 
QIAGEN DNeasy ® Tissue Kit (50) following the protocol for Animal Tissues. For 
polymerase chain reaction (PCR), a 1:10 dilution of genomic DNA was used. 
 
2.2 CLONING AND PROTEIN EXPRESSION 
2.2.1 Cloning procedures and vectors 
 The gene sequence of the S. acidocaldarius xpd (SacXPD) was kindly provided by 
Roger Garret (Copenhagen), since at that time the genome sequence was not yet available. 
The gene was amplified from genomic DNA using proof-reading KOD HiFi polymerase 
(Novagen) and the following primers: 
5’-CGTCGGATCCCCATGGAACTTAGAGAGTGGCAAAGC-3’ 
5’-CCGGGGATCCGTCGACTTACAGTTTAATTTTCCTTG-3’ 
The PCR product was cloned into vector pET28c (Novagen) using BamH1/NcoI 
recognition sites for expression of untagged recombinant protein. The insertion was fully 
sequenced. 
 The truncated his-tagged form of SacXPD (E72  D162) was obtained as described 
above using the following primers: 
5’-CGTCGGATCCCCATGGCAGAGAAGAGAAATATCACTTTTTCTTTTCTTGTAG 
G-3’ 
5’-CCGGGGATCCGTCGACTTAATCTATAAAGAAATATGGATAAGTTAGGGC-3’ 
The PCR product was cloned into vector pET28c (Novagen) using Sal1/NcoI recognition 
sites for expression of his-tagged recombinant protein. 
 The Saccharomyces cerevisiae (strain BY4741a) RAD3 gene was amplified from 
genomic DNA, kindly provided by Dr P. Dennison (CBMS, St Andrews), using Long PCR 
Enzyme Mix (Fermentas) and the following primers: 
5’-GAATCGGCCGGCATGCAAAGTGGGATTTTTGGTACCGTCTCTGGG-3’ 
5’-GCCGGCATGCAGATTATTACAAAAAAAGTGGG-3’ 
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The PCR product was gel purified and cloned into the TOPO 2.1 vector using the TOPO 
TA Cloning system (Invitrogen). The gene was excised from the TOPO vector using SphI 
and XhoI, the Rad3 fragment gel purified and subcloned into the SphI/SalI cloning sites of 
the yeast shuttle vectors YCplac33 and YCplac111 (donated by Prof Michael J. Stark, 
Dundee). The insertion was fully sequenced. 
 The three PCNA subunits from S. solfataricus were amplified from genomic DNA 
using proof-reading KOD HiFi polymerase and the following primers: 
PCNA1: 5’-GGCCCATGGTTAAGATTGTTTACCCTAATGC-3’ 
  5’-GGCGTCGACTTATAACCTTGGCGCTATCCAAAAGATC-3’ 
PCNA2:  5’-GGCCCATATGATGAAAGCTAAGGTAATTGACG-3’ 
  5’-GGCCTCGAGTTAGTCTGCCCTTGGTGCAATGTAAAAGTCC-3’ 
PCNA3: 5’-GGCCCCATGGCATATCTTAAATCTTTTGAAAGG-3’ 
  5’-GGCCGTCGACTTAAACTTTTGGAGCTAATAAATAAG-3’ 
The PCR products were cloned into vector pETDuetI (Novagen) using Sal1/NcoI (PCNA1 
and PCNA3) and NdeI/XhoI (PCNA2) recognition sites, respectively, for expression of 
untagged recombinant protein. The insertions were fully sequenced. 
 The sequence of the C-terminal Helix-hairpin-Helix (HhH) DNA interaction motif of 
SsoXPF was amplified from genomic DNA using proof-reading KOD HiFi polymerase and 
the following primers: 
5’-CGTCGGATCCCCCATGGCTAAATTGGAAAGTGTTTCTG-3’ 
5’-CCGGGGATCCGTCGACCTAAAGGAAATCAAATAAAG-3’ 
The PCR product was cloned into vector pET28c (Novagen) using Sal1/NcoI recognition 
sites for expression of his-tagged recombinant protein. The insertion was fully sequenced. 
 The vectors containing the his-tagged constructs of the SsoPCNA subunits (pET33b-
PCNA1, pET30a-PCNA2, pET30a-PCNA3) and the untagged form of SsoXPF (in 
pET19b) as well as the untagged form of ApeXPF (in pET28c) were provided by J. A. 
Roberts. 
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2.2.2 Site-directed mutagenesis 
Mutations the the SsoXPF, SacXPD and yeast RAD3 (in YCplac111) genes were 
generated using the Stratagene XL QuikChange Mutagenesis Kit and the primers indicated 
in Appendix 1 (Table 1). The mutations were confirmed by DNA sequencing. Amino acid 
substitutions were confirmed by mass spectrometry on pure protein preparations. 
 
2.2.3 Protein expression 
 All proteins were expressed in Escherichia coli BL21 Rosetta cells (Novagen) and 
cultures grown in Luria Bertani (LB) medium containing the appropriate antibiotics 
(ampicillin: 100 µg/ mL or kanamycin: 35 µg/ mL). For expression of full-length forms of 
SacXPD, cultures were grown at 37 ˚C to optical densities (ODs) of 1.0 to 1.2. After 
induction of protein expression with IPTG (of 0.2 mM), cultures were incubated overnight 
(~14 hours) at 28 ˚C with shaking at 180 rpm. Cultures for expression of the truncated form 
of SsoXPD, the HhH motif of SsoXPF, full-length forms of SsoXPF and the his-tagged and 
untagged SsoPCNA subunits were grown at 37 ˚C until the OD600 was between 0.7 - 0.9. 
Protein expression was induced with IPTG (0.2 mM) and cultures were grown at 37 ˚C 
with shaking for further three hours. 
 
2.3 PROTEIN PURIFICATION 
2.3.1 Purification of untagged recombinant SacXPD 
 The bacterial cell pellet from 2 L of culture was resuspended in 30 mL buffer A (20 
mM MES, pH 6.0, 200 mM NaCl, 1 mM EDTA, 1 mM DTT) containing benzamidine (1 
mM) and sonicated 3 x 4 min (at an amplitude of 15 microns) with cooling on ice. The 
lysate was centrifuged (48000 x g, 20 min, 4 ˚C), heat-treated (65 ˚C, 20 min) and 
centrifuged for a further 20 min. The extract was filtered (Aerodisc® 0.45 µm syringe 
filter), loaded onto a heparin column (HiTrap™ 5 mL Heparin HP, Amersham Biosciences), 
and eluted with a linear gradient of sodium chloride (1 M). Fractions containing the 
SacXPD protein were identified by SDS-PAGE (Invitrogen), pooled and purified to 
homogeneity using a HiLoad® 26/60 Superdex® 200 size exclusion column (Amersham 
Biosciences) equilibrated with Gel Filtration buffer (20 mM Tris, pH 7.8, 200 mM NaCl, 1 
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mM EDTA, 1 mM DTT). Identities of mutant and wildtype proteins were confirmed by 
mass spectrometry. 
 
2.3.2 Purification of His-tagged E72-D162 truncated SacXPD 
 Bacterial cell lysis was achieved as described in section 2.3.1 using binding buffer 
with 20 mM sodium phosphate, pH 7.4, 500 mM NaCl and 1 mM benzamidine. Cell lysate 
was not heat-treated and loaded onto a Nickel chelating column (HiTrap™ 5 mL Chelating 
HP, Amersham Biosciences) after filtration through an Aerodisc® 0.45 µm syringe filter, 
and eluted with a linear gradient of imidazole (0.5 M). Fractions containing the SsoXPF-
HhH protein were identified by SDS-PAGE (Invitrogen), pooled and purified to 
homogeneity using a HiLoad® 26/60 Superdex® 200 size exclusion column (Amersham 
Biosciences) equilibrated with Gel Filtration buffer. The protein was confirmed by mass 
spectrometry. 
 
2.3.3 Purification of his-tagged SsoXPF-HhH motif 
 Bacterial cell lysis was achieved as described in section 2.3.1 using binding buffer 
with 20 mM sodium phosphate, pH 7.4, 500 mM NaCl and 1 mM benzamidine. Soluble 
cell extract was loaded onto a Nickel chelating column (HiTrap™ 5 mL Chelating HP, 
Amersham Biosciences) and SsoXPF-HhH protein was purified to homogeneity as 
described in section 2.3.2. 
 
2.3.4 Purification of untagged recombinant SsoPCNA subunits 
 The bacterial cell pellet of 2 L culture of each expressed subunit of PCNA was 
resuspended in 30 mL buffer A (20 mM Tris, pH 7.8, 1 mM EDTA, 1 mM DTT) and 1 mM 
benzamidine and sonicated 3 x 4 min with cooling on ice. The lysate was centrifuged 
(48000 x g, 20 min, 4 ˚C). Heat-treatment (65 ˚C, 20 min) took place only for subunit 2, 
PCNA1 and PCNA 3 were not heat stable. Lysate containing PCNA2 was centrifuged for a 
further 20 min following heat-treatment. All extracts were filtered (Aerodisc® 0.45 µm 
syringe filter) before being loaded onto a sepharose anion exchange column (HiTrap™ Q 
HP 5 mL, Amersham Biosciences). Proteins were eluted with a linear gradient of sodium 
chloride (1 M) and fractions containing PCNA protein were identified by SDS-PAGE 
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(Invitrogen), pooled and purified to homogeneity using a HiLoad® 26/60 Superdex® 200 
size exclusion column (Amersham Biosciences) equilibrated with buffer (30 mM Tris, pH 
7.8, 200 mM NaCl, 1 mM EDTA, 1 mM DTT). Proteins were confirmed by mass 
spectrometry. Equivalent amounts of each subunit were mixed together and incubated at 4 
˚C on a rotary mixer for approximately one hour to form the heterotrimer. The heterotrimer 
was separated from dimers and monomers using size exclusion chromatography as 
described above. 
 
2.3.5 Purification of untagged SsoXPF, ApeXPF and his-tagged SsoPCNA subunits 
 These proteins, including the SsoXPF mutant proteins, were purified as described in 
the PhD thesis of J. A. Roberts (2004). 
 
2.3.6 Determination of protein concentrations 
 Protein concentrations were either estimated from measuring the absorbance at 280 
nm (A280) or using Bradford Reagent (Bio-Rad). Theoretical molar extinction coefficients 
were obtained from ProtParam analysis (http://ca.expasy.org/tools/protparam.html). 
Bradford reagent was used as described in the manufacturer’s manual and protein 
concentrations were calculated using a BSA standard curve. 
 
2.4 TRYPTIC DIGESTION OF SACXPD 
 A total reaction volume of 20 µL contained 6.5 µg recombinant SacXPD, 2.5 mM 
KCl and different concentrations of trypsin (200, 100, 50, 25, 12.5, 6.25 ng). Reactions 
were incubated for 90 min at 30 ˚C and stopped by addition of AEBSF protease inhibitor to 
a final concentration of 10mM. Fragments were separated on SDS-PAGE and analysed by 
MALDI-ToF mass spectrometry. 
 For N-terminal protein sequencing, reactions were set up as described above with 25 
µg SacXPD and 200 ng trypsin. Peptide bands were transferred onto a PVDF membrane in 
transfer buffer (10 mM CAPS, pH 11.0, 10 % methanol) and visualized by using amido 
black protein stain. Major bands were cut from the membrane and protein fragments N-
terminal sequenced using the Edman-Reaction.  
CHAPTER 2: MATERIALS AND METHODS 
 38 
2.5 GLUTARALDEHYDE CROSS-LINKING OF PROTEINS 
 Reactions containing 25 µg protein in 50 mM sodium phosphate buffer, pH 7.6, were 
incubated at room temperature (RT) for 10 min. Glutaraldehyde was added to a final 
concentration of 1 % and reactions were quenched after two minutes by addition of NaBH4 
(100 mM). Proteins were TCA-DOC precipitated and analysed by SDS-PAGE. 
 
2.6 WESTERN BLOT 
 Sheep antiserum containing polyclonal antibodies against SacXPD was purchased 
from Alba Bioscience. Protein samples were separated on SDS-PAGE and transferred onto 
Hybond Nitrocellulose membrane (Amersham Biosciences) soaked in transfer buffer (25 
mM Tris, pH 8.3, 250 mM glycine, 15 % methanol). Protein was transferred under semi-
dry conditions for 25 min at 25 V/ 400 mA. The membrane was blocked one hour (5 % 
milk, 0.1 % Tween 20 in PBS buffer) at room temperature and incubated with the primary 
antibody (1:20000) overnight at 4 ˚C. The membrane was washed with blocking buffer (3x 
10 min, RT) and the secondary antibody added (1:200000; Anti-Goat, Pierce ImmunoPure® 
Antibody) and incubated for one hour (RT). The membrane was washed in blocking buffer 
(3x 10 min) and ultrapure water (3x 5 min). Chemiluminescence detection was initiated by 
using SuperSignal® West Pico Chemiluminescent Substrate or Femto Maximum Sensitivity 
Substrate Kits (Pierce). The signal was visualized using the Fuji Luminescent Image 
Analyzer LAS-1000 and Image Reader software. 
 
2.7 BATHOPHENANTHROLINE ASSAY 
 The number of irons bound to SacXPD were quantified using a 100 µL aliquot of 50 
µM protein in gel filtration buffer, mixed with 30 µL concentrated HCl and heat treated for 
15 min at 100 ˚C. The control reaction contained buffer only. After 2 min centrifugation at 
13000 x g, 100 µL of the reaction was transferred into a clean sterile 2 mL tube and 1.3 mL 
500 mM Tris-HCl, pH 8.5 was added. Freshly prepared 5 % ascorbic acid (100 µL) and 0.1 
% bathophenanthroline (400 µL) were then added to the reaction. Samples were thoroughly 
mixed after each addition and reactions were incubated for 1 h at room temperature. The 
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absorbance of the reaction was measured at 535 nm against the control reaction. Iron bound 
to XPD was calculated using the molar extinction coefficient of 22369 mol-1 cm-1 (Pieroni 
et al. (2001)). 
 
2.7.1  Iron-sulfur cluster reconstitution 
 To reconstitute the FeS cluster, all buffers and solutions were purged with argon for 
at least 30 min. Tubes and other containers were as well purged with argon before usage. 
The protein was dialyzed against 20 mM Tris-HCl, pH 7.8 and 200 mM NaCl to remove 
the EDTA present in the storage buffer. The protein solution was divided into two 200 µL 
samples and freshly prepared DTT was added to a final concentration of 1 mM. The protein 
concentration was determined (127 µM) by measuring the absorbance at 280 nm (ND-1000 
Spectrophotometer, NanoDrop Technologies). Protein was transferred to anaerobic cuvettes 
and purged with argon. 10 mM Fe(II)(NH4)2(SO4)2 was made up in anaerobic buffer (20 
mM Tris-HCl, pH 7.8 and 200 mM NaCl) and further incubated in argon atmosphere.  
 Three reactions were set up: (1) Control containing buffer only, (2) control reaction 
containing 200 µL protein solution with addition of 40 µL buffer, (3) sample reaction 
containing 200 µL protein solution with 40 µL 10 mM Fe(II)(NH4)2(SO4)2. Every step was 
followed by absorbance readings between 600 and 300 nm. 4 µL of 5 mM dithionite (DT) 
was added 3 times subsequently to reaction (3) with incubations of 10 min before 
absorbance readings. This was done to ensure that all irons were present in the reduced 
form. After the third reading, the solution was incubated another 30 min at room 
temperature and a final spectra was taken. Microspin G-50 columns were prepared, placed 
in 15 mL Greiner tubes and incubated in argon atmosphere for 30 min. 100 µL of the 
protein solution was applied to each column and centrifuged for 2 min (800x g) to remove 
excess iron. Sodium chloride was added to a final concentration of 200 mM to the 
recovered samples to stabilize the protein. Absorbance measurements were taken on the 
ND-1000 spectrophotometer and the protein concentration determined. Numbers of irons 
bound to the protein were determined using the bathophenanthroline method (2.7). 
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2.8 SPECTROSCOPIC METHODS 
2.8.1 Circular dichroism (CD) 
 Protein was dialysed into CD buffer (10 mM Tris, pH 7.8, 200 mM NaF, 0.5 mM 
EDTA) overnight at 4 ˚C and protein concentrations adjusted. Spectra were taken on a 
JASCO J-810 Spectralpolarimeter using Spectra Manager Software. For near UV readings, 
the protein solutions were adjusted to a concentration of 1 mg/mL. The spectra were 
analysed between 450 nm and 260 nm at a scan rate of 20 nm/min using a cuvette with a 
pathlength of 0.5 cm. For far UV measurements, the protein solutions were adjusted to 
concentrations of 0.5 mg/mL. The spectra were taken between 260 nm and 180 nm at a 
scan rate of 50 nm/min using a cuvette with a pathlength of 0.02 cm. Spectra for each 
protein were taken six times, averaged and the blank (CD buffer) subtracted. Spectra were 
analysed using the DichroWeb (Lobley et al. (2002)) server 
(http://www.cryst.bbk.ac.uk/cdweb/html/home.html). 
 
2.8.2 Electron Paramagnetic Resonance (EPR) 
 For EPR spectroscopy, XPD (95 µM) was treated with either 1 mM potassium 
ferricyanide or 1 mM dithionite. The samples were incubated on ice for 5 min in 3 mm 
quartz EPR tubes before being quick frozen and stored in liquid nitrogen until usage. 
Spectra were obtained on a Bruker X-Band (cw) EPR Spectroscope at 30 K with the 
following settings: modulation frequency, 100 KHz; modulation amplitude, 0.32 mT; 
microwave frequency 9.49 GHz; microwave power 0.2 mW. A liquid helium transfer 
system was employed to regulate the temperature of the samples.  
 
2.8.3 Inductively Coupled Plasma – Optical Emission Spectroscopy (ICP-OES) 
 The elementary analysis of the Fe-S cluster bound to SacXPD was done on a Perkin-
Elmer Optima 5300 ICP-OES at the Chemistry Department of the University of Edinburgh. 
Protein was purified as described above (2.3.1) with the following changes: Gel Filtration 
buffer was free of DTT and the NaCl concentration was lowered to 100 mM. Standards 
used for standard curves contained 0.5, 1, 2, 3, 5 and 10 ppm of iron and sulfur. The Fe:S 
ratio of 10 µM SacXPD in Gel Filtration buffer was measured by comparing emission 
intensities with the standard curves. The blank contained Gel Filtration buffer alone. 
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2.9 CATALYTIC ASSAYS 
2.9.1 DNA substrates 
 The oligonucleotides (Operon) used for constructing DNA substrates were 5’-[32P]-
end-labelled and assembled into various structures (see Appendix 1, Table 2) by slow 
cooling from 85 °C to room temperature for a minimum of 3 hours to overnight. Substrates 
were purified on a native 8 % acrylamide:TBE gel, eluted overnight at 37 ˚C into buffer TE 
(10 mM Tris, pH 8.0, 1 mM EDTA) and ethanol precipitated. Constructs were resuspended 
in ultrapure water and stored at -20 ˚C. 
 
2.9.2 SsoXPF endonuclease assay 
 Endonuclease reactions were carried out in buffer containing 30 mM HEPES, pH 7.6, 
5 % glycerol, 40 mM KCl, 1 mM EDTA, 0.1 mg/mL BSA, 0.1 mg/mL calf thymus DNA 
and 80 nM DNA substrate. Samples were incubated at room temperature for 5 min with 1 
µM PCNA heterotrimer, before 1 µM XPF protein was added. The samples were incubated 
further for 2 min at 55 ˚C and each reaction was initiated by adding MgCl2 to a final 
concentration of 10 mM. Aliquotes of 5 µL were taken at selected time points and added to 
90 µL chilled stop solution (10 mM Tris, pH 8.0, 5 mM EDTA) to terminate the reaction. 
The DNA was ethanol precipitated and resuspended in formamide loading dye (95 % 
formamide, 0.25 % bromphenol blue, 0.1 % xylene cyanol). Samples were heated at 95 ˚C 
for 5 min and loaded onto a denaturating (7 M Urea) 12 % polyacrylamide gel and 
electrophoresed at 50 ˚C, 90 W for 30-45 min. Gels were exposed to phosphoscreen, 
imaged and quantified using Fuji Image Gauge software. 
 
2.9.3 SacXPD helicase assay 
 Helicase assays were carried out in 20 mM MES, pH 6.5, 1 mM DTT, 0.1 mg/mL 
BSA, 10 nM 32P labelled DNA-substrate and 200 nM protein. The reaction mix was 
incubated at 45 ˚C for 1 min and the reaction started with the addition of a 1:1 mix of 
MgCl2 and ATP to a final concentration of 1 mM (for reactions without ATP only 1 mM 
MgCl2 was added). At specific time points 10 µL samples were taken and immediately 
added to 20 µL of chilled stop solution (10 mM Tris-HCl, pH 8, 5 mM EDTA, 10 µM 
competitor DNA (unlabelled DNA oligo corresponding to DNA oligo that was labelled), 
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0.5 % SDS, 1 mg/mL proteinase K). The samples were incubated 15 min at room 
temperature to allow proteinase K digestion. The samples were mixed with 6 µL loading 
buffer (30 % ficoll, 0.25 % bromphenol blue, 0.1 % xylene cyanol) and 10 µL sample 
loaded onto a native 12 % acryl amide:TBE gel. Samples were electrophoresed for 2 hours 
at 130 V. Gels were exposed to phosphoscreen, imaged and quantified using Fuji Image 
Gauge software. 
 Control reaction contained the reaction mix without protein and 1 mM MgCl2:ATP. 
A 10 µL sample was immediately added to 20 µL stop solution. The dsDNA control was 
left at room temperature during the entire procedure. The ssDNA control was heat treated at 
95 ˚C for 2 min and cooled on ice. The third control, an indicator for the stability of the 
DNA substrate, was incubated at 45 ˚C for 5 min. 
 
2.9.4 Quantification and data processing of helicase assays 
 Single stranded (ss; unwound) and double stranded DNA (ds) fractions were 
quantified using Image Gauge software (Fuji). The DNA unwound (%) was calculated: (ss/ 
total) × 100 and plotted against the time (s) using KaleidaGraph software. 
 
2.10 STREPTAVIDIN DISPLACEMENT ASSAY 
 Assays were carried out either in buffer A (20 mM MES, pH 6.5, 1 mM DTT, 50 mM 
KCl) or buffer B (20 mM MES, pH 6.5, 1 mM DTT). If not otherwise stated, all 
concentrations are final concentrations. The reaction mix (buffer A or B, 0.1 mg/ mL BSA, 
1 µM Streptavidin, 10 nM 5’ 32P-labeled DNA substrate containing a biotin molecule on 
the 3’ end) was incubated at 55 ˚C for 3 min. 600 nM XPD protein was added followed by 
a further incubation for 3 min.  Reactions were initiated by addition of a mixture of 1 mM 
ATP or ADP, 1 mM MgCl2, 30 µM competitor DNA, and 10 µM biotin. Samples (5 µL) 
were taken at specific time points (1, 3, 5, 10 min) and transferred into 10 µL chilled EDTA 
(350 mM). Samples were mixed with 3 µL ficoll loading dye and 10 µL loaded onto a 12 % 
native acrylamide gel and run for 4 hours. [Byrd & Raney (2004)] 
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2.11 SACXPD ATPASE HYDROLYSIS REACTIONS 
2.11.1 Standard reactions 
 The Malachite Green Phosphate Assay Kit (BioAssay Systems) was used for 
detection of free phosphates after ATP hydrolysis. The standard curve was made with 
increasing concentrations of phosphate as described in the manufacture’s manual. Standard 
reactions contained 20 mM MES, pH 6.5, 1 mM DTT, 0.1 mg/mL BSA, 5 nM DNA 
(oligonucleotide) and 200 nM protein. When PhiX174 DNA was used, the concentration 
was lowered to 0.5 nM due to an increased number of available binding sites. Samples were 
preincubated at 45 ˚C for one minute. Reactions were started by adding a 1:1 mixture of 
MgCl2:ATP to a final concentration of 1 mM. At specific time points 40 µL samples were 
taken and immediately added to 40 µL chilled 0.3 M perchloric acid in a 96 well plate. 
Malachite green solution (20 µL) was added to each sample and incubated for 12 min at 
room temperature. Absorbance at 650 nm was measured using a plate reader (BIO-TEK®, 
PowerWave XS). 
 
2.11.2 Different lengths of oligonucleotides 
 The reactions were carried out as described above. Oligonucleotide concentrations 
were either adjusted to identical concentration of oligonucleotide (5 nM) or identical 
concentrations of nucleotides (2 µM). PhiX174 virion DNA (NEB) was used as a indefinite 
length DNA substrate (5 nM). The absorbances were read on a SpectraMAX 250 
Microplate Reader (Molecular Devices) after 12 min incubation at room temperature. The 
sequence of the oligonucleotides can be found in the appendix. 
 
2.12 DNA INTERACTIONS 
2.12.1 Electrophoretic Mobility Shift Assay for XPF (EMSA) 
 For DNA-binding studies, different concentrations of SsoXPF-HhH or SsoXPF-
D52A mutant protein were incubated in binding buffer (50 mM Tris, pH 7.5, 50 mM NaCl, 
1 mM EDTA, 0.1 mg/mL BSA, 10 nM DNA substrate and 20 µM PCNA if required) at 55 
˚C for 20 min. Reactions were cooled on ice, mixed with loading dye (6x : 60 mM Tris, pH 
7.6, 6 mM EDTA, 30 % glycerol, 0.03 % bromphenol blue, 0.03 % xylene cyanol), loaded 
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onto a 8 % native acrylamide:TBE gel and electrophoresed at 130 V for 2.5 hours. Control 
reactions were set up without protein. Gels were exposed to phosphoscreen, imaged and 
quantified using Fuji Image Gauge software. 
 
2.12.2 EMSA studies of XPD 
 For DNA binding studies of XPD, different concentrations of protein were incubated 
30 minutes at room temperature in binding buffer (20 mM HEPES, pH 7.6, 2 mM DTT, 50 
mM NaCl, 0.002 % Triton-X, 0.1 mg/ mL BSA) with 10 nM 32P-5’-radiolabelled DNA 
substrate (10 µL final volume). Reactions were mixed with 3 µL ficoll loading dye (30 % 
ficoll, 0.25 % bromphenol blue, 0.1 % xylene cyanol) and 10 µL sample immediately 
applied to a 6 % acrylamide:TBE gel and run for 2 hours at 130 V. Gels were exposed to 
phosphoscreen, imaged and quantified using Fuji Image Gauge software. 
 
2.12.3 Quantification and data processing of EMSA 
 Unbound DNA was quantified using Image Gauge software (Fuji). The fractions of 
bound DNA were calculated 1 – (unbound/ total) and plotted against the logarithm of the 
protein concentration (M) using KaleidaGraph software. The data points were fitted to the 
following equation: y = 1/ (1 + (m1/ m0)m2), where m1 is the apparent dissociation 
constant, m0 is the protein concentration (M) and m2 is a correction factor for deviations in 
the slope, which could arise from cooperativity.  
 
2.12.4 Analytical gel filtration (Superose 6) 
 Analytical gel chromatography was used to investigate if XPD binds DNA in form of 
a monomer or oligomer. For this a Superose 6 column (Amersham) was equilibrated in 
column buffer (50 mM Tris, pH 7.5, 50 mM KCl, 10 mM MgCl2, 5 mM DTT). Samples 
were incubated in column buffer and 200 µL injected onto the column and run at 0.5 mL/ 
min for 60 min. The absorbance at 280 nm was recorded.  
 First a standard curve was generated using the following proteins of known molecular 
weight: blue dextran (2000 kDa), beta-amylase (200 kDa), alcohol dehydrogenase (150 
kDa), albumin (66 kDa), carbonic anhydrase (29 kDa) and cytochrome c (12.4 kDa). The 
void volume (V0) of the column was determined by using blue dextran. The retention times 
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of the protein markers Beta-amylase/ cytochrome c, alcohol dehydrogenase/ carbonic 
anhydrase and albumin were recorded and elution volumes (Ve) calculated. The standard 
curve was obtained by plotting Ve/ V0 against the logarithm of the molecular weight of the 
proteins. The equation of the obtained standard curve was as follows: y = 6.3839 – 2.0157x 
(R = 0.98344). 
 All samples were prepared in column buffer and 50 µM ATPγS and incubated at 
room temperature for 30 minutes before they were applied to the Superose 6 column. The 
protein concentration was 25 µM and DNA concentrations were at 10 and 30 µM. A 5 nt 
and a 14 nt dT oligonucleotide, respectively, was used. The following samples were set up 
and analysed by gel filtration: (1) XPD, (2) 10 µM DNA (dT5 or dT14), (3) XPD + 10 µM 
DNA (dT5 or dT14) and (4) XPD + 30 µM DNA (dT5 or dT14). Retention times were 
recorded, Ve and the resulting molecular masses were calculated from the standard 
equation. 
 
2.12.5 Isothermal Titration Calorimetry (ITC) 
  For ITC experiments a MicroCalTM VP-ITC micro calorimeter was used (for further 
information see: http://www.microcal.com). XPD protein and ssDNA oligonucleotides (6 
nt, 14 nt, 20 nt dT) were dialysed overnight at 4 ˚C into ITC-buffer (20 mM sodium 
phosphate buffer, pH 7.4, 100 mM NaCl, 10 % glycerol). Protein and oligonucleotide 
concentrations were determined by measuring the absorbance at 280 and 260 nm, 
respectively. The reaction temperature was set to 25 ˚C (no binding was observed at higher 
temperatures tested, e.g. 45 ˚C and 50 ˚C) and all solutions were degassed for 15 minutes 
prior to use (ThermoVac, MicroCalTM). The reference power was set to 10 and the spacing 
between injections to 180 s. The syringe contained the ligand (ssDNA: dT6: 97.6 µM; 
dT14: 99.1 µM; dT20: 100.9 µM), which was injected into the protein solution (10.6 µM). 
The initial injection of 2 µL (within 4 s) was followed by 28 injections of 10 µL (duration: 
20 s). Control reactions were performed (titration of ligand into buffer) and subtracted from 
the integrated binding data.  
 In preliminary experiments the heat of dilution of the control reactions were too high 
and caused the binding curve to change from an exothermal to an endothermal reaction. 
Since it was not certain if this effect is real, a baseline was estimated of -1600 cal mole-1 
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(20 nt dT) and -1500 cal mole-1 (14 nt dT), respectively and subtracted from the original 
integrated binding data. The data were fitted to a one site of binding model using 
MicroCalTM ORIGIN software, because it was expected that XPD binds to DNA in a 1:1 
ratio.  
 
 
3 PURIFICATION AND 
CHARACTERISATION OF XPD FROM                                
SULFOLOBUS ACIDOCALDARIUS 
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3.1 INTRODUCTION 
 Human XPD (hXPD) is a 5’3’ helicase (Weber et al. (1988)) and it is part of the 
basal Transcription Factor II H (TFIIH) complex, which consists of 10 subunits 
(Schaeffer et al. (1993); Ranish et al. (2004); Giglia-Mari et al. (2004)). As part of the 
TFIIH core, hXPD is the major helicase in Nucleotide Excision Repair. As part of the 
TFIIH holocomplex it forms a structural bridge between the TFIIH core and the CAK 
subcomplex and participates in transcription initiation from RNA polymerase II (RNPII) 
promoters (Reardon et al. (1996); Coin et al. (1998)). 
 The functional homologue of XPD in bacteria is UvrB; extensive research has been 
carried out on this enzyme. UvrB binds to UvrA and the complex moves along the DNA, 
scanning for lesions by base pair flipping. Once damage is identified, UvrA is exchanged 
for UvrC, which performs a dual incision. Hence, in bacteria UvrB is thought to be the 
damage recognition factor (reviewed in van Houten et al. (2005)). 
 Because of its many complex interactions and regulations, which are still not fully 
understood, characterisation of XPD in eukarya remains difficult. At the initiation of this 
PhD project, nothing was known about XPD in archaea. Whole genome sequencing and 
sequence homologies made it possible to identify XPD in the hyperthermophilic 
crenarchaea Sulfolobus solfataricus and S. acidocaldarius. 
 This chapter deals with the initial characterisation of wildtype XPD from S. 
acidocaldarius (SacXPD). General structural and enzymatic features are described. The 
characterisation of the iron-sulphur (FeS) cluster is supported by some general and 
technical explanations. If not otherwise stated, XPD refers to SacXPD. 
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3.2 EXPRESSION AND PURIFICATION OF WILDTYPE SULFOLOBUS 
ACIDOCALDARIUS XPD 
 The gene encoding S. acidocaldarius XPD (Saci_0192) was PCR amplified from 
genomic DNA and cloned into the pET28c vector to produce untagged recombinant 
protein. The gene was fully sequenced to confirm it was free of base pair alterations and 
accurately cloned. Protein was expressed in Escherichia coli and purified using a heat 
step method to remove the majority of E. coli proteins, followed by a two-step 
purification scheme, consisting of affinity (heparin sepharose) and size exclusion 
chromatography. The whole protein mass was determined and confirmed by mass 
spectrometry.  
 Protein was recovered at 5-10 mg/ L culture after heparin sepharose and size 
exclusion chromatography (Figure 3.1A and B). As seen from the SDS-PAGE in Figure 
3.1C, only a small fraction of the total expressed protein was purified. This was a general 
observation with all XPD proteins and one possible explanation is that most of the protein 
denatures during sonication, thus not binding the heparin column. XPD eluted with a 
calculated mass of 49 kDa from the gel filtration column, which was smaller than the 
expected mass of around 64 kDa (Figure 3.1D). It indicated that SacXPD is a monomer in 
solution and tight folding of the protein may cause the observed mass differences. Mass 
spectrometry analysis gave a molecular weight of 63,842 Da which is in good agreement 
with the expected mass of 63,837 Da (Figure 3.2). 
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Figure 3.1: Purification of wildtype SacXPD 
Elution chromatograms from (A) heparin and (B) gel filtration columns. (C) SDS-PAGE 
showing the purification steps. From left to right: E. coli cell lysate before (1) and after 
heat treatment at 65 ˚C (2), flow through after heparin column (3), pooled fractions 
containing SacXPD after heparin column (4) and gel filtration column (5). Marker (M): 
Mark12 Standard Marker (Invitrogen). (D) Calculation of the molecular mass of XPD 
from the elution volume (201.5 mL) after gel filtration.  
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Figure 3.2: Whole mass determination of wildtype XPD by LCT mass spectrometry 
The molecular mass of wildtype XPD was determined to confirm an intact full-length 
protein and the absence of amino acid modifications. The major peak was calculated to a 
molecular mass of 63842 Da, which was in good agreement with the theoretical mass of 
63837 Da. 
 
3.3 IRON-SULPHUR CLUSTER CHARACTERISATION 
 The protein solution of purified XPD exhibited a brown/ yellowish colour, 
suggesting the presence of a bound cofactor (Figure 3.3A). UV/ visible 
spectrophotometry revealed a broad shoulder between 500 and 300 nm (Figure 3.3B), 
which was found to be characteristic for Iron-Sulphur (FeS) cluster proteins (e.g. Eady et 
al. (1988); Coldren et al. (1997); Wollenberg et al. (2003)). The absorbance in this region 
increased after addition of ferricyanide (an oxidant). On the other hand, no change was 
observed upon addition of the reductant dithionite (DT), implying that the cluster 
naturally exists in the reduced form. 
 The nature of the FeS cluster bound to XPD was investigated using three different 
methods: Electron Paramagnetic Resonance  (EPR) spectroscopy, Inductively Coupled 
CHAPTER 3: CHARACTERISATION OF WILDTYPE XPD 
 52 
Plasma – Optical Emission Spectroscopy (ICP-OES) and the bathophenanthroline (BA) 
method.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: Colour and UV/ visible spectra of wildtype XPD 
(A) Preparation of purified XPD (~150 µM). (B) UV/ vis spectra. The red line in the inset 
represents the slight absorbance increase, which was observed after oxidant (ferricyanide) 
treatment on the shoulder at around 400 nm. 
 
3.3.1 Introduction to EPR 
 Apart from mass and charge, a fundamental property of an electron is its angular 
momentum (spin). Electrons are spin 1/2 particles and the resulting spin angular 
momentum (S) may be clockwise (+1/2) or anticlockwise (-1/2). The angular momentum 
together with the charge of the electron induces a magnetic dipole (µ) which makes it act 
like a small bar magnet (Figure 3.4A). If a strong external magnetic field (B0) is applied, 
µ forces the electrons to align either parallel or antiparallel to the B0 (Figure 3.4B). This 
splits the energy of the ground level in a state of lowest (parallel) and highest 
(antiparallel) energy depending on the electron spin quantum number mS (as described 
above) with mS = -1/2 (lowest energy level) and mS = +1/2 (highest energy level). EPR 
measures the energy differences (ΔE) between these two energy states (Figure 3.4C).  
 
 
0
0.5
1
1.5
2
2.5
250 300 350 400 450 500 550 600
A
b
s
o
rb
a
n
c
e
Wavelength (nm)
XPD(ox) 
A B 
CHAPTER 3: CHARACTERISATION OF WILDTYPE XPD 
 53 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: The basics behind an EPR experiment: electrons, spins and energy levels 
(A) A free, unpaired electron in space shows a specific spin angular momentum (S) 
which induces, due to the charge of the electron, a magnetic moment µ. (B) If a strong 
external magnetic field is applied (B0) the unpaired electrons are forced to align either 
parallel or antiparallel to it, inducing a state of lowest (ms = -1/2) or highest (ms = +1/2) 
energy for the electrons. (C) EPR measures the energy differences (ΔE) between both 
energy levels. 
 
 More complex interactions can occur, because electrons do not exist free in space 
but form part of atoms and molecules. One of these interactions is called the orbital 
angular momentum L and describes the movement of the electron around the nucleus 
along three principle axes x, y and z. The probability distribution of an electron is called 
its orbital. An orbital is occupied by a maximum of two electrons with opposite spins. 
When electron spins are paired, the resulting net spin is zero and energy absorption does 
not occur during an EPR experiment, which is called “EPR silent”. Hence, for a 
successful EPR experiment it is necessary that a sample contains unpaired electrons. 
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Figure 3.5: Example of how an EPR signal is obtained 
The energy levels of the ground state of the unpaired electrons are split by the amount of 
ΔE, which is a function of the external magnetic field. As the external magnetic field 
strength is increased, the separation of the energy levels increases. Absorption occurs 
when the energy separation of the excited states equals that of the impinging microwave 
photon. The amplitude of the signal is transformed into its first derivative. 
 
 The energy difference between the excited states of an electron can be calculated 
from: ΔE = hν = gµBB0 (h, Planck constant; g, spectroscopic factor; ν, frequency of 
radiation (Ghz); µB, Bohr magneton; B0, magnetic field (Gauss)) An EPR spectrum is 
obtained by sweeping the magnetic field at constant microwave frequency (it is 
technically more difficult to vary the latter in a broad range). Irradiation of the EPR 
sample with microwave frequencies generates a microwave photon. When ΔE equals the 
energy of the impinging microwave photon, energy absorption occurs and an EPR signal 
is generated (Figure 3.5).  
 The spectroscopic factor g of a free electron equals ~ 2.00, while deviations from 
this number usually arise due to spin-orbit coupling between the ground state and the 
excited states of an electron and the specific orientation of the orbital (anisotropy). 
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Therefore, the spectroscopic factor measures along the three principle axes of a molecule, 
resulting in g-factors labelled as gx, gy and gz (Figure 3.6).  
 
 
 
 
 
 
 
 
Figure 3.6: Example of a transition metal coordinated by ligands in the three 
principle axes relative to B0 
The transition metal is coordinated by two equal ligands in z-direction and by two 
different but equal ligands in either x and y direction (gz > gy = gx). The resulting g-factor 
differs depending on whether B0 is parallel to the z-axis or the x and y-axes. 
 
 The temperature at which an EPR experiment is carried out is an additional 
variable. It can vary from high temperature gas phase to cryogenic temperatures. At 
which temperature EPR measurements are made, depends on the relaxation time of the 
species under observation. Transition metals for example have very high relaxation rates, 
hence the EPR experiment has to be carried out at very low temperatures to slow 
relaxation times. This generates a spectrum that is called a powder spectrum, because in a 
frozen solution the orientation of the unpaired electron along x, y and z relative to B0 is 
randomised (anisotrop). Examples of anisotropy are given in Figure 3.7.  
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Figure 3.7: Absorption and first derivative of three different classes of anisotropy 
For the first class of anisotropy gx=gy=gz all principle g-factors are the same (isotropy). 
The second class is called axial, meaning that one axis differs from the other two. In the 
third class (rhombic) all three g-factors differ from one another (image adapted from: 
http://www.auburn.edu/~duinedu/5%20samples.pdf.). 
 
 
 If two unpaired electrons from different ions or molecules are close enough 
together, they can exchange-couple, resulting in a net spin S = 0. This is the case for the 
iron ions in FeS clusters. A FeS cluster is a mixture of ferrous (Fe2+, reduced form, six 
electrons in the outer shell, S = 2) and ferric (Fe3+, oxidised form, five electrons in the 
outer shell, S = 5/2) iron. Depending on the number of irons present in a cluster, their 
oxidation states, electron coupling and coordinating ligands, specific signals are observed 
in an EPR experiment (Figure 3.8). In general, FeS clusters exist in two different 
oxidation states, whereas one of the oxidation states is always EPR silent due to spin-
coupling. For characterisation of the cluster, the g-values are important as they have 
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specific values for a specific type of FeS cluster. These values are calculated by the 
following equation (as shown above): hν = ΔE = gµBB0, where B0 and ν can be measured 
(h and µB are constants) resulting in g = 714.484 ν/ B0. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Examples of EPR signals of different types of FeS clusters 
Typical EPR signals obtained for different FeS clusters of ferredoxins from 
Mastigocladus laminosus (A), Desulfovibrio gigans (B), Bacillus stearothermophilus (C), 
Chromatium vinosum high potential FeS cluster (D) and Clostridium pasteurianum  8 Fe 
ferredoxin (E).  
(image adapted from: http://www.auburn.edu/~duinedu/5%20samples.pdf.) 
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3.3.2 EPR of XPD 
 EPR spectroscopy experiments on XPD only gave a signal for the oxidised form of 
the FeS cluster (Figure 3.9). There are two possible forms of FeS clusters which give 
EPR signals in the oxidised form: [3Fe-4S]1+ and high potential iron protein type (HiPIP) 
[4Fe-4S]3+ clusters (reviewed in: Beinert et al. (1997)). The shape of the signal and g-
values of both oxidised forms differ (Figure 3.8). For XPD, the signal and g-values (2.02 
and 1.99) indicated the presence of a [3Fe-4S] cluster bound to XPD. Obtaining an EPR 
spectrum turned out to be rather difficult and the EPR signal was very weak. The cluster 
is likely to be deeply buried within the enzyme and oxidation becomes difficult, as 
oxidising agents only have limited access to the FeS cluster. This was also found to be the 
case for other FeS cluster proteins and represents a natural protection mechanism. FeS 
clusters are sensitive to oxidising conditions and oxidation most likely leads to 
destruction. As these metallo-clusters fulfil important structural and catalytic roles as part 
of an enzyme, damage has to be avoided (reviewed in Imlay (2006)). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9: EPR Spectrum of oxidant treated XPD 
The shape of the EPR signal is typical of a [3Fe-4S]1+ cluster. The g-values were 
calculated as 2.02 and 1.99. The second peak which is not labelled with a g-value may be 
generated by a free radical. 
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3.3.3 ICP-OES 
 ICP-OES uses ionized argon gas. Temperatures of the created argon plasma reach 
approximately 10000 Kelvin. The sample is injected as an aerosol directly into the centre 
of the plasma where it completely atomises. The resulting emissions are detected and 
compared to standards of known concentrations (Figure 3.10). To calculate the iron to 
sulphur ratio of a protein, all bound iron (usually only the ones which are part of the FeS 
cluster) and all bound sulphurs (inorganic sulphurs as part of the cluster, as well as 
sulphurs incorporated in cysteines and methionines) have to be included. Expected ratios 
are calculated and compared to ratios obtained experimentally. [From: PerkinElmer: 
Guide to Inorganic Analysis] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Schematic diagram of the mode of operation of an ICP-OES instrument 
The sample is atomised in the argon plasma and the emitted light is directed and split 
through a mirror systems until it arrives at the detector where the emission spectrum is 
recorded (image adapted from: http://marine.rutgers.edu/LAICPMSintro/ICP-
OES%20mainframe.htm.htm) 
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 XPD contains 18 sulphurs bound to methionines or cysteines and four inorganic 
sulphurs as part of the FeS cluster. The expected Fe:S ratio for an 4Fe-4S cluster was 
calculated to be 0.182 and for a 3Fe-4S cluster 0.136.  ICP-OES yielded an iron to 
sulphur ratio for XPD of 0.133, consistent with the value of 0.136 expected for a 3Fe-4S 
cluster. 
 
3.3.4 The bathophenanthroline-method 
 BA (4,7-diphenyl-1,10-phenanthroline) is a Fe2+ chelator and forms a red complex 
with ferrous iron in solution. Iron becomes easily oxidised and a strong reductant (e.g. 
ascorbic acid) is used to bring all iron ions in the reduced form before BA is added. BA is 
one the most sensitive agents for the detection of ferrous iron and it forms a [FeII (BA)3]2+ 
complex similar to the ruthenium-BA complex shown in Figure 3.11. 
 
 
 
 
 
 
 
 
 
Figure 3.11: Bathophenanthroline -ruthenium complex 
Fe2+ and Ru2+ are bound in the same way by BA. The ion is coordinated by three 
molecules of BA through their nitrogen atoms. 
 
 The number of irons bound to one molecule of XPD were determined by 
measuring the absorbance of the sample at 535 nm and calculated using the molar 
extinction coefficient of 22369 M-1 cm-1 (Pieroni et al. (2001)) as described in Materials 
and Methods.  
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Table 3.1: Calculation of the number of irons bound to XPD from absorbance 
readings using the bathophenanthroline method 
Protein Abs535_1 Abs535_2 Abs535_3 Average Total Fe 
(pmol) 
Fe/ XPD 
WT-XPD 0.1412 0.1380 0.1655 0.1482 16364 3.27 
 
 The volume taken for analysis after protein denaturation was 100 µL out of the total 
volume of 130 µL (100 µL protein solution + 30 µL concentrated HCl). The volume of 
the final reaction was 1.9 mL. Therefore, the total number of irons (pmol) in the sample 
was determined with: (Average absorbance/ 0.022369 µM-1) x 1900 µL x 1.3 (Table 3.1). 
Initially, 5000 pmol XPD protein (100 µL of a 50 µM sample) was used. Hence, the 
number of irons per molecule XPD equals 16364 pmol Fe/ 5000 pmol XPD, which leads 
to a ratio of approximately 3 Fe per XPD (Table 3.1).  
 
3.3.5 Location of the FeS cluster domain. 
 Iron-sulphur clusters are mainly coordinated by cysteine residues due to the high 
affinity of iron for thiolate groups. The iron atoms are bridged by sulphide ions and thus a 
cluster is built. The main types of clusters found in nature are [2Fe-2S]2+/1+, [3Fe-4S]1+/0, 
[4Fe-4S] 2+/1+ or [4Fe-4S] 3+/2+ (reviewed in Imlay (2006)). 
 Sequence alignments of XPD with other archaeal XPD sequences as well as related 
human helicases, revealed four conserved cysteine residues near the N-terminus of the 
protein between Walker A and B boxes (Figure 3.12), which could be involved in the 
coordination of the FeS cluster (Rudolf et al. (2006)). These cysteines were also 
conserved in hXPD raising the possibility that hXPD contains an unrecognised FeS 
cluster. 
 Related human helicases other than XPD include FancJ, RTel1 and Chl1. The 
FancJ helicase takes part in the Fanconi anemia DNA repair pathway, which was 
introduced in Chapter 1. The RTel1 helicase is one of the helicases involved in regulation 
of telomere maintenance. Lack of RTel1 led to genomic instability and embryonic 
lethality in mice (Ding et al. (2004)). It is thought that RTel1 resolves secondary 
structures in telomeric repeats and hence prevents illegitimate recombination between 
telomeric DNA and between other intrachromosomal sequence repeats during 
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recombination induced by attempted DNA repair. The Chl1 helicase shows high 
sequence similarity to FancJ and XPD/ Rad3p (Amann et al. (1997)). In yeast it is 
involved in sister-chromatid cohesion and segregation. Although not essential for 
viability, yeast Chl1 null mutants show increased rates of chromatid missegregation with 
chromosome loss and non-disjuctions (Gerring et al. (1990)). Therefore, Chl1 may be 
involved in avoiding illegitimate recombination events (like RTel1) during sister-
chromatid cohesion (Skibbens (2004)).  
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              (RT)                                                                              FPSYE        QAIGRAIR 
   GSGKT                        DEAH                                SGT                   GKLAEG 
 
 
 
Sac    75  NITFSFLVGKPSSCLYAEKGAESE-----DIPCK-------------------------- 
Pfu    87  EVSGIEFRSRRDLCLHSYIQTFVQDAYTSMIVCK--------------------TLRKLG 
hXPD  103  PFLGLALSSRKNLCIHPEVTPLRFG-KDVDGKCHSLTASYVRAQYQHD-----TSL---P 
Rad3  102  DFRGLGLTSRKNLCLHPEVSKERKG-TVVDEKCRRMTNGQAKRKLEED---PEANV---E 
FancJ 270  GVPMTILSSRDHTCVHPEVVGNFNR----NEKCMELLD-----------------GKNGK 
RTel1 136  ----CVLGSREQLCIHPEVKKQESNHLQI-HLCRKKVAS--------------------R 
Chl1  254  DVRLVSLGSRQNLCVNEDVKSLGSV-QLINDRCVDMQRSRHEKKKGAEEEKPKRRRQEKQ 
 
 
Sac   104  -YCELKGSIVEVKTDDS-------------PLSLVK-KLKKDGLQDKFCPYYSLLNSLYK 
Pfu   127  -KCPFFENIKEKRDRVEEIVRFFLNSPPFPHEVLEYSELLE------LCPYEITKKIGEK 
hXPD  154  -HCRFYEEFDAHGREVP----------LPAGIYNLD-DLKALGRRQGWCPYFLARYSILH 
Rad3  155  -LCEYHENLYNIEVEDY----------LPKGVFSFE-KLLKYCEEKTLCPYFIVRRMISL 
FancJ 309  -SCYFYHGVHKISDQHTLQTFQGMC-----KAWDIE-ELVSLGKKLKACPYYTARELIQD 
RTel1 171  -SCHFYNNVEEKSLEQE----------LASPILDIE-DLVKSGSKHRVCPYYLSRNLKQQ 
Chl1  313  AACPFYNHEQMGLLRDE----------ALAEVKDME-QLLALGKEARACPYYGSRLAIPA 
 
                                           motif II 
Sac   149  ADVIALTYPYFFIDRYREFI----DIDL-REYMIVIDEAHN 
Pfu   180  ANVIVASYLYMISPPIRQAFLENLGVDY-SDLIVIFDEAHN 
hXPD  202  ANVVVYSYHYLLDPKIADLV----SKELARKAVVVFDEAHN 
Rad3  203  CNIIIYSYHYLLDPKIAERV----SNEVSKDSIVIFDEAHN 
FancJ 362  ADIIFCPYNYLLDAQIRESM----DLNL-KEQVVILDEAHN 
RTel1 219  ADIIFMPYNYLLDAKSRRAH----NIDL-KGTVVIFDEAHN 
Chl1  362  AQLVVLPYQMLLHAATRQAA----GIRL-QDQVVIIDEAHN 
 
Figure 3.12: Location of the FeS cluster domain in XPD and other related human 
helicases 
(A) The location of the FeS cluster domain relative to the conserved helicase motifs of 
SacXPD is illustrated. The seven conserved motifs are shown in green and the location of 
the FeS cluster domain is presented in brown. The core amino acid sequence of the 
helicase motifs of S. acidocaldarius XPD is shown across the top of the figure, strictly 
conserved residues within archaeal and eukaryal XPD proteins are shown in bold. (B) A 
sequence alignment of the FeS cluster domain of archaeal and eukaryal XPD and other 
related human helicases is shown. The FeS cluster domain is conserved within XPD 
proteins from different archaea and eukarya, including human XPD. The conserved 
cysteine residues, which could be involved in FeS cluster coordination are highlighted in 
yellow; similar amino acid residues are in grey and absolutely conserved residues are 
highlighted in black. Sac, S. acidocaldarius XPD; Pfu, P. furiosus XPD; hXPD, human 
XPD; Rad3, S. cerevisiae XPD homologue Rad3; FancJ, human FancJ; RTel1, human 
RTel1; Chl1, human Chl1. 
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3.4 IRON-SULPHUR CLUSTER RECONSTITUTION 
 As described in section 3.3, XPD contains a [3Fe-4S]0 cluster. It was also 
mentioned that FeS clusters are sensitive to oxidising agents. Reconstitution of the FeS 
cluster was carried out because the enzyme was purified under aerobic conditions. This 
could lead to the loss of one iron during the purification process (Tilley et al. (2001)). 
However, it does not necessarily imply a loss of activity. Several enzymes were shown to 
be active in the 3Fe and the 4Fe form, including E. coli MutY and ribonucleotide 
reductase and the F420-reducing hydrogenase from Methanococcus voltae (Mulliez et al. 
(1999); Bingemann & Klein (2000); Lu & Wright (2003)) 
 The reconstitution was carried out under semi-anaerobic conditions and the method 
is described in Chapter 2. Simply, reduced iron in the form of (Fe(II)(NH4)2(SO4)2) was 
added to the protein solution and the reconstitution progress was followed by measuring 
the absorbance between 600 and 300 nm. The iron quantification was carried out by using 
the bathophenanthroline method. A control was made containing buffer and 1.7 mM 
Fe(II)(NH4)2(SO4)2. This solution was applied to a G50-microspin column and the flow 
through analyzed for remaining iron. The absorbance measurement of the control was 
subtracted from the absorbance of the sample containing the protein with the 
reconstituted cluster. The final results were compared to a sample containing protein with 
a non-reconstituted FeS cluster. Even though this method is not very accurate and it has a 
high error rate, the results indicated, that XPD has a 3Fe-4S cluster bound, because both 
the unreconstituted and the reconstituted cluster revealed 3 moles of iron per one mole of 
protein (Table 3.2). 
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Table 3.2: Determination of iron bound to XPD before and after FeS cluster 
reconstitution 
 Control+Fe unreconstituted reconstituted 
A (535 nm) 0.0513 0.1290 0.1916 
 0.0857 0.1225 0.1722 
 0.0461 0.1246 0.1835 
Average absorbance 0.061 0.1254 0.1824 
Average minus (control + Fe) - - 0.1214 
Total Fe (pmol) - 14075.25 13630 
Fe/ XPD  - 2.82 2.73 
Table 3.2 shows data of triplicate absorbance readings (A (535nm)). The iron concentration 
was determined using the bathophenanthroline method. The control sample contained 
buffer and 1.7 mM Fe(II)(NH4)2(SO4)2 (Control+Fe). The unreconstituted sample 
contained XPD protein only while the reconstituted sample contained XPD and 1.7 mM 
Fe(II)(NH4)2(SO4)2. Before the iron content was determined, all samples were purified 
using a G50 microspin column followed by NaCl addition to a final concentration of 200 
mM. The total amount of irons in the sample and the number of irons bound to the XPD 
protein was calculated as described in section 3.3.4. 
 
3.5 CHARACTERISATION OF WILDTYPE HELICASE ACTIVITY 
3.5.1 Polarity and ATP-dependence  
 Most helicases unwind nucleic acids unidirectional, either 5’3’ or 3’5’. Two 
different DNA substrates were made to investigate the directionality of XPD: a 5’-
overhang and a 3’-overhang DNA substrate (Figure 3.13A). XPD can load either on the 
5’ or 3’ single stranded region to unwind the double stranded part in the opposite 
direction. If XPD is a 5’3’ helicase, unwinding should be observed with the 5’-
overhang DNA substrate, while a 3’5’ helicase would displace the strand of the 3’-
overhang. Helicase activity for XPD from S. acidocaldarius was only detected by using a 
5’-overhang DNA substrate (Figure 3.13B), confirming a 5’3’ directionality consistent 
with findings for hXPD (Weber et al. (1988)). 
 The energy for the motion of a helicase is provided by hydrolysis of NTP and the 
majority of helicases utilize ATP (Levin & Patel (2003)). The ATP dependence of XPD 
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for DNA unwinding was tested by performing reactions with and without ATP and 
detecting appearance of the 32P-radiolabelled single DNA strand. For this, and all 
following experiments, a 5’-overhang DNA substrate was used. As seen in Figure 3.13B 
strand displacement was only observed in the presence of ATP. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Helicase activity of wildtype XPD: Polarity and ATP dependence 
(A) 3’-overhang (left) and 5’-overhang (right) DNA substrates. The protein binds to the 
single stranded region and displacement of the 25 nt oligonucleotide, which is 32P-5’-
labelled, is expected for only one of the two substrates, depending on the polarity of 
XPD. (B) 12 % native acrylamide gels showing a time course (30, 60, 90, 120, 180 and 
300 s) of XPD unwinding activity. The amount of dsDNA (upper lane) is expected to 
decrease from left to right, while the amount of ssDNA (lower lane) should increase, if 
helicase activity takes place.  
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3.5.2 Influence of protein concentration on XPD helicase activity 
 The influence of the protein concentration (200, 100, 50, 25, 10 and 5 nM) at 
constant DNA concentrations (10 nM) on the helicase activity of XPD was investigated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14: Helicase activity of wildtype XPD: Influence of varying protein 
concentrations 
Representative 12 % native acrylamide gels showing time courses of DNA unwinding 
experiments with different concentrations of XPD (left). Time points were: 10, 30, 60, 
120 s (200 and 100 nM protein) and 2, 5, 10, 20 min (50, 25, 10, 5 nM protein). The 
quantification results from a single experiment are shown in graphical format on the 
right. Data points were connected by lines. 
 
 Sufficient helicase activity under the applied conditions was only observed with at 
least 10-fold excess of protein over DNA substrate (Figure 3.14). Limited activity was 
measured at protein concentrations of 50 and 25 nM, but no activity was seen at 10 and 5 
nM XPD. For all further experiments 200 nM protein was used. These observations could 
suggest a limited affinity of XPD for the DNA, with dissociation constants of around 100 
nM. On the other hand, it could also imply a positive cooperativity for the mechanism of 
action for XPD, as was described for the Dda helicase from bacteriophage T4 (Byrd & 
Raney (2004)). 
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3.5.3 Influence of the Temperature 
 Enzymatic reactions, as all reactions occurring in nature, are temperature 
dependent. XPD is an enzyme from a hyperthermophilic organism and one would expect 
the rate of DNA unwinding to increase with increasing temperature. Experiments with 
enzymes from Sulfolobus were usually carried out in our laboratory at 55 ˚C. However, 
the DNA unwinding activity of XPD was too fast at 55 ˚C to be able to compare different 
conditions in an appropriate way. Therefore, a slightly lower temperature, where XPD 
shows adequate helicase activity was sought.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15: Helicase activity of wildtype XPD: temperature dependence 
Representative 12 % native acrylamide gels are shown (left). Time points for the upper 
gel are: 30, 60, 90, 120, 180, 300 s; lower gel: 10, 30, 50, 70, 90, 120 s. The graph (right) 
shows quantification results of three experiments with indicated standard errors. Data 
points were fitted to a smooth curve. Black, 40 ˚C; red, 45 ˚C; green, 50 ˚C; orange, 55 
˚C.  
 
 As expected, XPD showed temperature dependence. There was not much difference 
in helicase activities between 40 ˚C and 45 ˚C, as well as between 50 ˚C and 55 ˚C 
(Figure 3.15). All subsequent experiments were carried out at 45 ˚C, because sufficient 
and reliable enzyme activity was obtained at this temperature. 
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3.5.4 Influence of NTP/ Me2+ on the helicase activity of XPD 
 As mentioned before, helicases are fueled by the energy derived from NTP 
hydrolysis. The NTP forms a 1:1 complex with a divalent metal ion. The helicase uses 
this metal ion to activate water to split the β-γ-phosphoanhydride bond of the NTP.  
 The effect of different concentrations of NTPs and divalent metal ions on the 
helicase activity of XPD was tested. Reactions were initiated by adding the following 
concentrations of NTPs or divalent cations: ATP or GTP and MgCl2 in equivalent 
concentrations of 5, 2, 1, 0.5 and 0.1 mM and MgCl2, MnCl2, CaCl2 at 1 and 2 mM with 
1 mM ATP. Control reactions contained 1 mM MgCl2 and 1 mM ATP only, respectively. 
Reactions were incubated 3 min at 45 ˚C. 
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Figure 3.16: Helicase activity of XPD with different concentrations of NTPs and 
Me2+ 
The top figures are examples of native 12 % acrylamide gels showing XPD helicase 
activity under various conditions as shown across the top. ds, double stranded DNA 
substrate; ss, 5’-32P radiolabelled single stranded DNA appearing after DNA substrate 
unwinding. The bottom figures are the quantifications of duplicate experiments 
(corresponding to the gels above) showing percentage DNA unwound; standard errors are 
indicated. ATP or GTP/ MgCl2 concentrations are: 5, 2, 1, 0.5, 0.1 mM.  
 
 XPD utilizes mainly ATP for its enzymatic activity (Figure 3.16). The highest 
activity was observed with 0.5 mM ATP, which matches results obtained for the ATPase 
activity (see Chapter 4). It seems that XPD can also utilize GTP at high concentrations, 
since the helicase activity increases with increasing concentrations of GTP.  
 Generally, most helicases and NTPases are able to use both Mg2+ and Mn2+ ions. 
From the quantification data (Figure 3.16) it seems that manganese is preferred over 
magnesium ions, a property mainly found for viral (RNA-dependent) NTPases/ helicases 
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(Warrener & Collett (1995), Borowski et al (1999)). The difference, however, was not 
significant. Ca2+ was used as well, but led to a much lower enzymatic activity.  
 
3.5.5 Influence of buffer conditions on the helicase activity of XPD 
 The influence of different salt concentrations on the DNA unwinding activity of 
XPD was tested by using reaction buffer (20 mM MES, 1 mM DTT) and different 
concentrations of KCl or NaCl (150, 100, 75, 50 and 25 mM final concentrations). 
Furthermore, the effect of different pH-values was investigated by using 20 mM of the 
following buffer solutions (including 1 mM DTT): MES, pH 6.0 and 6.5; Tris, pH 7.0, 
7.5 and 8.0. Reactions were incubated for 5 min at 45 ˚C. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17: Helicase activity of WT-XPD under different buffer conditions 
The figure on the left shows a representative 12 % native acrylamide gel of helicase 
activity under different salt and pH conditions (from left to right). The respective 
quantification data are shown on the right. Experiments were carried out in duplicate and 
standard errors are indicated. 
 
 As illustrated in Figure 3.17 the preferred buffer conditions were: no salt and pH 7-
7.5. In general, the enzyme activity did not vary much in different buffers. Salt 
concentrations above 100 mM and pH > 7.5 lead to a decrease in activity, probably 
through weakening the DNA interaction (ionic interactions). 
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3.5.6 Influence of oxidising and reducing conditions 
 XPD is a FeS cluster protein (3.3). These metallo clusters are sensitive to oxidizing 
and reducing agents. The influence of the oxidant potassium ferricyanide (K3Fe(CN)6) 
and the reductant dithiothreitol (DTT) was tested (Figure 3.18). Stock solutions were 
stored at -20 ˚C (DTT) or 4 ˚C (K3Fe(CN)6) and freshly added to the reactions.  
 
 
 
 
 
 
 
 
 
 
Figure 3.18: Helicase activity of wildtype XPD: Influence of reducing and oxidising 
agents 
A representative 12 % acrylamide gel of the helicase experiments is shown on the left. 
Concentrations were: 1, 0.5, 0.2, 0.1, 0.05, 0.01 mM ferricyanide and 10, 5, 2, 1, 0.5, 0.1 
mM DTT. The control reaction (N) contained neither of them. Quantification results are 
shown on the right. Experiments were carried out in duplicate and standard errors are 
indicated.  
 
 Reducing conditions did not have an influence on the enzyme activity, while 
oxidant-treatment showed a dramatic effect (Figure 3.18). Most likely protein 
precipitation upon oxidant treatment can be excluded as an explanation for enzyme 
inactivation, because EPR experiments were set up using 1 mM ferricyanide and no 
cluster destruction or protein precipitation was observed. Although, it is possible that the 
enzyme has a more compact structure at room temperature (setup for EPR) than at 45 ˚C 
(setup for helicase assays), which could limit the access of oxidant at lower temperatures. 
It could also account for the difficulties we had in obtaining EPR spectra for the oxidised 
form of the FeS cluster. Another possible reason for the observed enzyme inactivation 
upon oxidant treatment is that cyclic conformational changes in XPD induced by binding 
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to DNA and/ or ATP, lead to solvent exposure of the FeS cluster. Usually, as it was 
hypothesized for the glycosylases of the MutY/ EndoIII family (Boal et al. (2005)), FeS 
clusters are deeply buried within the enzymes. Access of oxidant to the FeS domain may 
eventually lead to a loss of irons. It is possible that one of the three irons is more exposed 
when bound to DNA and/ or ATP. Oxidation would change the overall oxidation state of 
the cluster and subsequently lead to instability. This can cause the loss of the oxidised 
iron, followed by loss of enzymatic activity and perhaps cluster destruction (Imaly 
(2006)). It remains to be shown whether the effect observed upon oxidant treatment is 
reversible, for example by addition of a reductant and checking for recovery of the 
helicase activity. 
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3.6 HELICASE ACTIVITY ON DIFFERENT LENGTHS OF SSDNA OVERHANGS 
 This experiment was conducted to examine the minimum binding site necessary to 
obtain efficient substrate unwinding. Double stranded DNA substrates (25 nt; see 
Appendix 1, Table 2) with different lengths of 5’-dT overhangs were made and helicase 
reactions carried out under standard conditions. Earlier time points were fitted to a linear 
regression and the slope represented the first order rate constant (kcat). The percentage of 
duplex unwinding per second was calculated into pM of unwound duplex DNA per 
second (Figure 3.19). 
 
 
 
 
 
 
 
 
 
 
Figure 3.19: XPD helicase activity on different lengths of dT 5'-overhangs 
The graph shows quantification results of at least duplicate experiments where XPD was 
tested on different lengths of dT 5’-overhangs (see legend) Time points for the figure on 
the left were 10, 30, 50, 70, 90, 120 s (T20); 10, 30, 60, 90, 120, 240 s (T15, T12); 30, 60, 
120, 240, 360, 600 s (T9, T6). Data were fitted to a smooth fit and standard errors are 
indicated. In the figure on the right the first three (T15, T20) or the first four (T6, T9 and 
T12) data points were fitted to a linear fit to obtain a comparable rate. The slope 
represented the kcat (% DNA unwound s-1) and was calculated in pM DNA unwound s-1: 
T6, 20; T9, 30; T12, 50; T15, 140; T20, 180.  
 
 As seen from Figure 3.19, the XPD helicase was found to be active with all DNA 
constructs used. Although, the rates of duplex unwinding decreased with decreasing 
lengths of the 5’-overhang. Six nucleotides were thought to be too short to load the 
enzyme properly onto the single strand overhang, however, helicase activity was 
observed. This could be most likely explained by the fact that monomeric helicases 
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possess a single and a double stranded DNA binding domain. Engagement of the duplex 
region may somewhat stabilize the enzyme on the DNA substrate, the single stranded 
binding domain would still be able to unwind DNA with lower rates in the beginning, 
increasing to faster rates once the extending single strand is long enough to engage it 
appropriately. Therefore, higher rates with longer single strand overhangs could be 
explained with a higher affinity and more stable binding of the enzyme to the DNA 
substrate. But lower initial rates with shorter 5’-overhangs should lead to a sigmoidal 
curve, which was not the case (Figure 3.19). Another explanation for the increased rates 
of duplex unwinding seen when the 5’-overhang is longer could also be due to a 
cooperativity of XPD (3.5.2). This would mean that, the more XPD molecules 
accumulate on a DNA strand, the faster the unwinding reaction becomes. Thermal 
fraying could also be a reason for the observed helicase activity on shorter overhangs, 
leading to a longer 5’ ss-overhang for enzyme loading. 
 
3.7 UNWINDING OF SUBSTRATES CONTAINING A LESION 
 The SF2 RNA helicase NPH-II was shown to have reduced unwinding activity if 
there was an alteration or a discontinuity in the ribose-phosphate backbone of the loading 
strand. Modifications in the displaced strand did not have an effect on enzyme activity 
(Kawaoka et al. (2004)). 
 Similar experiments were carried out to investigate if a lesion (fluorescein) in the 
loading or displaced strand has a similar effect on the helicase activity of XPD. A 5’ 
overhang DNA substrate was constructed from a 45mer and a 60mer oligonucleotide (see 
Appendix 1, Table 2 for oligonucleotide sequences). A fluorescein label was attached to 
either of the single strands and annealed with an intact complementary strand.  
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Figure 3.20: Examining the unwinding activity of XPD on fluorescein-labelled DNA 
strands 
Helicase activity of XPD on constructs with a fluorescein label on the displaced (45mer, 
blue) or loading strand (60mer, red) are shown. The 45mer single strand was 32P-5’-
radiolabelled. As a comparison, displacement of 25 nt oligonucleotide without 
fluorescein is shown (control, black). The figure on the left shows data fitted to smooth 
curves and the chemical structure of fluorescein is presented on the bottom right of the 
figure. In the right figure the first four (45mer (blue) or 60mer (red)) or the first three 
(control, black) data points were fitted to a linear fit. The slope represented the kcat (% 
DNA unwound s-1) and was calculated in pM DNA unwound s-1:  45mer, 50; 60mer, 30; 
control, 110. Data points represent an average from triplicate experiments and standard 
errors are indicated.  
 
 The results shown from Figure 3.20 indicate that XPD does not stall at a fluorescein 
lesion attached to either strand of the DNA substrate. It was not possible to synthesize the 
respective control DNA substrate without fluorescein lesion (the 45mer annealed 3’ to the 
60mer oligonucleotide without fluorescein attached to either of the two DNA strands). 
Instead, the displacement of a shorter 25mer annealed 3’ to a 50 nt oligonucleotide 
(oligonucleotides B1-25 and B50, see Appendix 1, Table 2) is shown in the graph as a 
comparison. A small difference was observed between the two constructs with a 
fluorescein lesion. Unwinding seems to be slower if the lesion is on the loading strand 
(30 pM s-1 compared to 50 pM s-1 in the displaced strand, Figure 3.20), indicating a 
similar, but attenuated effect as shown for NPH-II.  
 These data are still preliminary and it may be useful to repeat them using an 
appropriate control substrate as a comparison. Furthermore, other DNA substrates have to 
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be tested to investigate if XPD interacts directly with the bases of the DNA or the DNA 
backbone (e.g. using DNA substrates containing abasic sites or base modifications in 
either the leading or displaced strand). It also remains possible that XPD simply bypasses 
damage. 
 
3.8 TRANSLOCATION – DISPLACEMENT OF STREPTAVIDIN 
 The ability of XPD to translocate along DNA was tested by using a streptavidin 
displacement assay. Streptavidin and biotin form one of the strongest protein-protein 
interactions (KD = 10-15 M) known in nature. The DNA substrate was 32P-5’-radiolabelled 
and a biotin was attached to its 3’ end (Figure 3.21A). Streptavidin was prebound to 
biotin and displacement monitored by gel shifting as described in Byrd & Raney (2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21: Streptavidin displacement by XPD 
(A) Scheme of streptavidin removal: Streptavidin was prebound to the 3’ end of a biotin 
labelled oligonucleotide (32P-5’-radiolabelled). If XPD displaces streptavidin, the 
displaced molecule will immediately bind free biotin, which is in excess in the buffer 
solution, to avoid rebinding to the biotin attached to the oligonucleotide. (B) 
Representative 12 % acrylamide gel of the displacement assay. The protein concentration 
was 600 nM and assay temperatures 55 ˚C. Buffer A contained 50 mM KCl, while buffer 
B did not contain any salt. Time points were 10, 30, 60 and 120 s.  
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 Initially, this assay was intended to visualize translocation of XPD along ssDNA, 
but no streptavidin displacement was observed. This does not rule out that XPD does 
translocate along ssDNA. As discovered in later DNA binding experiments, the affinity 
of XPD to DNA is very weak. Therefore, this experiment was not optimal to show 
translocation because XPD would not be associated strongly enough with the DNA to 
even displace streptavidin. However, the experiment showed that XPD does not remove 
proteins that are tightly associated with DNA, which might include proteins such as SSB 
or Alba in Sulfolobus (Cubeddu & White (2005); Jelinska et al. (2005)), for example. The 
removal of DNA-bound proteins during NER is probably completed before the repair 
machinery assembles. Hence, there would be no need for XPD to have this function. 
There is still the possibility that XPD is able to remove molecules, which bind to DNA 
with lower affinities, but this requires further investigation. 
 
3.9 INFLUENCE OF TEMPERATURE ON THE ATPASE ACTIVITY 
 All helicases are also NTPases and they transfer the free energy derived from NTP 
hydrolysis directly into translocation along nucleic acid. The next chapter will address the 
characterisation of ATPase activity of wildtype XPD in more detail; it will also describe 
that XPD shows single stranded DNA stimulated ATPase activity.  
 Temperature dependence assays were carried out using 50 nM WT protein and a 
70mer single stranded oligonucleotide (see Appendix 1, Table 3) was included in the 
reaction mix to stimulate ATPase activity. Samples and the ATP/ MgCl2 stock solution 
were incubated 2 min at the indicated temperatures prior to the initiation of the reactions. 
After addition of ATP/ MgCl2 only one time point was taken after 2 min incubation. 
Control reactions without protein were run in parallel and absorbance readings subtracted 
as background from the respective samples with protein. 
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Figure 3.22: Temperature dependence of wildtype XPD ATPase activity 
The graph shows pmol of ATP hydrolysed per minute by XPD at different temperatures. 
Data from three independent experiments were averaged and standard errors are 
indicated. 
 
 As shown in Figure 3.22 the ATPase activity of XPD increased with increasing 
temperature, as expected for an enzyme from a hyperthermophilic organism. The activity 
approximately doubles every 10 ˚C up to 75 ˚C, which is the optimum growth 
temperature of S. acidocaldarius. Rates at 75 ˚C were determined as approximately 2900 
pmol ATP min-1 ([19 moles ATP/ mol XPD] sec-1). The enzyme activity observed at 85 
˚C probably represents an equilibrium between active XPD and heat-inactivated enzyme. 
For the duration of the experiments, the enzyme appeared stable and no aggregation was 
observed. Enzyme activities observed at temperatures as high as 85 ˚C also confirmed 
that the ATPase activities measured can be solely attributed to XPD and did not originate 
from a contaminating highly active E. coli helicase. 
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3.10 SUMMARY AND CONCLUSION 
 This chapter described the characterisation of the wildtype XPD protein from S. 
acidocaldarius, a hyperthermophile crenarchaeon. In contrast to hXPD, SacXPD is a 
monomer in solution and does not form stable complexes with other proteins. Like its 
eukaryotic counterpart SacXPD is an ATP-dependent DNA helicase with a 5’3’ 
polarity. As a monomeric helicase, XPD would follow the inchworm model as the 
proposed mechanism for nucleic acid unwinding (reviewed in e.g.: Soultanas & Wigley 
(2000)).  
 This chapter showed that the in vitro helicase activity of XPD was concentration 
dependent. Duplex unwinding was only observed with XPD in at least 10-fold excess 
over DNA. One possible explanation is that XPD has a low affinity for DNA. Another 
explanation could be positive cooperativity, as described for the Dda helicase T4 (Byrd & 
Raney (2004)) or a combination of both.  
 XPD contains the seven conserved helicase motifs and a highly conserved DEAH 
motif in the Walker B box, classifying it as a SF2 helicase (Gorbalenya & Koonin (1993); 
Rudolf et al. (2006)). This study presents XPD as the first helicase described containing 
an iron-sulphur (FeS) cluster. Elemental analysis and EPR identified the cluster to be of 
the 3Fe-4S type and the FeS cluster domain is located near the N-terminus of the protein 
between Walker A and B motif (Figure 3.12). Analysis of sequence alignments revealed 
that the cluster may be present in the related E. coli helicase DinG (see Chapter 
Introduction), hXPD and other related human helicases (Figure 3.12; Rudolf et al. 
(2006)). Preliminary experimental data suggested that DinG has indeed a FeS cluster 
bound (R. D. Camerini-Otero, personal communication). 
 Iron-sulphur clusters usually occur in a wide range of redox active proteins, 
involved in rapid electron tunnelling, for example in photosystem I and II or the 
nitrogenase complex. Other enzymes use the high affinity of iron for oxygen as sensor to 
modulate oxygen levels within the cell. They induce downstream regulatory processes or 
they are directly involved in regulation of gene transcription. Other iron proteins take part 
in iron metabolism (transport, storage, regulation and FeS cluster assembly) or iron can 
be used to bind substrate to an enzyme (e.g. aconitase). Furthermore, some FeS clusters 
fulfil exclusively structural roles (for reviews see: Rouault & Klausner (1996); Sicht & 
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Roesch (1998); Beinert & Kiley (1999); Rees (2002); Kiley & Beinert (2003)). It was 
shown in this chapter that the FeS cluster of XPD is redox sensitive, as oxidant treatment 
(ferricyanide) abolishes helicase activity. This is the first evidence for a possible function 
of the FeS cluster, which will be further investigated in the following chapter.  
Streptavidin displacement assays showed that XPD does not remove proteins that 
are tightly associated with the DNA. XPD was able to bypass lesions (fluorescein) 
present in either of the two strands of a DNA duplex, although with lower rates if the 
lesion was located on the loading strand. It was suggested that SF1 and SF2 helicases 
differ in the way they bind nucleic acids. While SF1 (PcrA) contact the bases directly, it 
was thought that SF2 (NPH-II, NS3) helicases mainly interact with the sugar-phosphate 
backbone (reviewed in: Singleton & Wigley (2002)). But only limited biochemical 
evidence is available yet. The helicase experiments using DNA substrates with a 
fluorescein molecule either on the loading or displaced strand showed, that an intact 
desoxyribose-phosphate backbone on the loading strand is important, but not crucial. 
How DNA is bound by XPD during the duplex unwinding process, however, requires 
further investigation.  
4 PURIFICATION AND 
CHARACTERISATION OF XPD MUTANTS 
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4.1 INTRODUCTION 
 The previous chapter described the characterisation of wildtype XPD from S. 
acidocaldarius, the first helicase described with an iron-sulphur cluster. This cluster may 
also be present in hXPD and other related human helicases. 
 Mutations in the XPD gene are found in patients with three distinct disorders: 
xeroderma pigmentosum (XP), Cockayne Syndrome (CS) and Trichothiodystrophy 
(TTD) (Lehmann (2001)). XP-patients show increased UV-sensitivity and are prone to 
develop skin cancers. CS and TTD patients do not develop skin cancer but show severe 
photosensitivity. CS is a multisystem disorder and causes mental retardation and skeletal 
abnormalities, whereas TTD leads to characteristic sulphur-deficient brittle hair, mental 
retardations and dwarfism. These multiple phenotypes caused by mutations in a single 
gene are explained by the fact that XPD is involved in NER, transcription and cell cycle 
regulation. 
 Mutations in the hXPD protein are mainly found at the C-terminus, which is the 
domain interacting with the p44 subunit of the transcription factor TFIIH (Figure 4.1; 
Coin et al. (1998)). Mutations located outside the conserved motifs are likely to influence 
the helicase activity, which is stimulated by p44, or the general protein stability. Some 
mutations are also found at the N-terminus, mainly in the conserved motifs. Only one 
mutation outside the conserved motifs was frequently found in TTD patients (reviewed in 
Lehmann (2001)). Dubaele et al. (2003) showed that this mutation (R112H) results in a 
loss of unwinding activity. The reason for the loss of activity was unclear.  
 This chapter will describe a set of different mutant proteins, which were used to 
assess the importance of several conserved and non-conserved residues for the enzyme 
activity of SacXPD. It also sought to find an answer to the question: what is the function 
of the FeS cluster in a helicase?  
 The FeS cluster was not previously described for eukaryotic XPD. This was due to 
the fact that eukaryotic XPD can only be purified in extremely low concentrations. This 
makes it impossible to detect the FeS cluster visually, because this was how the FeS 
cluster in SacXPD was initially discovered and a colour is only visible if the protein is at 
high concentrations. Furthermore, apart from the conserved cluster coordinating cysteines 
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there are not many conserved residues within the FeS cluster domain. The spacing 
between the cysteines also differs within the different helicases identified with a FeS 
cluster. Therefore, it is difficult to detect the FeS cluster domain using bioinformatics.  
 Specific mutations were made in the yeast Rad3p orthologue of hXPD. These 
mutations were made on the basis of mutations introduced in SacXPD and specific 
expected phenotypes proved the existence of the FeS cluster in eukaryotic XPD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Common mutations in the human XPD gene 
The schematic shows the domain organisation of hXPD (blue) with the seven conserved 
helicase motifs in orange. The flags indicate amino acid changes found in different 
patients and the number of symbols equals the number of times a particular allele has 
been found mutated in patients (adapted from Lehmann (2003)). 
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4.2 SELECTION OF MUTANT PROTEINS  
 For characterisation of the enzyme activity and the function of the FeS cluster, a set 
of mutant proteins was generated by site directed mutagenesis. Residues were selected 
with regard to a possible influence on the FeS cluster formation. Other mutations were 
introduced in SacXPD, because the analogous amino acid modification in human 
helicases, such as XPD and FancJ, were found to cause certain diseases (Figure 4.2).  
 Lysine 35 is located in the Walker A box and mutation to an alanine should abolish 
the ATPase activity (Sung et al. (1988); Velankar et al. (1998)). This mutant was used as 
a negative control. The four conserved cysteine residues (C88, C102, C105, C137), which 
were thought to be involved in FeS cluster coordination, were mutated to serines. The 
importance of conserved hydrophobic residues around the FeS cluster was investigated 
by generating the mutants Y139F and Y140F in addition to the two double mutants 
Y139A/Y140A and Y156A/Y158A. Hydrophobic residues were found to surround FeS 
clusters and to have important roles in protecting the FeS cluster from the access of 
solvents and oxidising agents and to stabilise the cluster through hydrogen bonding of the 
aromatic ring with the cluster (Iwagami et al. (1995)). These residues are also involved in 
the maintenance of an anaerobic environment around the cluster and may have other 
structurally important features as well. It was described that the prosthetic centre of FeS 
clusters is sensitive to side chain substitutions. This means, that changing tyrosine to a 
polar residue would lead to instability, while a change to an unpolar residue, especially 
with an aromatic side chain, would have fewer consequences and is likely to maintain the 
stability of the cluster (Agarwal et al. (1995)).  
 The remaining mutants that were engineered represented human mutations, which 
were found in XP-D (T56A, K84H, G447D, C523R, R531W) or Fanconi anemia patients 
(FancJ; SacXPD: F136P) (Table 4.1). A truncated version of the protein was generated, 
which only contained the FeS cluster domain from residues Glu72 to Asp162. 
 Other mutant proteins were made by B. Petrovic-Stojanovska (CBMS, University 
of St Andrews) for spin-labelling experiments. All non-essential cysteines were changed 
to serines generating mutant XPD-3CS (XPD-C360S/C523S/C543S). This mutant was 
used to introduce the following amino acid substitutions: F38C, N58C, D186C and 
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A511C. The enzymatic activity was tested, but the phenotypes were not further 
characterised.  
 
 
 
 
 
 
 
 
 
 
Figure 4.2: Overview of mutations introduced into S. acidocaldarius XPD 
In the top panel a schematic of the XPD gene is shown, including the six main helicase 
motifs (labelled I-VI) and the FeS cluster domain. The alignment in the bottom panel 
shows the abbreviated XPD sequences of the human (H) compared to the S. 
acidocaldarius (S) protein. Residues that were selected for mutation in SacXPD are 
highlighted in yellow and the residues they were mutated to are shown in the bottom line 
(M). Double mutants are underlined and (*) indicates the position of the FancJ mutation 
A349P (the equivalent residue in human FancJ is an alanine). 
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4.3 PURIFICATION OF MUTANT PROTEINS 
 Mutants were purified as described for the wildtype protein. The mutations and the 
whole protein mass were confirmed by mass spectrometry. Three different species were 
observed and are summarized in Table 4.1. Class I mutants were devoid of the FeS 
cluster and completely colourless on purification. Class II mutants expressed with FeS 
cluster, but lost it during purification or upon storage. A fading of the initial wildtype 
colour could be followed by eye, until the protein solution was completely colourless. 
These mutants are referred to as mutants containing an unstable FeS cluster. Class III 
mutants bound a stable cluster and showed wildtype colour. T56A was not characterised, 
because the recombinant protein could not be expressed. 
 In general, class II and III mutants purified as wildtype and eluted from the heparin 
column at ~380 mM NaCl. Only the R531W mutant showed very weak binding and 
eluted at around 260 mM NaCl. This could suggest that this mutation influences DNA 
binding. Class I mutants showed lower expression, but bound tighter to the affinity 
column and eluted at ~420 mM NaCl. The only exception from that scheme was the 
C523R mutant which, although possessing a stable FeS cluster, eluted at ~420 mM NaCl 
from the heparin column. The histidine tagged truncated mutant showed extremely low 
expression and from the absence of colour it can be concluded that no cluster was bound 
(data not shown). Therefore, this mutant was not characterised further. All proteins 
purified as monomers by gel filtration (GF) chromatography.  
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Table 4.1: Characteristics of XPD mutant proteins 
Mutation in  
S. acidocaldarius 
Mutation in Human Yield compared to 
WT (%) 
Cluster? 
K35A - 100 stable 
T56A T76A (XP) 0 - 
K84H R112H (TTD) 100 unstable 
C88S - 30 non 
C102S - 100 stable 
C105S - 30 non 
F136P A349P (FA) 100 unstable 
C137S - 30 non 
Y139F - 100 stable 
Y140F - 100 stable 
Y139A/ Y140A - 100 unstable 
Y156A/ Y158A - 100 stable 
G447D G602D (XP/ CS) 100 stable 
C523R G675R (XP/ CS) 100 stable 
R531W R683W (XP) 30 stable 
XPD-trunc - 10 non 
Table 4.1 shows mutated residues of S. acidocaldarius XPD and the equivalent mutations 
in human, when the mutation was selected because of clinical relevance in humans. The 
clinical symptoms in humans are labelled: XP, xeroderma pigmentosum; CS, Cockayne 
Syndrome; TTD, trichothiodystrophy; FA, Fanconi anemia. Purification results, presence 
and stability of the FeS clusters are also indicated.  
 
4.4 PURITY AND FOLDING 
 The purity of XPD mutants was analysed by SDS-PAGE. The folding of selected 
proteins was studied by circular dichroism (CD) spectroscopy. This included one 
example of a class I mutant (C105S), two class II mutants (K84H, F136P), which 
represent human mutations and a class III mutant (C102S). The latter was of particular 
interest, because it was the only one out of four cysteine mutants that possessed a stable 
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FeS cluster. Differences in the FeS cluster due to change of ligands could induce changes 
in the overall folding of the protein. The wildtype protein in Figure 4.3A (right gel) 
shows a band at ~120 kDa, which may be a non-specific protein carried over during 
protein purification. 
 The proteins appeared pure after gel filtration chromatography. Breakdown 
products seen for some of the mutants (Figure 4.3A) appeared typically upon thawing 
after long-term storage at -20 ˚C. These bands were also seen after tryptic digestion and 
varied between mutants with and without cluster. The formation of these different 
proteolytically sensitive fragments indicates different domain organisation between 
cluster and “clusterless” proteins, which will be discussed in Chapter 5.  
 Far UV-CD spectroscopy confirmed that all mutants maintained the overall 
secondary structure (Figure 4.3B). Minor changes in the spectrum of the C105S mutant 
enzyme reflects local perturbations in the Fe-S domain, but suggested that the mutant 
enzyme adopts a stable folded structure. A general observation was, that the K84H 
mutant showed an increased instability after the complete loss of the FeS cluster leading 
to precipitation. In contrast, the F136P mutant appeared stable. These differences in 
stability led to small differences in the far UV-CD spectra of both mutants as seen in 
Figure 4.3B. 
 It seemed that in general the FeS cluster had no crucial function in protein folding 
or structural stability, because all proteins could be purified and were folded. Problems 
with expression, purification or stability were most likely brought about by the mutation 
itself and not through a loss or instability of the cluster. As seen from the C105S mutant, 
the cluster may have a very localized structural influence. 
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Figure 4.3: Mutant protein purification and analysis 
SDS-gels of purified proteins after gel filtration chromatography are shown in (A). The 
Mark12TM Standard Marker (Invitrogen) is indicated with M. CD spectroscopy analysis 
are shown in panel (B). Colour scheme for WT and mutant proteins are indicated in the 
figure.  
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4.5 IRON QUANTIFICATION 
 From the purification of XPD mutant proteins, it became evident, that only three of 
the four conserved cysteines may be involved in FeS cluster coordination. Although WT 
XPD was described in the previous chapter to bind a 3Fe-4S cluster, there was still the 
possibility that in position 102 a serine could substitute for a cysteine, as was found in 
other cases (Kowal et al. (1995)). Indeed, in the amino acid sequence of Thermoplasma 
volcanium XPD, a serine instead of a cysteine is present at the equivalent position of S. 
acidocaldarius C102 (Figure 4.4).  
 To confirm the presence of three iron ions, the iron content was determined for 
wildtype (control), C102S and C105S mutants by using the bathophenanthroline method. 
Experiments were carried out in triplicate and the average absorbance used to calculate 
the numbers of irons bound to 1 molecule of XPD. As expected, no iron was detected for 
the C105S mutant (A535: 0.0005), which was colourless on purification. The C102S (A535: 
0.129 = 2.85 Fe/XPD) and the wildtype (A535: 0.1482 = 3.27 Fe/ XPD) protein both lead 
to a ratio of 3 iron bound to 1 molecule XPD. 
 This experiment proved that colourless mutant proteins did not have iron bound, 
while coloured mutant proteins possessed a 3Fe-4S cluster. Serine does not substitute for 
a cysteine in position 102 and no iron ion is coordinated by C102. Only three cysteines 
are essential for coordination of the cluster, consistent with spectroscopic and elemental 
analysis carried out on wildtype protein. The 3Fe-4S cluster was confirmed for the 
wildtype XPD by EPR and ICP-OES. Also, FeS cluster reconstitution strengthened the 
hypothesis that XPD has only a 3 Fe not a 4 Fe cluster bound (Chapter 3). 
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        motif I 
Sac  32 GSGKTLFSLLVSLEVKP----KVLFVVRTHNEFYPIYRDLTKIREKRNITFSFLVGKPSS 
Sto  31 GSGKTLFSLLVGLNTKG----KVIFVVRTHNEYFPVYRDVKKIDP--SLKFSFVIGKPSA 
Sso  31 GSGKTLFALYTALKVKP----KVAFVVRTHNEFFPVYRELSLHFK--DKKYGFLVGKSSA 
Pto  40 GSGKTSFILYLAFLSGK----KFIYSVRTHNEFTRIYEDNKRFFN---LDIAYMFGKKSL 
Tvo  32 GSGKTMMALLGSLKYAYNGHLKILYLVRTNSQEEQVIRELRTISKNRKIRALPMQGRINL 
 
Sac  88 CLYAEKGAESEDIP----CKYCELKGS-IVEVKTDDSPLSLVKKLKKDGLQ--------- 
Sto  85 CPFAAKDVDTEDIN----CKYCEIKN--AIEVKIDKSPFEKLKELKENGIK--------- 
Sso  85 CVFSSSDVDAQDIY----CNGCEIFN--ASAVTVTDSPKVSLNKLKEEGKK--------- 
Pto  83 CPLPDRWLENDDSDRD-ICTGCFLKDK-TIDVKFDMDPEELCNFLLRESMENINIDIKNR 
Tvo  92 CILYKTADDLKEATAESLSKFCNSRKRQVMEGHQEACPYYTIKVRSKETKDFLFEN---- 
 
Sac 133 ------------------DKFCPYYSLLNSLYKADVIALTYPYFFID----RYREFIDID 
Sto 130 ------------------EGFCPYYSLLESAKEADIITITYPYFFIE----KYLSLLDIN 
Sso 130 ------------------LGFCPYYSLLETIKTADVILLTYPYLFIP----WLRESLDIN 
Pto 151 SLVKNERGDYYYKREKKSLGFCPYYSVRLSALSHNIIVMTYNYLLNPGI--RYRTFGIEN 
Tvo 148 -----LPTAEEFYEYAFTNNLCPYESIKASLSDADIVVAPYMYFLNKTVADRFLSHWGVS 
 
               motif II 
Sac 172 LREYMIVIDEAHN 
Sto 168 LEEYFIVIDEAHN 
Sso 168 WEDYVVIVDEAHN 
Pto 209 FNDYCIVFDEAHN 
Tvo 203 REQLIIVLDEAHN 
 
Figure 4.4: Sequence alignment of XPD homologues from different archaea 
Amino acid sequence alignment of XPD proteins (from helicase motif I to II) from 
different archaea. Highly conserved residues are highlighted black and conserved similar 
residues are highlighted dark grey. The four conserved cysteine residues are highlighted 
in yellow, and the serine substitution at the equivalent position of SacXPD-C102 is 
highlighted in red. Sac, S. acidocaldarius; Sto, S. tokodaii; Sso; S. solfataricus; Pto, 
Picrophilus torridus; Tvo, Thermoplasma volcanicum. 
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4.6 FUNCTION OF THE FES CLUSTER DOMAIN 
4.6.1 Helicase activity 
 The influence of the FeS cluster on the helicase activity was investigated using the 
four cysteine mutants (C88S, C102S, C105S and C137S) and the four tyrosine mutants 
(Y139F, Y140F, Y139A/ Y140A and Y157A/ Y159A) (4.2). Duplex unwinding activities 
were compared to the WT enzyme. The K35A mutant served as negative control, because 
it should not show helicase activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4: CHARACTERISATION OF XPD MUTANTS 
 94 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Helicase activity of XPD FeS cluster mutants 
(A) Representative 12 % native acrylamide gels showing helicase activity of mutant XPD 
proteins. Upper bands represent dsDNA and lower bands are the 32P-labeled ssDNA. The 
latter arises if unwinding takes place. Time points were: 30, 60, 90, 120, 180, 300 s. 
Green circles with a tick indicate the presence of a stable FeS cluster, while white circles 
and a cross indicate the absence of the FeS cluster. (B) The schematic shows the setup of 
the helicase assays. (C) Quantification results of triplicate experiments are shown and 
standard errors are indicated. The zero time point was given a value of DNA unwinding = 
zero. WT and K35A mutants are shown as positive and negative controls, respectively. 
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 The results of the helicase assays using N-terminal mutant enzymes are shown in 
Figure 4.5. The Walker A box mutant K35A had a stable cluster, but was inactive due to 
an inability to hydrolyse ATP. This mutant was used as a negative control. The side chain 
of this invariant lysine residue at this position is located at the same position as the 
magnesium ion after binding of the ATP-Mg2+ complex. It was found that this side chain 
binds the β-phosphoryl group of ATP and is thought to stabilize the transition state 
during hydrolysis (Velankar et al. (1999)). Mutation of this residue leads to enzyme 
inactivation.  
 The three cysteine mutants (C88S, C105S, C137S), which did not coordinate a FeS 
cluster, did not show helicase activity. In contrast, the C102S, which retained a stable 
cluster showed wildtype helicase activity.  
 The FeS cluster was destabilised in the double mutant Y139A/Y140A. Single 
mutations of these two residues to phenylalanine did not show an equivalent effect, 
although, a slight decrease in general protein stability was observed with the Y139F 
compared to the Y140F mutant. Both residues are highly conserved, even if Y140 is 
conserved either as a tyrosine or as a phenylalanine. Structurally, there is not much 
difference between tyrosine and phenylalanine and to maintain the hydrophobic 
environment around the cluster, Phe could fulfil this function just as well. To gain a more 
profound effect, both residues have to be mutated to a different amino acid, such as 
alanine. The Y140F mutant, which is a stable protein containing a stable FeS cluster, 
showed wildtype activity (Figure 4.5). The mutation in position 139 to Phe decreased the 
stability of the protein, but did not directly influence that of the FeS cluster. The 
unwinding experiments mirrored this effect, leading to a reduced activity relative to the 
wildtype. The double mutant Y139A/Y140A lost the FeS cluster and did not exhibit 
unwinding activity. Similar to the Y140F mutation, the double mutant Y156A/Y158A, 
however, did not influence the structure of the FeS cluster, but decreased the stability of 
the protein. This is reflected in the rate of unwinding analogous to Y139F. 
 These experiments indicate an essential role of the FeS cluster for the helicase 
activity of XPD. 
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4.7 CHARACTERISATION OF HUMAN MUTATIONS 
 Most of the known human mutations in XPD are located at the C-terminus. Human 
XPD is a functional bridge between the TFIIH core complex and the CAK subunit. The 
TFIIH holocomplex is only formed when taking part in transcription, while the TFIIH 
core, including hXPD, acts in NER. The C-terminus of hXPD interacts with the p44 
subunit of the TFIIH core, while the N-terminus binds to the MAT1 subunit of the CAK 
subcomplex. No mutations have been reported on the amino-terminal end, which would 
abolish the interaction with MAT1. However, mutations located on the C-terminus of the 
hXPD influence the binding to p44. Apart from that, three of the seven conserved 
helicase motifs are located in this area and mutations are likely to affect the ATPase 
activity of XPD. Lastly, this region may be involved in DNA binding and substrate 
specificity (Lehmann (2001); Sandrock & Egly (2001), Chen & Suter (2003)). Some of 
the C-terminal mutants (G447D, C523R, R531W) were purified and characterised by M. 
J. Stacey, an Honours student.  
 Fanconi anemia is a recessively inherited disorder leading to chromosomal 
instability and subsequently to developmental abnormalities, bone marrow failure and 
increased risk of cancer. The Fanconi anemia pathway is a fairly recently discovered 
DNA repair mechanism and not very much is known about the factors involved and the 
mechanism of action. The gene corresponding to FancJ was only discovered recently 
(Levitus et al. (2005), Levran et al. (2005)) and turned out to be an already known 
helicase called BACH1/ BRIP1, which interacts with BRCA1 (Cantor et al. (2001); see 
Chapter 1). 
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Figure 4.6: Helicase characterisation of mutants resembling human mutations 
(A) Representative 12 % acrylamide gels showing helicase activity of mutant proteins. 
Upper bands represent dsDNA and lower bands are ssDNA. The latter arises if 
unwinding takes place. Time points were: 30, 60, 90, 120, 180, 300 s. Green circles 
indicate the presence of a stable FeS cluster, while white circles indicate the absence of 
the FeS cluster. (B) Quantification results of triplicate experiments are shown and 
standard errors are indicated. Data points were connected by lines. The zero time point 
was given a value of DNA unwinding = zero. WT and K35A mutants are shown as 
positive and negative controls, respectively.  
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 The two human mutations located at the amino-terminus of XPD were frequently 
found in TTD (R112H) and FancJ (A349P) patients, respectively. Although, they are not 
located in one of the conserved motifs, these two mutants represent inactive helicases 
(Dubaele et al. (2003); Levran et al. (2005)). The mutants K84H (R112H) and F136P 
(A349P) of SacXPD led to disruption of the FeS cluster and subsequent enzyme 
inactivation (Figure 4.6). Dubaele et al. (2003) found that the R112H mutant protein 
shows no helicase activity and was therefore deficient in in vitro reconstituted NER. In 
addition hXPD-R112H showed partial inhibition of transcription, but exhibited wildtype 
interaction with the TFIIH holocomplex. The mechanism of helicase inactivation, 
however, remained unclear. Furthermore, Berneburg et al. (2000a) showed that human 
cell lines harbouring the R112H XPD mutation resemble phenotypes which are closer 
related to phenotypes observed with XP-cell lines, rather than other TTD cell lines. They 
found decreased accumulation of incision products during NER and lower rates of CPD 
removal, similar to other XP-cell lines tested. In addition, in vitro experiments using a 
UV-sensitive S. pombe rad15.P strain, rad15-R111H (human: R112H) managed to restore 
UV-sensitivity only partially, in contrast to TTD-cell lines where almost full restoration 
was observed. An explanation for these differences could not be provided. The discovery 
that SacXPD contains an essential FeS cluster, which is also present in the human 
homologue, provided a possible explanation for the effect this mutation has on the 
enzyme activity. The same applied for the FancJ mutation A349P (Levran et al. (2005)). 
This residue is not conserved at all, however it is located prior to the last cysteine of the 
FeS cluster domain. It was found in patients with severe symptoms of Fanconi anemia. 
An amino acid change to a rigid proline can induce structural alterations and destabilise 
the cluster. Indeed, the F136P mutant of XPD possessed an instable FeS cluster.  The loss 
of the FeS cluster was associated with a loss of the helicase activity of F136P (Figure 
4.6). 
 The remaining human mutations are situated at the C-terminus of XPD, where most 
of the human mutations are located. All three mutants (G447D, C523R, R531W) showed 
abolished helicase activity (Figure 4.6). The residue G447 (human: G602) is located in 
motif V. The affected patient was identified to be hemizygote for the G602D mutation 
and showed symptoms of XP and CS (Broughton et al. (1995)). The human mutant 
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protein was shown to interact with p44, but represented a deficient helicase leading to a 
deficiency in NER (Berneburg et al. (2000b); Dubaele et al. (2003)). In accordance with 
these findings, the mutation G447D in Sulfolobus abolished the ATPase activity (Figure 
4.7), leading to an inactive helicase (Figure 4.6). 
 Residue C523 (human: G675) is located C-terminal from motif VI. The respective 
patient showed a combined XP/ CS phenotype with a hemizygote genetic background for 
the hXPD-G675R mutation (Broughton et al. (1995)). In contrast to the above mutation, 
the hXPD-G675R mutation does not affect the helicase activity, but disrupts the 
interaction with p44. Therefore, the helicase activity is similar to that observed with the 
unstimulated wildtype protein and the mutant was shown to support low but significant 
NER in vitro while having no influence on transcription initiation (Dubaele et al. (2003)). 
In vivo experiments using a UV-sensitive S. pombe strain showed that the analogous 
mutation in the rad15 protein could not restore UV-sensitivity. Furthermore, hXPD-
G675R cells from cell lines of the respective patient were shown to be deficient in 3’ 
incision and hence unable to complete NER (Berneburg et al. (2000a & b)). The 
analogous mutation in SacXPD, C532R, led to an almost complete loss of ATPase and 
helicase activity (Figure 4.6 and Figure 4.7), indicating differences in the mechanism of 
action between SacXPD and human XPD.  
 XPD patients harbouring the R683W mutation (Sac: R531W) exhibit an XP 
phenotype. The mutation is located outside the conserved motifs at the C-terminus of the 
protein. It abolishes the interaction with the p44 subunit of TFIIH, which leads to low 
levels of NER (Dubaele et al. (2003)). Helicase activity of hXPD-R683W was similar to 
the basal wildtype activity, but much lower than the p44 stimulated wildtype activity. In 
vivo (S. pombe) this mutant partially restored UV-sensitivity in a rad15.P strain 
(Berneburg et al. (2000a)). The mutation in S. acidocaldarius led to an inactive helicase 
(Figure 4.6). This may be caused by weak DNA interaction (Chapter 5), which caused a 
half-maximal ATPase activity (Figure 4.7).  
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 no DNA ssDNA 
G447D 0 1.6 
C523R 0 1.4 
R531W 0 11.6 
WT - 22.3 
 
 
 
 
Figure 4.7: ATPase activity of the XPD mutants G447D, C523R and R531W 
The graph shows results from duplicate experiments for wildtype and mutant enzymes 
(200 nM) with ssDNA (0.5 nM PhiX175 virion) and without DNA. The ssDNA 
stimulated ATPase activity of the wildtype enzyme is shown as a control. Time points 
were: 20, 40, 60, 90, 120, 180, 300 s. Data were fitted to a linear regression and standard 
errors are indicated. The table summarises the results of the ATPase assays for the 
wildtype and the three mutant proteins. Numbers indicate ATP hydrolysed/ second in 
pmol.  
 
4.8 YEAST RAD3 & THE PRESENCE OF THE FES CLUSTER IN EUKARYOTES 
 Bioinformatic analysis showed a strong conservation of the FeS cluster domain not 
only within the domain of the archaea, but also in hXPD, other related human helicases 
and yeast Rad3p (Chapter 3, Figure 1.13). In order to prove the presence of the FeS 
cluster in an eukaryotic model organism, Saccharomyces cerevisiae strains were 
constructed and characterised by Dr. V. Makrantoni in the laboratory of Prof M. J. Stark 
(Wellcome Trust Center, University of Dundee).  
 On the basis of these sequence alignments three amino acid residues were selected 
in the yeast Rad3p orthologue of hXPD and mutated in analogy to the already 
characterised mutations in SacXPD. These amino acid substitutions were expected to 
induce specific degrees of UV-sensitive phenotypes. 
 The first mutant, Rad3-K48A, represents the control mutant, which is completely 
inactive due to an inability to hydrolyse ATP (Sung et al. (1988); Velankar et al (1999)). 
-1000
0
1000
2000
3000
4000
5000
6000
7000
0 50 100 150 200 250 300 350
WT+DNA
C523R+DNA
C523R-DNA
G447D+DNA
G447D-DNA
R531W+DNA
R531W-DNA
A
T
P
 h
y
d
ro
ly
s
e
d
 (
p
m
o
l)
Time (s)
CHAPTER 4: CHARACTERISATION OF XPD MUTANTS 
 101 
This mutation is analogous to XPD-K35A, located in motif I and impairs the ATPase 
activity. Rad3-C115S is the analogue of XPD-C88S. In S. acidocaldarius this mutation 
led to an inability in coordinating the FeS cluster and subsequently to enzyme 
inactivation. The third mutation was one of the human mutations (R112H), which was 
found in TTD patients. The analogue in yeast is Rad3-R111 and K84 in S. 
acidocaldarius. Mutation to a histidine was shown to lead to cluster destabilisation and 
enzyme inactivation of SacXPD (section 4.3 and 4.6.1).  
 In yeast RAD3 is an essential gene. A RAD3 knockout mutant and two shuttle 
vectors (YCplac33 and YCplac111) were used to create the Rad3 strains. One copy of the 
S. cerevisiae RAD3 gene in the wildtype diploid strain was deleted, generating a strain 
containing a HISMX marker cassette. This strain was then transformed with an URA3-
marked plasmid (YCplac33) generating a wildtype RAD3 (YCplac33-RAD3) strain with 
a selective marker. After sporulation and tetrad dissection, strains containing the 
URA3/HIS3 markers were selected. The positive segregants were subsequently 
transformed with derivatives of a LEU2-marker plasmid YCplac111 carrying either 
wildtype RAD3 or one of the RAD3 mutant genes (K48A, R111H and C115S). 
Following two rounds of YCplac33-RAD3 counter selection using 5-fluoroorotic acid, 
six independently-derived isolates of each RAD3 construct dependent solely on the 
YCplac111-RAD3 plasmids for Rad3p function were identified. All RAD3 genes were 
fully sequenced. Evaluation of UV-sensitivity was performed by irradiating cells with 
different doses of UV-light. Following UV-treatment, cells were grown for two days in 
the dark to avoid photolyase activation (Rudolf et al. (2006)). The results are shown in 
Figure 4.8. 
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Figure 4.8: Mutations in yeast Rad3p show influence on the FeS cluster and leads to 
an UV-sensitive phenotype 
Each image shows YPD-agar plates with serial dilutions (1:10) of a yeast culture. Plates 
were irradiated with different doses of UV-light and grown in the dark for 2 days. As the 
UV dose increases K48A and C115S mutants show highly sensitive UV phenotypes, 
while R111H is only mildly affected. 
 
 The results obtained from these experiments (Figure 4.8) proved the presence of the 
FeS cluster in yeast in vivo. The K48A negative control showed no resistance to UV-light 
and all cells died after exposure to only 6 J/ m2 UV-irradiation.  
 The residue C88 of SacXPD is the first cysteine in the amino acid sequence, which 
is involved in coordination of the FeS cluster. Mutation to a serine led to cluster loss and 
subsequently abolished the helicase activity. The analogous mutation in yeast, C115S, 
caused a severe NER deficiency phenotype with extreme UV-sensitivity. The majority of 
yeast cells were not able to survive the lowest level of UV exposure (6 J/ m2) and showed 
a similar UV-sensitive phenotype as the control mutant K48A, which has an impaired 
ATPase activity.  
 The last mutation, Rad3-R111H, is the equivalent of the human R112H mutation, 
which causes TTD, and K84H in S. acidocaldarius XPD. The results obtained in the 
yeast system showed moderate UV-sensitivity, in accordance with data obtained for the 
S. pombe rad15-R111H mutant, which partially restored UV-sensitivity in a rad15 null 
control 6 J/m2 10 J/m2 
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background (see section 4.7; Berneburg et al. (2000a)). In human cell lines from different 
patients harbouring the R112H mutation, cells showed a range of very mild to extremely 
severe effects of UV-light sensitivity. Yeast cells exposed to low doses of UV-light can 
cope relatively well with DNA damage that arises. However, if the number of damages 
increases with increasing UV-irradiation, the mutated helicase is not proficient enough to 
support NER and cells die due to accumulation of DNA damage. In S. acidocaldarius the 
cluster is initially there, which means that initially there is an efficient helicase available 
for DNA damage repair. The cluster also appeared to be stable in vivo, because cluster 
destruction was only observed after purification. It is possible, that the labile bound 
cluster is lost during the DNA unwinding process, caused by alternating conformational 
changes of the enzyme. This could lead to delayed damage repair, which only becomes 
evident after acute DNA damage. 
 
4.9 SPIN-LABELLED MUTANTS 
 Spin-labels are paramagnetic due to an unpaired electron and can easily be 
monitored by EPR (see introduction to EPR in previous chapter). The reporter is mostly a 
nitroxyl radical (the unpaired electron is mainly localized to the N-O bond), which is 
incorporated in a heterocyclic structure (the label; Figure 4.9). The functional group of 
the spin-label reacts at neutral pH with thiol-groups in cysteines of the protein generating 
a covalent bond. Therefore, it is possible to attach spin-labels at every position in the 
protein by introducing cysteines by site-directed mutagenesis (site-directed spin-label, 
SDSL). If two or more spin labels are present in a protein structure, the distances between 
them can be measured by EPR. Since proteins are flexible macromolecules, they change 
their conformations in response to changes in the environment or in the presence of an 
interacting partner molecule. These conformational changes can be monitored by 
measuring the changing distances between SDSL. Therefore, SDSL is a powerful tool to 
study structure and dynamics of macromolecules (Hubbell et al. (1996)). 
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Figure 4.9: Side-directed spin-labeling (SDSL) of proteins 
The most common procedure to attach a spin label (nitroxide side chain) to a protein is as 
follows: Cysteines are specifically introduced into the protein primary structure by site-
directed mutagenesis. The nitroxide side chain reacts specifically with the sulfhydryl 
group of the cysteine and generates a site-directed spin-label attached at a specific 
position in the protein sequence. The most commonly used reagent is 
methanethiosulfonate which generates side chain R1 (Figure adapted from Hubbell et al. 
(1996)). 
 
 SDSL was used to observe conformational changes of XPD upon binding of 
ligands, e.g. ATP or DNA. Distance measurements were carried out relative to the 
cysteines of the FeS cluster domain. In that respect, all cysteines outside the FeS cluster 
domain were changed to serines, creating the triple mutant C360S/C523S/C543S (XPD-
3CS). This triple mutant was used to introduce cysteines for SDSL at the following 
positions: F38, N58, D186 and A511. Respective XPD mutants were recombinantly 
expressed, purified and spin-labelled by B. Petrovic-Stojanovska (CBMS, St Andrews). 
These mutants were tested for helicase activity and the influence of the SDSL was also 
investigated (Figure 4.10 and Figure 4.11). 
 The XPD-3CS mutant was tested for helicase and ATPase activity and showed rates 
identical to the wildtype (data not shown). Subsequently introduced mutations were 
tested for their influence on the helicase activity before and after spin-labelling (Figure 
4.10 and Figure 4.11). Mutants N58C and D186C showed wildtype activity, while F38C 
and A511C exhibited abolished and lower activity, respectively. The spin-label seemed 
not to alter the general properties of the mutants, since there were no significant 
differences observed between labelled and unlabelled mutant proteins.  
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 F38 is not a conserved residue and is located in motif I. This mutant was also tested 
for ATPase activity and no free phosphates could be detected (data not shown). Hence, 
the mutation to a cysteine abolishes the ATPase activity due to its proximity to the 
Walker A motif.  
 N58 is a non-conserved residue within motif IA. Substitution by a cysteine did not 
alter the enzyme activity relative to the wildtype. The same was observed for the D186C 
mutant. The residue at this position is conserved, either as an aspartic acid or a proline 
and it is located close to the Walker B box. One would assume that amino acid 
replacements at this position may influence ATP hydrolysis, but it seemed that this 
residue is not critical for catalysis. 
 A511 is also not conserved and is situated in motif VI. The mutant protein 
exhibited wildtype helicase activity during the first minute, then strand displacement 
activity appeared to come to a halt. The assays were carried out with an excess of protein 
therefore one would assume that all DNA substrates are occupied by proteins before the 
reaction is initiated. Slower rebinding after substrate release can thus be excluded. One 
possibility is that the protein sample used represented a mixture of active and inactive 
enzyme and only the DNA substrates occupied with active XPD proteins contributed to 
the observed helicase activity.  
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Figure 4.10: Native acrylamide gels showing helicase activities of mutants with and 
without spin-label 
Representative 12 % acrylamide gels of helicase assays. The upper bands show dsDNA, 
lower bands represent the radiolabelled ssDNA arising if unwinding takes place. UL, 
unlabelled (no SDSLs attached), SP, spin-labelled (SDSLs attached). Time points were: 
30, 60, 90, 120, 180, 300 s.  
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Figure 4.11: Quantification results showing helicase activities of mutants with and 
without spin-label 
Quantification results of triplicate helicase experiments comparing XPD mutants with 
and without spin-label are shown and standard errors are indicated. The zero time point 
was given a value of DNA unwinding = zero. WT is shown as positive control. Data 
points were fitted to a smooth curve. 
 
4.10 MONITORING ATPASE ACTIVITY UNDER DIFFERENT CONDITIONS 
4.10.1 Single and double stranded DNA stimulation of the ATPase activity 
 Most NTPases show nucleic acid stimulation of their NTP hydrolysing activity. The 
majority of helicases are stimulated by single stranded nucleic acid although a few show 
double stranded nucleic acid stimulation (Singleton & Wigley (2002); Tuteja & Tuteja 
(2004)). Many helicases also show a very low basic level of NTP hydrolysis activity 
(Levin & Patel (2003)). The stimulation of the ATPase activity of XPD was investigated 
by using PhiX174 virion (ssDNA) and RFII DNA (dsDNA). The protein concentration 
used was 50 nM. This ensured accurate absorbance readings at later time points and that 
all proteins were bound to DNA. The C88S and K84H mutants were chosen as 
representative examples for enzymes without FeS cluster (Class I) and those with an 
instable cluster (Class II). Results were compared to the wildtype protein and are shown 
in Figure 4.12. 
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 no DNA ssDNA dsDNA 
K84H 3 10.6 0.03 
C88S 2 11.6 0.4 
WT 1 9.6 0.06 
 
 
 
 
 
Figure 4.12: ATPase activity of XPD wildtype and mutants in the absence and 
presence of DNA 
The graph shows results from triplicate experiments for wildtype and mutant enzymes 
with ssDNA, dsDNA and without DNA. Time points were: 20, 40, 60, 90, 120, 180, 300 
s. Data were fitted to a linear regression and standard errors are indicated. The table 
summarises the results of the ATPase assays for the wildtype and the two mutant 
proteins. Numbers indicate ATP hydrolysed/ second in pmol.  
 
 Wildtype and mutant XPD showed similar rates of ATP hydrolysis with ssDNA 
and dsDNA, as well as without DNA (Figure 4.12). This indicates that the ATPase 
activity is not dependent on the presence of the FeS cluster. This means, that the loss of 
the FeS cluster uncouples the ATPase and helicase activity. Mutant and wildtype XPD 
showed ssDNA stimulated ATPase activity with a rate of approximately 10 moles ATP 
hydrolysed per second (~ 0.7 mol ATP sec-1 per mol XPD). There was a general trend 
where mutants with uncoupled helicase and ATPase activity showed a slightly higher 
ATP hydrolysing activity than the wildtype (data not shown). A very low background 
was observed without DNA (1-3 ATP sec-1) and binding to dsDNA completely inhibited 
ATP hydrolysis (0.03-0.4 ATP sec-1). An initial lag phase, typical for pre-steady state 
kinetics, was observed (Eoff et al. (2005); Figure 4.12). It arises from the fact that the 
enzymes pre-bound to DNA have to undergo several conformational changes after 
addition of ATP/ MgCl2 before they can hydrolyse ATP and release the product (ADP 
and Pi).  
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 XPD is a monomer in solution. Monomeric helicases have two sites of DNA (ds/ 
ss) binding per monomer. Binding to ssDNA with the ssDNA binding site induces the 
correct domain movements and enables the enzyme to efficiently bind and hydrolyse 
ATP. Binding to dsDNA with the dsDNA binding site induces domain movement that 
leads to an incorrectly formed ATP binding pocket. This leads to an inability of the 
enzyme to bind and/ or hydrolyse ATP and inhibition of the ATPase activity is observed. 
In solution, a basal ATP hydrolysing activity is seen, due to the fact that the flexible 
enzyme may occasionally adopt the correct conformation of the ATP binding pocket, and 
hydrolyses ATP (Korolev et al. (1997), Velankar et al. (1999), Soultanas & Wigley 
(2000)). 
 
 All other mutants were then tested and all showed ssDNA dependent ATPase 
activities similar or slightly higher than the wildtype, with a few exceptions (data not 
shown). No free phosphates were detected for XPD-K35A. This mutation is located in the 
Walker A box and leads to an inability to hydrolyse ATP (Sung et al. (1988)). The 
C523R and G447D mutants showed extremely low activities, with 1.5 ATP hydrolysed 
sec-1 (Figure 4.7). The R531W mutant showed an ATP hydrolysing rate approximately 
half of that of the wildtype enzyme (see also Table 4.2.). 
 
4.10.2 ATPase activity on different lengths of oligonucleotides 
 Reactions were carried out to investigate if the FeS cluster of XPD is necessary for 
translocation of the enzyme along ssDNA. For this experiment two representative 
mutants were chosen, which contained an instable (K84H) and no FeS cluster (C88S), 
respectively, and were compared to the wildtype XPD. It was found that the rate of ATP 
hydrolysis is directly proportional to the length of the oligonucleotide (Young et al. 
(1994)). Hydrolysis of one ATP molecule is directly coupled to movement of the helicase 
of one step-size (a specific number of bases) along the DNA. Thus, the longer the 
oligonucleotide, the more ATP is hydrolysed before the enzyme releases the DNA strand. 
The two different approaches to test this are visualised in Figure 4.13. 
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Figure 4.13: Schematic of the two different approaches to investigate translocation 
by measuring ATPase rates 
The figure depicts the different setups described in 4.10.2.1 and 4.10.2.2. The black lines 
symbolise the numbers of available single DNA strands of an 25mer compared to an 
50mer oligonucleotide. 
 
4.10.2.1 ATPase activity of XPD using identical concentrations of oligonucleotide 
 Different lengths of ssDNA using identical concentrations of oligonucleotides (5 
nM; Figure 4.13) led to an increase of ATPase activity, which was directly proportional 
to the length of the oligonucleotide (Figure 4.14). The maximum rate appeared to be 
reached with 100 nt for mutants K84H and C88S, because no further increase was 
observed by using circular PhiX174 virion DNA. The wildtype exhibited slightly lower 
ATP hydrolysing rates, as was observed before (4.10.1). All tested XPD proteins reached 
a maximum rate of between 30 and 35 mol ATP hydrolysed per second (~ 0.5 - 0.7 mol 
ATP sec-1 per mol XPD). 
 The translocation rate for the PcrA helicase has been calculated to be 50 bases/ 
second, with a step size of 1 ATP/ base. In these experiments different lengths of ssDNA 
with identical concentrations of oligonucleotide were used and the oligonucleotide was in 
excess (8 µM) to PcrA (0.1 µM) (Dillingham et al. (2000)).  
 In the experiments described in this section, the concentration of oligonucleotide 
was low (5 nM), due to limited availability compared to an excess (200 nM) of protein. 
This could lead to the effect that the longer the oligonucleotide, the more proteins can 
bind and the observed increase in ATPase activity is solely due to the fact that more 
ATPases are stimulated. Hence, translocation cannot be proven. Considering that XPD 
25mer 50mer 25mer 50mer 
= = 
Identical concentrations of 
nucleotides = identical 
numbers of binding sites 
Identical concentrations of 
oligonucleotides = identical 
numbers of DNA strands 
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was in 40-fold excess over DNA substrate, even the 100 nt oligonucleotide would not 
provide enough binding sites for all proteins to bind. Nonetheless, maximum ATP 
hydrolysing rates were reached for the mutant proteins with an oligonucleotide length of 
100 nt and no further increase with longer ssDNA substrates was observed (Figure 4.14).  
There are several possibilities to explain these results. It could mean that when the 100 nt 
oligonucleotides were used, all proteins were already bound to nucleic acid and ATPase 
activity is stimulated, but no translocation occurs. On the other hand it could mean that all 
protein molecules were bound to the 100 nt oligonucleotide and maximum translocation 
rates are already reached and therefore no further increase in ATPase activity is observed 
using the PhiX174 ssDNA. But in contrast to this, the wildtype enzyme (which is 
assumed to be able to translocate along ssDNA) showed only approximately 60 % of its 
maximum ATPase activity when the 100 nt oligonucleotide was used, while the endpoint 
of maximum ATP hydrolysing rate was slightly higher than the ones observed for the 
mutant proteins. This could indicate, that mutants and wildtype have different step sizes 
(ATP hydrolysed/ base) when they are tracking along ssDNA. The loss of the FeS cluster 
in mutant proteins might not only lead to an uncoupling of ATPase and helicase activity, 
but also to the effect that mutants hydrolyse more ATP to track one base further along 
ssDNA than the wildtype enzyme, while maximum ATPase rates are approximately the 
same. This would lead to the observed effect that mutants reach maximum rates faster 
under the experimental conditions than the wildtype. It would also indicate that mutants 
without FeS cluster are able to translocate, although in a less efficient manner compared 
to the wildtype enzyme. Further experiments have to be carried out to fully prove 
translocation ability of mutant XPD proteins.  
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4: CHARACTERISATION OF XPD MUTANTS 
 112 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14: Rates of ATP hydrolysis with equal numbers of single DNA strands 
The table shows obtained rates with different lengths of ssDNA. Concentrations were: 
DNA, 5 nM (oligonucleotide); protein, 200 nM. The assays were carried out at 45 ˚C. 
Time points (20, 40, 60, 90, 120, 180, 300 s) were plotted against the free phosphates, 
which were released after ATP was hydrolysed. The rate of ATPs hydrolysed sec-1 was 
obtained by linear regression. The rates were plotted against the length of the DNA 
strands and visualized on a half-logarithmic scale. Experiments were carried out in 
duplicate. 
 
4.10.2.2 ATPase activity of XPD using identical concentrations of nucleotides 
 Compared to the setup described in the previous section, this experiment keeps 
available binding sites constant, rather than the number of single DNA strands (Figure 
4.13). The concentration of nucleotides used was 2 µM, the protein concentration was 
reduced to 20 nM and the experiments carried out at 55 ˚C. 
 By using identical concentrations of nucleotides the ATPase activity only 
increased until a length of 25 nt (Figure 4.15). One possibility is that there were too few 
oligonucleotides available for binding as the length of the DNA strands increased, which 
led to the observed decrease in ATP hydrolysis with longer oligonucleotides.  
 The more likely explanation is that the concentration of the oligonucleotides used 
was inaccurate, as they were not gel purified prior to use. Therefore it is possible, that the 
oligonucleotide samples presented a mixture of different oligonucleotide lengths that 
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length ATP hydrolysed sec-1 
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6 1.3 2.7 2.6 
14 3.8 6.1 3.6 
25 4 8.9 7.1 
50 8.4 16.6 14.8 
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would lead to an incorrect calculation of the concentration of nucleotides after UV 
absorbance readings. The nucleotide concentration of the PhiX174X ssDNA was correct, 
as supplied by the manufacturer.  
 To make a valid comparison of the data shown in Figure 4.15 with experiments 
described in section 4.10.2.1 the protein concentration used has to be considered 10 times 
higher in the latter experiment. Hence, maximum ATPase rates observed with PhiX174 
ssDNA in the experiments described in this section are approximately double compared 
to the ones in the previous section. This is an effect of the increased temperature used in 
the setup described in this section (55 ˚C instead of 45 ˚C). The only obvious difference 
when the rates of ATP hydrolysis are compared between the two different experimental 
setups is that the mutant proteins showed higher maximum ATPase rates (Figure 4.15) 
(1.4-1.5 ATP sec-1 per molecule XPD for PhiX174 DNA) than the wildtype enzyme (1.1 
ATP sec-1 per molecule XPD for PhiX174 DNA). This would match the smaller step 
sizes of mutants without FeS cluster compared to the wildtype, as described in section 
4.10.2.2, only that maximum ATPase rates also increase.  
 As stated for the previous section, these experiments do not prove translocation of 
mutants without FeS cluster and experiments to elucidate this are ongoing. 
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Figure 4.15: Rates of ATP hydrolysis with equal numbers of nucleotides 
The table shows ATP hydrolysis rates obtained with different lengths of ssDNA. 
Concentrations were: DNA, 2 µM (nucleotides); protein, 20 nM. The assays were carried 
out at 55 ˚C.  Time points (20, 40, 60, 90, 120, 180, 300 s) were plotted against the free 
phosphates, which were released after ATP was hydrolysed. The rate of ATPs hydrolysed 
sec-1 was obtained by linear regression. The rates were plotted against the length of the 
DNA strands and visualized on a half-logarithmic scale. This experiment was only 
carried out once. 
 
4.10.3 ATPase activity using different concentrations of ATP 
Reactions were carried out as described previously using 200 nM protein and 0.5 
nM PhiX174 virion DNA with different concentrations of ATP:MgCl2 (0, 0.1, 0.2, 0.5, 1, 
2, 5, 10 mM). Reactions were stopped at specific time points (20, 40, 60, 90, 120, 180, 
300 s) and results fitted to a linear fit (Figure 4.16).  
 
 
 
 
 
 
 
Oligonucleotide WT K84H C88S 
length ATP hydrolysed sec-1 
0 1 3 2 
6 8.4 7 4.5 
14 13.5 11.7 11.7 
25 14.7 13 11.2 
50 9.4 7.1 5 
70 10 9.6 7.6 
100 6.6 6.6 7.1 
5800 6.7 8.5 8.8 
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ATP hydrolysed s-1 ATP concentration 
(mM) WT C88S K84H 
0 0.3 -0.1 0.1 
0.1 4.3 4.6 3.1 
0.2 13.2 18.1 14.3 
0.5 24.4 30.9 35.9 
1.0 30.4 35.3 38.6 
2.0 29.5 37.9 34.9 
5.0 22.2 25.8 28.1 
10.0 8.3 10.6 10.2 
Figure 4.16: Influence of the ATP concentration on the ATPase activity of XPD 
The plots on the top of the figure show data of ssDNA stimulated ATPase activity of 
XPD wildtype and two representative mutants from duplicate experiments. Reactions 
were initiated using different concentrations of ATP/ MgCl2. Time points were 20, 40, 
60, 90, 120, 180 and 300 s. Data were fitted to a linear fit and standard errors are 
indicated. The rates obtained from the linear regression are summarized in the table on 
the bottom of the figure. 
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 Km ± 
standard error 
(mM) 
Vmax ± 
standard error 
(pmol s-1) 
WT 0.36 ± 0.13 38 ± 4.5 
C88S 0.35 ± 0.12 46.9 ± 5.4 
K84H 0.35 ± 0.22 47.5 ± 9.8 
 
 
Figure 4.17: Rates of ATP hydrolysis depending on the ATP concentration 
The rates (per second) shown in the table in Figure 4.16 were plotted against the ATP 
concentration and data points up to 2 mM ATP fitted to Michaelis-Menten kinetics. Km 
(mM ATP) and Vmax values (pmol ATP hydrolysed per second) are shown in the table. 
The graph shows the WT with red circles, C88S in black triangles and K84H in blue 
squares. All reactions were carried out in duplicate. 
 
 As seen from the standard errors in Figure 4.17, the Michaelis-Menten fit was not 
very good. This was due to an inhibition of the ATPase activity above 1 mM ATP/ 
MgCl2. The Km values are in good agreement with rates measured for wildtype XPD 
using different concentrations of ATP in helicase assays (Chapter 3). The maximum 
ATPase activity was obtained with approximately 0.35 mM ATP/ MgCl2 for wildtype 
and mutant enzymes. As previously observed, the mutants showed slightly higher ATP 
hydrolysing activity compared to the wildtype protein (4.10.1).  
 The inhibition at higher concentration of ATP/ MgCl2 may be due to a general 
inhibitory effect of high concentrations of magnesium ions on the enzymatic activity. It 
was reported that magnesium concentrations above 4 mM inhibit the enzymatic activity 
of hXPD, while increasing concentrations of ATP increased the enzyme activity (Dubaele 
et al. (2003)). Therefore, it has yet to be tested if the inhibitory effect is due to an 
inhibition by ATP or by Mg2+-ions.  
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4.11 SUMMARY AND CONCLUSIONS 
 Archaea are excellent models for studying eukaryotic DNA repair pathways. This 
chapter showed how work on an archaeal protein can lead to the discovery of completely 
new features of the human homologue and can help to understand the pathology of 
human disorders such as TTD and Fanconi anemia. 
 This chapter demonstrated the importance of the FeS cluster for the helicase 
activity of XPD. It showed that three of the four conserved cysteines are involved in 
coordination of the FeS cluster consistent with findings that wildtype XPD binds a 3Fe-
4S cluster as described in the previous chapter. The cluster was shown to be essential for 
DNA unwinding but not for ATPase activity. Indeed, mutants which do not coordinate a 
(stable) FeS cluster were still able to hydrolyse ATP and most likely translocate along 
DNA, while they were no longer able to unwind DNA (a summary is given in Table 4.2). 
Hence, destruction of the FeS cluster uncouples helicase and ATPase activity.  
 Strong evidence was provided for the existence of the FeS cluster in hXPD and 
other related human helicases such as FancJ, which takes part in the Fanconi anemia 
pathway. Indeed, the human mutation R112H was shown to abolish the helicase activity 
of hXPD, the reason for which was unclear (Dubaele et al. (2003)). Here it was shown, 
that this mutation and the FancJ-A349P mutation disrupt the FeS cluster and inactivate 
the helicase activity. The presence of the cluster was also confirmed in vivo, using S. 
cerevisiae as an eukaryotic model. The UV sensitivity of corresponding mutations, which 
were known to disrupt the FeS cluster in S. acidocaldarius were evaluated in yeast. This 
study was also strengthened by an earlier study on Chinese hamster ovary cell lines, 
where one cell line (UV-5) was found to possess the XPD mutation C116Y (equals Rad3-
C115; Table 4.2), which caused a highly UV-sensitive phenotype (Weber et al. (1994)). 
 Other human mutations on the C-terminus of hXPD were introduced in S. 
acidocaldarius XPD and characterised. All mutations abolished the helicase activity in 
accordance with findings in hXPD, but no uncoupling of helicase and ATPase activity 
was observed. The two mutations G447D and C523R abolished the ATPase activity of 
SacXPD, although the latter is not located in one of the conserved motifs. In human, the 
R683W mutation abolishes the interaction with the p44 subunit of TFIIH, which 
stimulates the helicase activity of XPD (Dubaele et al. (2003)). On the contrary, archaeal 
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XPD is functional as a monomer and its helicase activity is not likely to be further 
stimulated by binding to a partner protein. The equivalent mutation in S. acidocaldarius 
(R531W) leads to a low ATPase activity, which could be explained by a weak interaction 
with ssDNA (Chapter 5). This weak interaction could cause the mutant protein to easily 
fall off the DNA substrate, which would in turn disable the helicase from unwinding 
dsDNA. Indeed, SacXPD-R531W did not exhibit helicase activity.  
 The FeS cluster most likely plays a structural role by stabilising a fold similar to the 
UvrB beta-hairpin (Figure 4.18; reviewed in Theis et al. (2000)). This fold extrudes from 
the protein structure and could be inserted into the DNA substrate near the ss/ dsDNA 
fork. When XPD translocates along DNA, this hairpin structure could either be used to 
physically disrupt the hydrogen bonds between base pairs or to lock one single DNA 
strand to the enzyme and actively distort the ss/ dsDNA fork, which would subsequently 
lead to duplex destabilisation. If the FeS cluster is not present, the hairpin cannot be 
formed and the ability to unwind DNA will be lost.  
 This chapter has shown, how mutagenesis studies can be used effectively to 
investigate the function of the FeS cluster of XPD. The results presented have also shown 
the FeS cluster to be essential for the strand displacement activity of the helicase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4: CHARACTERISATION OF XPD MUTANTS 
 119 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18: Hypothetical model of UvrB-DNA pre-incision complex 
The UvrB protein is shown as a space-filled model in grey, the DNA phosphate backbone 
is shown in red and the beta-hairpin extruding from the protein in cyan. [adapted from 
Theis et al. (2000)]. The beta-hairpin is inserted into the DNA duplex and locks UvrB 
near the site of damage, which leads to the release of UvrA and the recruitment of UvrC. 
In XPD a similar structure could be used to actively disrupt base pairing during 
translocation. 
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Table 4.2: Summary of XPD mutations 
Mutation Phenotype     
SacXPD hXPD Rad3p (human/ yeast) Helicase? ATPase? FeS? 
K35A ND/ 
(G47R) 
K48A (XP)/ high UV 
sensitivity 
N N stable 
F38C ND ND ND N N stable 
N58C ND ND ND Y Y stable 
K84H R112H R111H TTD/ mild UV-
sensitivity 
N Y unstable 
C88S ND C115S ND / High UV 
sensitivity 
N Y non 
C102S ND ND ND Y Y stable 
C105S ND ND ND N Y non 
F136P A349P ND FA/ ND N Y unstable 
C137S ND ND ND N Y non 
Y139F ND ND ND Y* Y stable 
Y140F ND ND ND Y Y stable 
Y139A/ 
Y140A 
ND ND ND N Y unstable 
Y156A/ 
Y158A 
ND ND ND Y* Y stable 
D186C ND ND ND Y Y stable 
G447D G602D ND CS + XP/ ND N N stable 
A511C ND ND ND Y** Y stable 
C523R G675R ND CS + XP/ ND N N stable 
R531W R683W ND XP/ ND N Y** stable 
X-3CS ND ND ND Y Y stable 
Table 4.2 shows a summary of all XPD/ Rad3 mutants described in this chapter. SacXPD, 
S. acidocaldarius XPD; hXPD, human XPD; Rad3p, orthologue of XPD in S. 
cerrevisiae; FancJ, human helicase FancJ (Fanconi anemia); FeS?, FeS cluster present?; 
X-3CS, XPD-C360S/ C523S/ C543S; ND, not defined; Y, mutant shows WT activity; 
Y*, activity slightly reduced relative to the WT; Y**, activity ~ 50 % reduced compared 
to the WT; N, no activity detected; XP, xeroderma pigmentosum; TTD, 
trichothiodystrophy; CS, Cockayne Syndrome; FA, Fanconi anemia. 
 
5 DOMAIN ARRANGEMENT OF XPD 
AND INTERACTIONS WITH DNA AND OTHER 
PROTEINS 
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5.1 INTRODUCTION 
 In solution helicases are highly flexible enzymes. Large domain movements are 
observed upon binding to nucleic acid and during NTP binding and hydrolysis cycles. 
Some helicases also oligomerise following binding to nucleic acid, which changes their 
mode of action as was described in Chapter 1. This will be investigated for the case of 
XPD from S. acidocaldarius. 
 This chapter will also investigate changes in domain organisation when XPD is in 
the open or closed conformation. One of the best studied helicases is the SF1 helicase 
PcrA. Crystal structures revealed four domains, which were entitled 1A, 1B, 2A and 2B 
(Subramanya et al. (1998); Figure 5.1). It was hypothesised that domains 1A and 2A are 
common to all SF1 and SF2 helicases (Bird et al. (1998)). They are generally called the 
RecA-like motor domains, due to their similarity and first identification in the RecA 
enzyme (Story et al. (1992)). Domains 1A and 2A contain the seven conserved motifs 
and form a cleft for nucleotide binding. This cleft opens and closes while ATP is bound 
and hydrolysed (Velankar et al. (1999)). Domain 1A and 2A mediate ssDNA binding, 
while domains 1B and 2B, at least in PcrA and Rep helicases, are involved in dsDNA 
binding (Korolev et al. (1997); Velankar et al. (1999)). The two latter domains show high 
variability between helicases and are sometimes completely absent (Figure 5.2; reviewed 
in Singleton & Wigley (2002)).  
 
 
 
 
 
 
Figure 5.1: Contribution of the helicase motifs and their affiliations to the RecA-like 
motor domains 
On the left the domain and helicase motif distribution of the SF1 helicase Rep is shown 
and compared to an SF2 helicase (NS3 from hepatitis C virus) on the right. The TxGx 
motif was originally identified by Pause & Sonenberg (1992) for members of the 
DEX(D/H) helicase family to be involved in ssDNA binding (Figure adapted from 
Korolev et al. (1998)) 
1A 1B 1A 2A 2B 2A 1A 2A 3 
I IA TxGx II III IV IVa V VI 
N C C N 
I IA 
TxGx 
II III IV IVa V 
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 As described in Chapter 3, the FeS cluster domain of XPD is located between 
helicase Walker A and B boxes. Hence, it could either represent domain 1A or 1B. This 
chapter will investigate DNA binding of XPD wildtype and mutants to different DNA 
constructs, as well as the influence of ATP.  
 In eukarya, XPD is part of a multi-subunit complex which regulates and stimulates 
its enzymatic activity. In archaea it is a monomer in solution and the question, whether 
XPD interacts with other proteins will be addressed in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Structural conservation of the RecA-like motor domains 
Crystal structures of different SF1 and SF2 helicases are shown. Domain 1A (blue) and 
2A (red) are indicated. A, PcrA from Bacillus stearothermophilus (SF1); B, Rep from E. 
coli (SF1); C, NS3 helicase domain from hepatitis C virus (SF2); D, eIF4A-type RNA 
helicase from Methanococcus jannaschii (SF2); E, UvrB from Thermus thermophilus 
(SF2); F, RecG from Thermotoga maritima (SF2) (Figure adapted from Singleton & 
Wigley (2002)).  
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5.2 TRYPTIC DIGESTION 
5.2.1 Domain mapping of wildtype protein and a “clusterfree” cysteine mutant 
 Tryptic digestion was used to identify possible domains of the XPD wildtype 
protein and examine differences in a mutant without the FeS cluster (C88S, for 
characterisation see Chapter 4). The wildtype protein showed seven major fragments after 
a 90 min incubation, indicating a highly flexible domain organization. There were 
obvious differences in the digestion pattern between wildtype and mutant. The mutant 
showed only five major protein bands arising after 90 min, some of which are completely 
different to the wildtype (Figure 5.4). Major protein fragments were analyzed by N-
terminal sequencing and/ or mass spectrometry (Table 5.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: Analysis of XPD domain structure by tryptic digestion 
The protein gel shows the migration of tryptic fragments of XPD. Numbers on the right 
indicate protein bands, which were analysed by N-terminal sequencing or mass 
spectrometry. Samples of wildtype (with cluster) and C88S (no cluster) were incubated 
10 and 90 min, respectively, at 30 ˚C, before reactions were stopped.  
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Table 5.1: Results of analysed peptides after tryptic digestion 
Fragment N-Terminal 
Sequence 
Mass spec, 
possible 
fragment 
MW (kDa) 
estimated 
from gel 
MW (kDa) 
from 
protparam 
analysis 1 
Origin of 
the band 
1 (K73)RNITF N(75)  K(538) 55.5 54.2 wildtype 
2 - G(94)  K(538) 50.0 52.1 C88S 
3 (K73)RNITF N(75)  R(373) 37.8 35.1 wildtype 
4 (K73)RNITF N(75)  K(369) 35.8 34.2 wildtype 
5 - G(94)  K(352) 30.3 29.2 C88S 
6 (K128)KDGLQ K(129)  K(352) 27.4 26.6 wildtype 
7 (M372)RSDNM S(374) K(538) 22.1 19.4 wildtype 
8 (M372)RSDNM S(374) R(460) 10.4 10.1 wildtype 
9 (M1)AKLRD L(4)  K(49) 5.5 5.5 wildtype 
1 http://www.expasy.ch/tools/protparam.html 
Table 5.1 summarizes the results obtained by mass spectrometry and N-terminal 
sequencing for selected peptide bands from both wildtype XPD and C88S mutant. The 
numbers of the fragments in the first column on the left refer to the indicated bands in 
Figure 5.3. The accurate molecular masses of the bands from the SDS-gel were obtained 
by linear regression by plotting the molecular weight of the marker bands against the 
logarithm of the distance the marker proteins migrated in the gel. 
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Figure 5.4: Possible tryptic digestion pattern of XPD wildtype and C88S mutant 
Schematic domain structure of the XPD protein (wildtype and mutant) is shown. The 
seven conserved helicase motifs are indicated in green and the FeS domain is shown in 
brown (wildtype) and gold (C88S), respectively. The arrows indicated trypsin sensitive 
sites relative to the helicase motifs and the FeS cluster domain. Sites confirmed by N-
terminal sequencing are indicated with black arrows and assumed sites (mass 
spectrometry data only) with grey arrows. The major cleavage site on the N-terminus of 
the wildtype and mutant protein is indicated with a “X”.  
 
 Without N-terminal sequence information for the tryptic fragments generated from 
the C88S mutant it would be difficult to determine with any certainty where the trypsin 
sensitive sites are positioned if only using the mass spectrometry data. As seen from 
Figure 5.3 the first incision site in C88S changes the position in the “clusterfree” mutant 
when compared to the first incision site in the wildtype. This leads to a 5 kDa smaller C-
terminal fragment and an intense protein band of about 13 kDa, which resembles the N-
terminal peptide (number 10, Figure 5.3). However, the peptide could not be identified by 
mass spectrometry. This experiment confirmed local structural changes upon loss of the 
FeS cluster as seen in the spectrum obtained by CD spectroscopy (Chapter 4, Figure 1.3). 
Data for other proteolytic fragments of the mutant protein obtained by mass spectrometry 
were not very conclusive. It would be useful to obtain N-terminal sequence information 
on these fragments.  
 The domain organisation of XPD can only be assumed (Figure 5.5). Most likely the 
FeS cluster domain is distinct from the domains harbouring motifs I, IA and II, because 
incisions are made by trypsin on both sides of the cluster. Since all helicase motifs must 
be located in domains 1A and 2A, the following domain organisation could be possible 
(Figure 5.5): Motifs I, IA and II are part of domain 1A; the FeS cluster represents an 
I IA II III IV V VI FeS 
WT 
FeS I IA II III IV V VI 
C88S 
X 
X 
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insertion and resembles domain 1B; the C-terminal motifs are located in domain 2A. This 
is, despite the fact that there is a major tryptic sensitive site between motif III and IV 
(Figure 5.4), which could indicate that motif III does not belong to domain 2A. The 
insertion between motif II and III could represent domain 2B.  
 The reason for the observed trypsin sensitive site between motifs III and IV in XPD 
could be a loop structure, which was found to couple ATP hydrolysis to DNA binding 
(and subsequently translocation) in SF1 helicases. In the helicases PcrA (motif III loop) 
and Rep (loop2) this loop structure was found to be part of motif III. In the SF2 helicase 
RecQ, the so-called aromatic-rich loop was located between motifs II and III. It is 
possible that this loop structure is also present in XPD, located between motifs III and IV, 
leading to an additional tryptic sensitive site within domain 2A (Korolev et al. (1997); 
Velankar et al. (1999); Dillingham et al. (1999); Zittel & Keck (2005)). 
 
 
 
 
 
Figure 5.5: Possible domain organisation of S. acidocaldarius XPD 
The upper figure represents a schematic representation of the secondary structure 
elements in XPD. The conserved helicase motifs are in green, the FeS cluster domain is 
in brown. The lower figure demonstrates a possible distribution of the two RecA-like 
motor domains (1A and 2A) in orange and blue, respectively. The additional domains 1B 
and 2B are presented in grey and magenta. The FeS cluster domain could represent an 
insertion (domain 1B) into domain 1A. 
 
 
 
 
 
 
 
 
 
I IA II III IV V VI FeS 
1A 1A 1B 2B 2A 
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5.2.2 Influence of ADP on the tryptic digestion pattern 
 To investigate the domain structure of wildtype XPD and the C88S mutant protein 
upon binding of ADP, samples were incubated 90 min with and without 1 mM ADP/ 
MgCl2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: Influence of ADP on the domain structure of XPD 
SDS-PAGE showing tryptic digest fragments of XPD in the absence and presence of 
MgADP. Samples were incubated 90 min at 30 ˚C before inactivation of trypsin.  
 
 The binding of ADP led to a striking structural change in the enzyme (Figure 5.6) 
and protection of almost all trypsin sensitive sites was observed. Most of the wildtype 
protein persisted as full length after 90 min incubation with trypsin. This is consistent 
with the hypothesis that helicases undergo large domain movements following binding of 
ATP/ ADP and transform from an open conformation to a more compact closed 
conformation. This event brings the helicase motifs in close three-dimensional proximity, 
ready to detach the terminal phosphate from ATP. It was also suggested that the gamma 
phosphate group functions as a molecular switch, which induces domain swivelling and 
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eventually results in translocation along nucleic acids (Korolev et al. (1997); Lorsch & 
Herschlag (1998)).  
 Interestingly, the first tryptic sensitive site from the N-terminus of the C88S mutant 
remained unprotected and available for tryptic digestion, while all other protein 
fragments disappeared (Figure 5.6). This site is located within the FeS cluster domain in 
clusterfree mutants (Figure 5.4). The ATP binding and hydrolysing pocket is still 
correctly formed, as this mutant showed ssDNA stimulated ATPase activity (Chapter 4). 
DNA binding is also not affected (section 5.4.3). Therefore, the hypothesis of stabilizing 
a region or fold by the FeS cluster is strengthened by the observation that ADP binding 
protects this area completely when the cluster is present. In mutants without cluster the 
amino acid chain may extrude from the protein and present a target for trypsin.  
 
5.3 OLIGOMERIC STATE OF XPD UPON BINDING TO DNA 
 Some helicases, such as Rep or UvrB are monomers in solution, but the active form 
of the enzymes is a dimer, which assembles upon binding to nucleic acid (Chao & 
Lohman (1991); Verhoeven et al. (2002b)). The following experiments were carried out 
to investigate if the active form of S. acidocaldarius XPD is a monomer or an oligomer. 
This was performed by analytical gel filtration chromatography. XPD was incubated for 
30 min at room temperature with ATP-γS and a 5 nt or 14 nt oligonucleotide before the 
mixture was applied to a Superose 6 analytical column. The control samples (XPD 
without DNA and DNA without XPD) were set up in the same way and ATP-γS was 
added to the reaction buffer. 
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 MW (kDa) 
5 nt ssDNA 14.1 
XPD 35.4 
XPD + 10 µM ssDNA 37.1 
XPD + 20 µM ssDNA 35.5 
 
 
 
 
 
 
 
 
 
 
 
 MW (kDa) 
14 nt ssDNA 24.3 
XPD 35.4 
XPD + 10 µM ssDNA 45.3 
XPD + 30 µM ssDNA 48.6 
 
 
 
 
 
 
 
 
 
Figure 5.7: Oligomeric state of XPD upon DNA binding 
Superose 6 column elution volumes and calculated masses derived from a standard curve 
using proteins of known molecular masses. Controls were XPD without DNA and DNA 
without XPD and all samples were setup using the same conditions (including ATP-γS). 
Ve, elution volume; V0, void volume; MW, molecular mass. (A) Binding of XPD to a 5 
dT single stranded oligonucleotide. (B) Binding of XPD to a 14 dT single stranded 
oligonucleotide. Calculated masses are shown in the tables on the right. 
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 The molecular mass of XPD estimated from analytical gel filtration is rather low 
(35 kDa) compared to its expected mass of 64 kDa. Nevertheless, the intact protein mass 
was identified as full-length XPD by mass spectrometry. One likely reason for this size 
discrepancy could be, that after binding to the non-hydrolysable ATP-analogue ATP-γS, 
XPD changes into its closed conformation thus leading to a smaller diameter of the 
protein globular shape and retarding its passing through the superose column matrix. A 
lower mass for XPD was also observed in gel filtration chromatography using the 
Superdex 200 matrix, in the last step of protein purification. Here the buffers were 
virtually ATP-free and the calculated molecular mass of 48 kDa represents the open 
conformation of XPD, which is also likely to be tightly folded.  
 XPD bound ssDNA as a monomer. XPD-DNA binding was only observed in the 
presence of the 14 nt oligonucleotide, suggesting that the minimum DNA binding site of 
XPD exceeds 5 nt and stable protein-DNA interactions do not occur with 
oligonucleotides of 5 nt length (Figure 5.7). As seen from Figure 5.7B, XPD binds to the 
14 nt ssDNA oligonucleotide, inducing a molecular mass shift of around 10 kDa relative 
to the sample that contained XPD only. This mass shift was not observed upon addition 
of a 5 nt oligonucleotide (Figure 5.7A). Small molecular mass differences between 
samples containing 10 and 30 µM dT14 DNA can arise due to differences in sample 
loading (Figure 5.7B). In general, it does not imply that XPD forms higher complexes 
upon binding to ssDNA indicating that the active form is also a monomer. From these 
experiments, there is a high possibility that the active form of XPD is a monomer. If 
dimer formation was to occur upon binding DNA, the expected molecular mass of the 
complex would be at least 70-80 kDa based on the elution volume.  
 Preliminary data obtained using Isothermal Titration Calorimetry (ITC) showed 
similar results. No XPD-DNA binding was obtained using a 6 nt long oligonucleotide, 
while 14 nt and 20 nt were bound efficiently. An increase in binding affinity was 
observed when using the 20 nt instead of the 14 nt oligonucleotide, consistent with a 
higher affinity to DNA with increasing length. (For ITC data see Appendix 2. Results are 
preliminary and experiments have to be repeated.) 
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5.4 XPD-DNA BINDING – ELECTROPHORETIC MOBILITY SHIFT ASSAYS 
(EMSA)  
5.4.1 Defining buffer conditions for EMSA 
 Conditions were tested using high (20 mM HEPES, pH 7.6, 2 mM DTT, 200 mM 
NaCl, 0.002 % Triton-X) and low (20 mM HEPES, pH 7.6, 2 mM DTT, 50 mM NaCl, 
0.002 % Triton-X) salt buffer, 10 nM duplex or 5’ overhang DNA substrate (B50/ 
B50comp and B1-25/ X50, respectively; see Appendix 1 Table 2) with and without 0.1 
mg/ mL calf thymus DNA. XPD protein concentrations used were 0 and 10 µM and BSA 
at 0.1 mg/ mL.  
  As shown in Figure 5.8, duplex and 5’ overhang DNA substrates were bound 
with similar affinities to XPD. As expected, salt concentrations had the main influence on 
binding. For further experiments 50 mM NaCl was used. Calf thymus DNA also inhibited 
binding of XPD to DNA substrates, probably due to an increase of available DNA 
binding sites. Therefore, calf thymus DNA was excluded from further experiments.  
 
  
 
 
 
 
 
 
 
 
 
Figure 5.8: Wildtype-XPD DNA binding under different buffer conditions 
Fractions of DNA bound are plotted against the reaction conditions. H, high salt (200 
mM NaCl); L, low salt (50 mM NaCl); ds, double strand DNA (50 nt length); 5’, 5’ 
overhang DNA (50 nt length with 25 nt 5’ ssDNA overhang); +CT, with calf thymus 
DNA; -CT, without calf thymus DNA. 
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5.4.2 The FeS cluster in XPD is not essential for DNA binding 
 The glycosylases MutY/ EndoIII take part in the Base Excision Repair (BER) 
pathway and contain a [4Fe-4S] cluster. This cluster stabilises a loop structure (FeS 
cluster loop, FCL), which coordinates positively charged residues for interaction with the 
DNA backbone. Indeed, it was found that MutY mutants without cluster lose their ability 
to bind DNA and to remove 8-oxo-guanine lesions from the DNA (Thayer et al. (1995); 
Chepanoske et al. (2000)). Experiments in this section were carried out to determine if 
the FeS cluster of XPD could have a similar structural function. The importance of the 
FeS cluster for binding of DNA was tested using mutants C88S (lacking the cluster), 
K84H and F136P (unstable cluster) and C102S (stable cluster). DNA binding of the 
mutants was tested using a duplex and a 5’ overhang DNA substrate and compared to the 
wildtype enzyme. A representative gel is shown in Figure 5.9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9: EMSA of wildtype XPD binding to a 5' overhang DNA substrate 
The figure shows a representative 6 % native acrylamide gel of wildtype XPD binding to 
a 5’ overhang DNA substrate. Protein concentrations were: 10, 5, 2, 1, 0.5, 0.1 and 0 µM 
XPD. Unbound DNA was quantified and Fractions bound calculated as described in 
Materials and Methods. 
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32P 
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 apparent KD (µM) 
 5’ overhang dsDNA 
C88S 1.3 ± 0.02 1.2 ± 0.01 
C102S 0.7 ± 0.01 0.7 ± 0.01 
K84H 1.4 ± 0.01 1.5 ± 0.02 
F136P 1.5 ± 0.02 1.2 ± 0.03 
wildtype 1.1 ± 0.03 1.1 ± 0.02 
 
 
Figure 5.10: DNA binding of XPD mutants and wildtype to dsDNA and 5' overhang  
substrate 
Binding curves show fraction DNA bound versus the logarithm of XPD protein 
concentration. Binding of wildtype XPD and mutants to (A) 5’ overhang and (B) dsDNA; 
colours are as follows: C88S, black; C102S, blue; K84H, green; F136P, brown; wildtype, 
magenta. Data were fitted to the following equation (for explanation see Materials and 
Methods): Fraction bound = 1/ 1+ (KD/ [XPD])m). Apparent KDs (in µM) from these 
binding curves are tabulated in (C). In (D) the wildtype XPD binding affinity to dsDNA 
(open circles) and 5’ overhang (closed circles) DNA were compared directly. 
Experiments were carried out in triplicate and standard errors are indicated. 
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 As seen from Figure 5.10, the FeS cluster is not essential for XPD-DNA binding 
and a similar role to the FCL of MutY/ EndoIII can thus be excluded. XPD wildtype and 
mutant proteins bound DNA with similar affinities. A 5’ overhang DNA substrate is the 
preferred substrate for the 5’3’ helicase XPD, as the enzyme can load onto the 5’ single 
stranded DNA overhang and unwind duplex DNA in 3’ direction. Duplex DNA on the 
other hand was shown not to be a substrate for XPD, as dsDNA did not stimulate the 
ATPase activity (Chapter 4). Nonetheless, 5’ overhang and dsDNA were both bound with 
the same affinities by wildtype and mutant XPD. Dissociation constants were calculated 
to be around 1 µM, indicating that XPD binds DNA weakly.  
 There may be several reasons for the observed weak binding affinity of XPD for 
DNA. Bandshift assays can give an idea about protein-DNA interactions; they are 
straightforward; different conditions and substrates can be tested quickly and easily. 
However, moving a large complex through a matrix of networked polymers for hours 
could potentially lead to complex disassembly, especially if binding is not very tight. 
Therefore, the observed KD can appear much higher than the real one and is therefore 
called an apparent KD. Another possibility is that XPD is missing a ligand or a partner 
protein to bind DNA more strongly. Lastly, there is the possibility that XPD has high on/ 
off rates or that tight DNA binding by XPD is not required as this would hinder ssDNA 
tracking of the helicase.  
 During the course of the aforementioned experiments, another observation made 
was that XPD-DNA complexes tended to remain in the wells of the polyacrylamide gels. 
In addition, two different slower migrating complexes were observed within the gel, 
which appeared and disappeared with increasing protein concentrations. This was seen 
for all DNA constructs of 50 nt length, no matter if the substrate was dsDNA, 5’ 
overhang or different bubble substrates (Figure 5.14). The formation of several 
complexes in EMSA was also observed for the P143 helicase from the virus Autographa 
californica (McDougal & Guarino (2001)). The authors suggested, that multiple 
molecules bound to the DNA substrate in a non-cooperative manner, thus accounting for 
the various protein-DNA complexes seen. 
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 The R531W mutant was tested separately. It was thought that this mutation could 
interfere with DNA binding (see Chapter 4), as this mutant bound only weakly to the 
heparin affinity column and its ATPase activity was reduced. These observations could 
arise from a decreased ability of the R531W mutant to bind to DNA resulting in a loss of 
helicase activity. The mutant was tested on a 5’ overhang DNA substrate and preliminary 
data confirmed a weaker ability to bind DNA (Figure 5.11). The apparent KD was 
calculated with 12.2 ± 0.03 µM, which is about 10-fold higher than the wildtype (1.1 
µM). Further investigations are necessary to determine if the XPD-R531W mutation 
affects dsDNA or ssDNA binding.  
 
 
 
 
 
 
 
 
 
 
Figure 5.11: Comparison of DNA binding affinity of XPD-R531W and wildtype to a 
5' overhang substrate. 
DNA binding curves showing fractions of bound DNA versus the concentration of XPD-
R531W and wildtype on a semilogarithmic scale. The wildtype is shown in magenta and 
the R531W mutant in blue. Data were fitted to the following equation (for explanation 
see Materials and Methods): Fraction bound = 1/ (1+ (KD/ [XPD])m). Experiments were 
carried out once. 
 
5.4.3 Influence of ATP on binding to a 5’-overhang DNA substrate 
 It was shown in section 5.4.2 that the FeS cluster in XPD is not essential for its 
interaction with DNA, but these experiments were carried out in the absence of ATP. The 
following experiments tested whether ATP has an influence on the observed DNA 
binding affinity of XPD. Accordingly, 1 mM MgCl2/ ATP-γS was included in the 
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reaction. The DNA binding affinity of a representative mutant protein lacking the FeS 
cluster (C105S) was compared to the wildtype using a 5’ overhang DNA substrate 
(Figure 5.12).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12: Effect of ATP on the binding affinity to a 5’ overhang DNA substrate 
Native EMSA showing XPD-DNA binding of wildtype and C105S mutant to a 5’ 
overhang DNA substrate in the presence (left) and absence (right) of 1 mM MgATP-γS. 
Protein concentrations for each experiment were 10, 5, 2, 1, 0.5, 0.1 µM. “0” indicates 
the control without protein. Experiments were carried out once. 
 
 Unbound DNA was quantified and calculated to fractions of DNA bound as 
described in Materials and Methods. No significant differences in DNA binding by 
wildtype XPD and C105S mutant were observed in the presence or absence of ATP-γS, 
indicating that ATP does not increase the affinity to a 5’ overhang DNA substrate (Figure 
5.12) and is therefore not necessary for the XPD-DNA interaction.  
 
5.4.4 XPD binding to single stranded DNA 
 The 14mer dT oligonucleotide, which had already been used for gel filtration XPD-
DNA binding analysis (section 5.3), and a 25mer (B25comp, see Appendix 1, Table 2 for 
oligonucleotide sequence) of a mixed DNA sequence were used to investigate the ssDNA 
binding affinity of wildtype XPD. It was assumed that XPD would bind ssDNA in a 
sequence independent manner, as it has been described for other helicases (Ayora et al. 
(2002); Levin & Patel (2002); Tuteja & Tuteja (2004)). 
C105S WT C105S WT 
+ γS-ATP/MgCl2 - γS-ATP/MgCl2 
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Figure 5.13: Single stranded DNA binding of wildtype XPD 
Native EMSA showing binding of wildtype XPD to a 14mer (left) and a 25mer (right) 
ssDNA with and without MgATP-γS. Protein concentrations were: 50, 25, 12.5, 5, 0 µM. 
MgCl2 and ATP-γS were at a concentration of 1 mM. Experiments were carried out in 
duplicate. 
 
 XPD binding affinities for ssDNA were considerably weaker than those observed 
for double stranded or partial duplex DNA (section 5.4.2). The strength of single stranded 
DNA binding was also dependent upon the length of the oligonucleotide (Figure 5.13). 
Generally, most helicases show tighter interactions with ssDNA than with dsDNA 
(Tuteja & Tuteja (2004)). In the case of XPD, however, the above data show that for 
stable binding to occur only the length of the oligonucleotide is important. Thus, it could 
be possible that XPD binds a 50mer ssDNA with the same affinity as a 50mer dsDNA 
(section 5.4.2).  
 Binding assays were also carried out in the presence and absence of MgATP-γS. 
From gelshift experiments it appears that the presence of ATP slightly decreases the 
affinity of XPD for ssDNA (Figure 5.13). However, these differences were not significant 
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(e.g. apparent KDs for the 25 nt oligonucleotide from duplicate experiments: 10.5 µM (-
ATP-γS) vs. 12.1 µM (+ATP-γS)). 
 It will be necessary to carry out the same experiment on a fully complementary 
DNA duplex and a ssDNA oligonucleotide of the same length in the presence and 
absence of ADP and ATP-γS, to investigate if changes occur in the DNA binding 
affinities during ATP hydrolysis cycles of XPD. It would also be more useful to obtain 
data in solution (e.g. using fluorescence polarisation experiments), rather than using 
bandshift assays, because the protein-DNA complex is not likely to be stable enough to 
observe small differences in protein-DNA binding affinities using gel shifts.  
 
5.4.5 DNA binding affinities of XPD to bubble vs. 5’ overhang substrates 
 In humans, XPD takes part in DNA repair. Single stranded regions in a DNA 
duplex can arise after DNA damage has occurred or during the repair process by 
formation of the so-called repair bubble (Evans et al. (1997)). In the following 
experiments a possible preference of XPD for bubble DNA substrates, compared to a 5’ 
overhang, was tested as bubble DNA structures naturally occur during DNA repair. Two 
different DNA constructs were made containing a central uncomplementary region of 4 
and 10 nt, respectively. These constructs are referred to as “bubble” substrates. 
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Figure 5.14: Comparison of XPD binding to bubble and 5' overhang DNA 
substrates 
Native gelshift experiments (A) show binding of wildtype XPD to a 32P-radiolabeled 5’ 
overhang (left panel), 4 nt bubble (middle panel) and 10 nt bubble (right panel) DNA 
substrate. Schematics of substrates are shown across the top. Protein concentrations in 
descending order are 10, 5, 2, 1, 0.5, 0.1, (0) µM. The arrows indicate the three different 
complexes formed within the gel. (B) Binding curves of triplicate experiments showing 
total fraction XPD bound to each substrate on a semilogarithmic scale. Green, 10 nt 
bubble; blue 4 nt bubble; magenta, 5’ overhang. Data were fitted to the following 
equation (for explanation see Materials and Methods): Fraction bound = 1/ (1+ (KD/ 
[XPD])m). Standard errors are indicated. 
 
 Bandshift experiments showed that XPD preferentially bound the bubble substrates 
(Figure 5.14). Dissociation constants of triplicate experiments were determined as 5.5 ± 
0.02 µM (5’ overhang), 2.8 ± 0.02 µM (Bubble 4 nt) and 2.4  ± 0.01 µM (Bubble 10 nt). 
It appeared that the wildtype enzyme used in this series of experiments was not fully 
active. The same sample was tested for helicase and ATPase activity and showed much 
lower activity than normally observed, although mass spectrometry confirmed the correct 
mass for wildtype XPD. This is reflected in higher KD values for DNA binding in this set 
of experiments, compared to previous experiments using 5’ overhang DNA substrates 
(section 5.4.2). A direct comparison between the three substrates was still meaningful, as 
the reactions were treated in the same way, using the same reaction mix. Therefore, XPD 
binding affinities obtained for these three DNA substrates were comparable to each other.  
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 It seems that XPD prefers to bind to unpaired regions within a DNA duplex, rather 
than long stretches of ssDNA or dsDNA. As shown in section 5.4.2 dsDNA and 5’ 
overhang substrates were bound with similar affinities by XPD. If a perturbation in the 
DNA duplex is introduced in form of a bubble, the affinity of XPD to DNA doubles. This 
is consistent with the observation that human XPD takes part in NER and the active 
conformation of the repair complex is a bubble structure, which varies in size during the 
different stages of DNA repair (Evans et al. (1997)). These data will nonetheless require 
confirmation using different experimental approaches, as described in section 5.4.4. 
 Damage recognition factors have not yet been identified in archaea. The single 
stranded DNA binding (SSB) protein has been proposed to be involved in the early stages 
of damage recognition, as it is able to melt duplex DNA and preferentially binds damaged 
DNA while stabilising appearing single stranded regions (Cubeddu & White (2005)). In 
vivo, such local unwinding of duplex DNA results in the formation of a bubble. This 
could be a possible reason why XPD prefers to bind bubble substrates to 5’ overhangs. 
After SSB has melted part of the DNA duplex, the presence of a bubble and SSB could 
lead to positive cooperativity and recruitment of the other NER factors. SSB, when bound 
to immobilized ssDNA was also shown to interact specifically with certain NER factors, 
such as XPB, but not XPD. XPD is the major helicase in NER (Coin et al. (1998)). 
Therefore, strong interactions of SSB with XPD would probably reduce the processivity 
of the helicase. In contrast, XPB has almost no detectable helicase activity and interaction 
with SSB could contribute to positioning XPB within the DNA repair complex. 
 
5.5 XPD PROTEIN-PROTEIN INTERACTIONS 
 In humans, XPD is part of the transcription factor IIH complex and interacts with 
the p44 and the MAT1 subunit of the TFIIH holocomplex (Coin et al. (1998); Busso et al. 
(2000); Feaver et al. (2000)). These interactions regulate the enzymatic activity of hXPD. 
In archaea, XPD appears to be a monomer in solution and has no obvious necessity for a 
binding partner to stimulate its helicase activity (Rudolf et al. (2006)). There is no current 
evidence supporting the idea that the homologue of hXPD in archaea has the same 
function in DNA repair. One avenue to investigate its role in the archaea, would be to 
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identify interacting proteins. As part of the NER machinery, some interactions would be 
expected in analogy to hXPD, for example with the 3’ endonuclease XPG or the 3’5’ 
helicase XPB (Iyer et al. (1996)).  
 XPD protein-protein interactions were investigated using Affi-Gel 10 affinity 
matrix to immobilize untagged recombinant XPD on gel agarose beads.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15: Protein-protein interactions of XPD 
A Sypro-stained SDS-gel of Affi-Gel column elutions is shown. S. acidocaldarius cell 
lysate was applied to a column containing Affi-Gel with prebound recombinant XPD (X) 
or a control column without XPD (C). Lanes show wash steps with 0.5 and 1 M NaCl. M, 
Mark12 Standard Marker (Invitrogen). Major bands and corresponding proteins are 
indicated.  
 
 After XPD was bound to the Affi-Gel matrix, remaining free active ester groups 
were blocked with ethanolamine (pH 8.0). After the column was extensively washed with 
binding buffer (20 mM HEPES, pH 7.8, 100 mM NaCl, 1 mM DTT, 1 mM EDTA, 10 % 
glycerol), agarose beads were analysed by SDS-PAGE to confirm binding of XPD to the 
column matrix. The control was treated in the same way, only that no protein was 
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prebound to the column matrix and all active ester groups were blocked with 
ethanolamine. S. acidocaldarius cell lysate was applied to each column and after 
extensive washing, proteins bound to the column were eluted with increasing 
concentrations of NaCl (Figure 5.15). 
 No significant protein-protein interactions were observed for archaeal XPD (Figure 
5.15). There are several reasons why no binding partner was detected: (1) the 
experimental conditions need to be further optimised, (2) the interaction is weak, 
transient and unstable or (3) the interaction with other proteins only occurs if XPD is 
bound to DNA. Another possibility that a binding partner could not be detected because it 
is not (highly) expressed under normal growth conditions, was investigated using UV-
irradiated S. acidocaldarius cells. This experiment led to the same result and no XPD 
protein-protein interactions could be detected (data not shown). 
 
5.6 SUMMARY AND CONCLUSIONS 
 This chapter described possible domain structures of XPD, as well as interactions 
with DNA and other proteins. 
 The tryptic digestion pattern of wildtype XPD and a mutant without FeS cluster  
(C88S) revealed subtle differences, based on an altered trypsin sensitive site near the N-
terminus of the proteins. This clearly indicated local changes in secondary or tertiary 
structure in this region depending on the presence of the FeS cluster. Putative domains in 
XPD were mapped according to the configuration of domains found in other SF1 and 2 
helicases. Domain mapping suggested that the FeS cluster domain represents domain 1B 
as an insertion within RecA motor domain 1A and could be involved in the interaction 
with the ss/ ds junction. In the previous chapters it was proposed that the FeS cluster 
domain of XPD forms a loop structure similar to the beta-hairpin of UvrB. Accordingly, 
XPD could use this loop structure as a “clamp” to engage ssDNA and actively distort the 
ss/ dsDNA region. Alternatively, it could clamp the single DNA strand to the two motor 
domains in such a way that it comes in close proximity to the aromatic-rich loop, which 
can then couple the free energy derived from ATP hydrolysis onto translocation.  
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 Binding of ADP protected all trypsin sensitive sites in wildtype XPD, suggesting 
domain rearrangement and a change from the open to the closed conformation of the 
enzyme (Korolev et al. (1997)). In contrast, in the clusterfree mutant C88S the first 
tryptic sensitive site was unprotected and located within the FeS cluster domain. Mutants 
without FeS cluster were able to efficiently hydrolyse ATP (see previous chapter) 
indicating the correct formation of the ATP binding pocket. Therefore, the cluster is not 
involved in promotion of the correct domain movement of the Walker A box relative to 
the other motifs.  
 The [4Fe-4S] clusters of the glycosylases MutY/ EndoIII are involved in the 
formation of the FeS cluster loop (FCL), which facilitates DNA interaction (Thayer et al. 
(1995); Chepanoske et al. (2000)). The FeS cluster domain of XPD was shown not to 
promote DNA binding to 5’ overhang and duplex DNA substrates as no changes in 
affinities were observed between wildtype and mutant proteins with and without FeS 
cluster. Therefore, it is unlikely that the FeS cluster domain in XPD has an analogous 
structural function to the FCL in MutY/ EndoIII. 
 The mutation R531W, which is located at the C-terminus of the protein led to 
around 10-fold reduction in DNA binding compared to the wildtype. In humans, this 
mutation (hXPD: R683W) abolishes the interaction with p44, which stimulates the 
helicase activity of hXPD 10-fold (Coin et al. (1998)). This leads to a significantly 
reduced helicase activity (Dubaele et al. (2003)). In archaea, XPD does not interact with a 
TFIIH analogous complex, however the higher KD seen for DNA binding leads to 
reduced ATPase activity and abolishes the helicase activity.  
 The binding of XPD to DNA was very weak in general, subsequently leading to a 
weak helicase activity. At least a 5-fold excess of XPD was required to detect any 
helicase activity (Chapter 3). Single stranded DNA was shown not to be a good substrate 
for XPD-DNA binding, as observed affinities were very low. This effect could arise from 
the fact that the ssDNA oligonucleotides used in these experiments were much shorter 
than dsDNA constructs. In fact it was found that ssDNA binding affinities increased with 
increasing length of the oligonucleotide. ATP did not dramatically alter binding affinities 
to ds or ssDNA. Possible reasons could be non-optimal experimental conditions to 
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produce the desired effects or the effects were too subtle to be observed by gel shift 
assays.  
 Some helicases exist as monomers in solution (inactive form) and form oligomers 
upon binding to DNA (active form). In this chapter, it was confirmed that the active form 
of XPD in archaea is a monomer, strengthening the hypothesis that the mechanism of 
action of this helicase follows the Inchworm Model. Preliminary data also suggest that 
XPD binds tighter to DNA constructs containing a bubble, compared to duplex DNA or 
duplex DNA containing a 5’ overhang. This does not necessarily imply that XPD is a 
damage recognition factor, yet it could imply indirect damage recognition by defined 
substrate preference. The SSB protein was proposed to be a possible candidate for early 
stage damage recognition (Cubeddu & White (2005)) and the emerging bubble around 
the damage after duplex melting by SSB could lead to repair factor recruitment. 
However, no protein-protein interactions could be shown for XPD under the experimental 
conditions used, suggesting that the XPD interaction with other proteins is rather weak or 
only transient. Different approaches will be undertaken to further address the question of 
identifying putative interacting partners of XPD.  
6 THE ARCHAEAL ENDONUCLEASE 
XPF 
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6.1 INTRODUCTION 
 XPF is a structure specific endonuclease, which generates the 5’ incision during 
NER (Sijbers et al. (1996); Komori et al. (2002); Roberts et al (2003)) and takes part in 
recombination (Davis et al. (1995)) and interstrand cross-link repair (Kuraoka et al. 
(2000)). XPF belongs to a large nuclease superfamily which includes type II restriction 
enzymes, Holliday junction resolving enzymes and endonuclease I (Nishino et al. 
(2003)). These enzymes are dependent on divalent metal ions for catalysis and possess 
the highly conserved signature sequence V/I-E-R-K-X3-D, which represents the catalytic 
center (Aravind et al. (1999)). 
 The eukaryal XPF (Saccharomyces cerevisiae: Rad1) forms a heterodimer with 
ERCC1 (S. cerevisiae: Rad10), a feature that is essential for stability of XPF, protein-
protein interactions with XPA and DNA binding. XPF contains an inactive N-terminal 
SF2-like helicase domain, a central nuclease and a C-terminal double Helix-hairpin-Helix 
(HhH2) domain (Figure 6.1). ERCC1 consists only of the nuclease domain, which is 
inactive, and the HhH2 motifs (Bardwell et al. (1992); Park et al. (1995); Sgouros et al. 
(1999)). Helix-hairpin-helix motifs are found in a variety of DNA-interacting proteins 
and are thought to mediate non-sequence specific DNA interactions (Shao & Grishin 
(2000)). 
 In Euryarchaea, XPF has essentially the same domain structure as its eukaryal 
counterpart, but displays an active helicase fused to the N-terminus (Figure 6.1). The 
enzyme forms a homodimer (Komori et al. (2002)). XPF is also present as a homodimer 
in crenarchaea, but consists only of the nuclease and HhH2 domains. In addition, the 
nuclease activity of crenarchaeal XPF is stimulated and has an absolute requirement for 
the proliferating cell nuclear antigen protein (PCNA). PCNA is bound via a C-terminal 
PCNA interaction motif (PIP; Figure 6.1) that is found in a variety of proteins. Deletion 
of the PIP motif abolishes the nuclease activity of S. solfataricus XPF (Roberts et al. 
(2003)). 
 PCNA forms a heterotrimer in archaea (Dionne et al. (2003)), while it is a 
homotrimer in eukarya (Krishna et al. (1994)). It forms a ring-like structure encircling 
DNA and functions generally as a sliding clamp, mediating interactions between several 
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proteins and DNA. Interacting proteins include FEN1/ XPG, DNA polymerase δ and 
DNA-ligase (Warbrick (2000)). 
 Archaeal XPF shows substrate specificity for stalled replication forks and nicked 
Holliday junctions suggesting a role in recombination and replication. In eukarya these 
substrates are processed by Mus81, which dimerises with Mms4 in S. cerevisiae and 
Eme1 in Schizosaccharomyces pombe. Crenarchaeal XPF also cleaves XPF-like 
substrates with lower preference. Eukaryal XPF favours cleavage of DNA 3’ to 
pyrimidines, whereas Mus81 and probably also crenarchaeal XPF shows no sequence 
preference. XPF from crenarchaea is thought to be the ancestral version of XPF-like 
endonucleases (deLaat et al. (1998a); Kaliraman et al. (2001); Boddy et al. (2001); 
Bastin-Shanower et al. (2003); Roberts et al. (2003); Roberts & White (2005a)). 
 A third eukaryal XPF-like homologue has been described recently and is called 
FancM. It consists of an N-terminal active helicase and and C-terminal inactive nuclease 
domain. FancM is an essential component of the Fanconi anemia DNA repair pathway 
(see Chapter 1). It most likely forms a heterodimer, but the binding partner has not yet 
been identified. A function for FancM has also not yet been assigned (Meetei et al. 
(2005)). 
 In this chapter the cloning and purification of the HhH2 motif of XPF from S. 
solfataricus is described complemented by a short general characterization. DNA binding 
of full-length XPF is also addressed as well as the influence of several amino acid 
residues on the catalytic activity. 
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Figure 6.1: Domain organisation of XPF and Mus81 in Archaea and Eukarya 
The schematic shows the domain organization of XPF within the domains of the archaea 
and the eukarya. Crenarchaeal XPF probably represents an ancestral form of XPF from 
which all other XPF types evolved. The domains are indicated as follows: Orange, the 
Helix-hairpin-Helix domain; dark gray, intact nuclease domain; light gray, inactive 
nuclease domain; dark blue, active helicase; light blue, inactive helicase. A binding 
partner has not yet been described for FancM. The heterotrimeric PCNA is shown as a 
circle in yellow-red-blue.  
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6.2 PURIFICATION OF THE SSO-XPF-HHH MOTIF 
  The Helix-hairpin-Helix (HhH) motif of Sulfolobus solfataricus XPF (SsoXPF) 
was PCR amplified and cloned into the BamH1/ Sal1 cloning sites of the pET28c vector 
for expression of histidine tagged protein. The gene fragment was fully sequenced to 
confirm the absence of PCR mediated mutations. Protein was expressed in Escherichia 
coli and purified using a heat step method to remove the majority of E. coli proteins 
followed by a two-step purification scheme, consisting of nickel-chelating and size 
exclusion chromatography (Figure 6.2C). The calculated molecular weight (MW) of the 
his-tagged monomer was 13.1 kDa. The elution volume of the peak fraction in gel 
filtration chromatography was 218 mL (Figure 6.2A), corresponding to an approximate 
MW of 29 kDa (Figure 6.2B). Although the molecular masses calculated from size 
exclusion chromatography are only approximate, the mass of the HhH2 protein in solution 
was clearly that of a dimer.  
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Figure 6.2: Purification of the histidine tagged HhH2 domain of SsoXPF 
The elution chromatogram (A) and the calculation of the molecular mass of SsoXPF-
HhH2 from the elution volume (218 mL) after gel filtration (B). SDS-PAGE analysis 
showing HhH purification steps (C). From left to right: pooled fractions after elution 
from nickel chelating column (1), E. coli lysate after heat treatment at 65 ˚C (2), flow 
through after Ni-column (3) and pooled fractions containing SsoXPF-HhH2 after gel 
filtration chromatography (4). Marker (M): Mark12 Standard Marker (Invitrogen).  
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6.2.1 Oligomeric state of the HhH2-domain 
 The isolated nuclease domains and full-length SsoXPF form homodimers (Roberts 
(2004)). Dimerization is a common theme in the XPF protein family. The C-terminal part 
of the euryarchaeal Hef protein from Pyrococcus furiosus, including the nuclease and 
HhH2 domains, forms a homodimer as well (Nishino et al. (2003)). In contrast the 
eukaryal XPF/ Mus81 proteins exist as heterodimers with only one active nuclease (Park 
et al. (1995)). Glutaraldehyde cross-linking was used to confirm the hypothesis that both 
the HhH2 and the nuclease domains dimerise in crenarchaeal XPF. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3: Glutaraldehyde cross-linking of SsoXPF-HhH2 
Cross-linking experiments show dimer-formation of the HhH2 domains upon treatment 
with glutaraldehyde (HhH-X), compared to the control (HhH). M, Mark12 Standard 
Marker (Invitrogen). 
 
 Glutaraldehyde cross-linking confirmed what was already clear from gel filtration 
(Figure 6.2) that the HhH-domains of XPF dimerise (Figure 6.3). Therefore, the HhH2 
motif not only mediates DNA interaction, but also contributes to the interaction between 
both XPF monomers, to form a stable dimeric molecule.  
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6.3 STRUCTURE AND FUNCTION OF THE HHH-MOTIFS 
 HhH-motifs are found in many different DNA binding proteins, including 
polymerases, ligases and glycosylases. HhH motifs show more structural than sequence 
conservation and are generally arranged in pairs consisting of five helices (Thayer et al. 
(1995); Doherty et al. (1996)). Two antiparallel α-helices bridged by a hairpin form the 
Helix-hairpin-Helix structure (Figure 6.4B). The hairpin promotes contact with the DNA 
double helix. The two HhH-pairs are connected by a fifth helix. A HhH-structure allows 
an asymmetric protein to obtain a pseudo-2-fold symmetry to be able to interact with the 
highly symmetric DNA molecule. The DNA is bound via the phosphodiester backbone, 
mainly by hydrogen bonds between peptide backbone nitrogens and oxygens of the DNA 
phosphate groups. The presence of two consecutive HhH motifs also allows the protein to 
contact both DNA strands at the same time (Figure 6.4A). Most proteins containing this 
motif exist as dimers, hence the HhH-motifs also mediate protein-protein-interactions. 
This enables the protein to bind two different sites of the DNA simultaneously, which 
leads to bending of the DNA molecule (Shao et al. (2000).  
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Figure 6.4: The HhH2 domains of crenarchaeal XPF show structural rather than 
sequence conservation 
(A) Crystal structure of A. pernix XPF showing the two HhH2 motifs in dark and light 
green bound to a DNA duplex. The two loops of each HhH2 motif contact both strands of 
the DNA duplex in the minor groove. (B) Sequence alignment of XPF from different 
archaea and human. The positions of the five helical structures are referred to as α6 to 10 
(adapted from Newman et al. (2005)). 
 
 Indeed, for the Aeropyrum pernix (Ape) XPF structure it was shown that the HhH2 
domains of each monomer contact the downstream and upstream duplex simultaneously 
(Figure 6.4A). Initial binding of the downstream duplex by protomer A triggers the linker 
(between HhH2 and nuclease domain) to flex and kink the DNA duplex around 90 ˚. Each 
hairpin contacts one phosphate of different strands in the minor groove of the DNA 
backbone, which leads to binding of XPF with a specific polarity. The HhH2 domains 
A 
B 
downstream duplex 
upstream duplex 
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were not only found to be responsible for protein-DNA interactions, but also for 
positioning the nuclease domain through the action of the flexible linker region (Newman 
et al. (2005)).  
 
6.4 DNA BINDING OF SSOXPF AND THE SSOXPF-HHH2 DOMAINS 
6.4.1 HhH2-DNA interactions 
 The HhH2 domains are thought to promote non-sequence specific DNA binding 
(Shao & Grishin (2000)). The DNA binding affinity of the isolated HhH2 domain of 
SsoXPF was tested by gel shift experiments using a 3’-flap (Mus81-like) and a splayed 
duplex (XPF-like) DNA substrate. Roberts & White (2005a) showed, that SsoXPF has a 
preference for Mus81-like DNA substrates and cleaves XPF-like structures with lower 
rates. This preference was expected to be reflected in the DNA binding affinity of the 
HhH2 domains of SsoXPF.  
 The observed binding affinity of the HhH2 domains to DNA was very weak (Figure 
6.5). Apparent KDs were around 15 µM for splayed duplex DNA substrates and 19 µM (- 
PCNA and 26 µM (+PCNA), respectively, for 3’-flap DNA substrates. PCNA did not 
increase the binding affinity to DNA. It is widely accepted that the HhH motifs mediate 
DNA binding (Shao et al. (2000)). The crystal structure of ApeXPF revealed how these 
domains bind to DNA (Newman et al. (2005)). It is possible that the HhH2 domains 
without the nuclease domain cannot engage the DNA substrate in a proper and efficient 
way. It was shown that ApeXPF also makes interdomain contacts upon binding of DNA, 
which probably stabilizes the enzyme on the DNA (Newman et al. (2005)). It is possible 
that PCNA has no influence on DNA binding at all and only stabilizes the complex once 
XPF is already bound. It may induce some conformational changes enabling the nuclease 
to engage the 3’ single DNA strand properly, which will subsequently be subject to 
incision activity.  
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Figure 6.5: DNA binding of the HhH2 domains 
Representative 8 % acryl amide gels are shown on the top, for splayed duplex DNA 
substrates (left) and 3’-flap DNA substrates (right). Protein (HhH2) concentration were: 
100, 50, 25, 17.5, 12.5, 10, 7.5, 5, 2.5, 1, 0.5, 0.05 and 0 (C) µM. C1, no HhH2/ no 
PCNA; C2, no HhH2/ 20 µM PCNA. The respective quantification results of triplicate 
experiments are shown beneath the gels. The DNA fractions bound to the HhH2 protein 
are plotted against the logarithm of the protein concentration (M). The data points were 
fitted to the following equation: Fraction bound = 1/ (1+ (KD/ [XPD])m) (for explanation 
see Chapter 2) Standard errors are indicated. Apparent KDs (µM) were: 14.8 ± 1.1 (-
PCNA, black) and 15.1 ± 1.1 (+PCNA, blue) for splayed duplex substrates and 18.9 ± 1.0 
(-PCNA, black) and 25.8 ± 1.1 (+PCNA, blue) for 3’-flap substrates. 
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6.4.2 DNA binding of full-length SsoXPF  
 To investigate whether HhH2-mediated DNA binding depends on the presence of 
the nuclease domains of the XPF protein, untagged full-length wildtype SsoXPF was 
used in the presence and absence of PCNA. No DNA binding could be observed on a 
splayed duplex substrate (Figure 6.6). It is known that individual repair factors have very 
low affinities for DNA, but cooperativity, molecular matchmaking and kinetic proof-
reading increases the affinity of an individual protein to DNA and other proteins and thus 
facilitates assembly of the repair machinery (reviewed in Reardon & Sancar (2005)). In 
solution experiments (e.g. using ITC or fluorescence polarization experiments) could give 
better data for XPF-DNA binding. It is possible that the protein-DNA complex was not 
stable for the duration of the gelshift experiments. 
 
 
 
 
 
Figure 6.6: DNA binding of untagged WT-SsoXPF 
Gel shift experiments showing amounts of unbound DNA in WT-XPF DNA binding 
experiments. WT-XPF was tested on a splayed duplex substrate with (right) and without 
(left) PCNA. Protein concentrations were in descending order (from left to right): 100, 
50, 25, 12.5 and 6.25 µM WT-XPF. C, control without XPF protein. 
 
 An inactive mutant of SsoXPF was also tested for its ability to bind DNA. XPF-
D52 is a highly conserved residue and the mutant (D52A) was shown to be completely 
inactive (Roberts et al. (2003)). The equivalent residue in ApeXPF, D68, is part of the 
hydrophobic cleft, which was proposed to accommodate the free 3’ single DNA strand 
which becomes subject to incision by the nuclease domain (Newman et al. (2005)). 
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Figure 6.7: DNA binding of the SsoXPF-D52A mutant 
Representative 8 % acryl amide gels are shown on the top, for splayed duplex DNA 
substrates (left) and 3’-flap DNA substrates (right). Protein (XPF-D52A) concentration 
were: 100, 50, 25, 17.5, 12.5, 10, 7.5, 5, 2.5, 1, 0.5, 0.05 and 0 (C) µM. The respective 
quantification results of triplicate experiments are shown beneath the gels. The DNA 
fractions bound to the XPF-D52A protein are plotted against the logarithm of the protein 
concentration (M). The data points were fitted to the following equation: Fraction bound 
= 1/ (1+ (KD/ [XPD])m) (for explanation see Chapter 2) Standard errors are indicated. 
Apparent KDs (µM) were: 16.6 ± 1.1 (-PCNA, black) and 17.1 ± 1.1 (+PCNA, blue) for 
splayed duplex substrates and 11.3 ± 1.1 (-PCNA, black) and 12.2 ± 1.1 (+PCNA, blue) 
for 3’-flap substrates. 
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 In contrast to the wildtype protein, the inactive SsoXPF mutant D52A was able to 
bind DNA, although the reason for this is unclear (Figure 6.7). Apparent KDs for splayed 
duplex DNA binding were similar to those observed for the HhH2 domains alone and KDs 
for binding a 3’-flap were approximately half as those obtained for the HhH2 (Figure 6.5 
and Figure 6.7). However, these differences are not significant and further experiments 
have to be carried out. As shown for the HhH2 motif, PCNA did not show an influence on 
DNA binding affinities.  
 The D52A mutant was shown to lack nuclease activity (Roberts et al. (2003)). The 
same result was obtained for the analogous human XPF mutant D720A (Enzylin & 
Scharer (2002)). Residue D720 is not involved in metal ion coordination and showed no 
influence on DNA binding activity. Thus, the function of this acidic residue is not clear. 
It was suggested that it could be involved in the activation of water for the nucleophilic 
attack on the phosphodiester bond. Therefore, DNA binding effects can almost certainly 
be attributed solely to the HhH2 domains. There is still no explanation why DNA binding 
could not be observed with the wildtype XPF protein. It is possible that the D52A mutant 
obtains a slightly different structure which enables it to bind DNA tighter compared to 
the wildtype protein. 
 DNA binding was also tested towards dsDNA and ssDNA. Both for the D52A and 
the HhH2 dimer binding was observed, although only very weak. Apparent KDs were 
around ~60 µM for the HhH2 domains and ~50 µM for the D52A mutant.  
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6.5 SSOXPF MUTAGENESIS 
6.5.1 Selection of XPF mutants 
 The ApeXPF crystal structure was solved in complex with duplex DNA (Figure 
6.8A). Although duplex DNA is not a substrate for XPF, one of the HhH2 domains of the 
ApeXPF homodimer bound to the DNA (position referred to as downstream duplex). 
This XPF monomer is referred to as protomer A. Binding of one of the HhH2 domains to 
DNA induced conformational changes in the XPF homodimer mediated by a flexible 
linker region that made it possible to model the missing upstream duplex bound to the 
HhH2 domain of protomer B. In addition, the position of the nuclease domain of protomer 
A allowed for the proposition of a model of DNA substrate binding and incision. Thus, it 
was suggested that the free 3’ single DNA strand, which becomes subject to incision, 
enters a hydrophobic cleft in the nuclease domain of protomer A lined by the active site 
residues E-R-K (Figure 6.8B; highlighted in yellow in Figure 6.9). The conserved 
residues of the hydrophobic cleft were thought to make contacts to the phosphodiester 
backbone of the DNA stabilizing the 3’ single strand. Here the importance of some of the 
conserved residues in the hydrophobic cleft was investigated by mutating analogous 
residues in SsoXPF to alanine.  
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Figure 6.8: Crystal structure of ApeXPF, modes of DNA binding and the 
hydrophobic cleft 
(A) The HhH2 domain of protomer A (dark green) contacts the downstream duplex of the 
DNA substrate, which induces a rotation of about 95 ˚ relative to the nuclease domain. 
The DNA substrate is kinked so that the free 3’ ssDNA can enter the hydrophobic cleft of 
the nuclease domain of protomer A (dark blue). (B) The residues S72, R77, F79 (not 
shown) and Q81 are believed to be involved in stabilizing the single strand and 
coordinate it relative to the active site E(62)-R(63)-K(64) which is on the bottom of the 
hydrophobic cleft. The nuclease domain of protomer B is inactive (cyan (A)), but is 
involved in stabilisation of the whole protein complex on the DNA substrate by 
facilitating interdomain contacts (adapted from Newman et al. (2005)) 
A 
B 
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 XPF from S. solfataricus was preferentially used for mutagenesis and kinetic 
assays, because it showed a more robust enzymatic activity and the Sulfolobus PCNA 
heterotrimer was readily available. Mutations in SsoXPF were selected according to 
conserved residues in the ApeXPF crystal structure (highlighted in green, Figure 6.9).  
 
APE  MGDYLVSDSIIVERKTSSDFAKSLFDGRLFEQASRLAEHYETVFIIVEGPP--------V 101 
SSO  VADYVITDDVAVERKSVNDLVNSVFDKRFFDQISRLSEVYRFPILLVEGDI--------N 85 
PFU  VGDYIISEDVAIERKSANDFIQSIIDGRLFDQVKRLKEAYSRPIMIVEGSL--------Y 633 
HSA  VGDYILTPEMCVERKSISDLIGSLNNGRLYSQCISMSRYYKRPVLLIEFDPSKPFSLTSR 772  
Figure 6.9: Sequence alignment of archaeal and human XPF 
Sequence alignment showing the active site residues of XPF proteins from different 
archaea and human. The active site motif V/I-E-R-K-X3-D is highlighted in yellow, 
absolutely conserved residues are in blue, similar residues are in grey and residues that 
were subject to mutagenesis are highlighted in green. APE, A. pernix XPF; SSO, S. 
solfataricus XPF; PFU, Pyrococcus furiosus hef; HSA, Homo sapiens XPF. 
  
 As described in Newman et al. (2005), ApeXPF also has a strict requirement for the 
PCNA sliding clamp (Figure 6.10). Endonuclease activity of ApeXPF was shown to be 
stimulated by the SsoPCNA heterotrimer, while no activity was observed without PCNA. 
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Figure 6.10: Stimulation of ApeXPF nuclease activity by SsoPCNA 
Products of endonuclease reactions were analysed on a denaturing 12 % polyacrylamide 
gel. Radiolabeled DNA substrates and incision products were detected by 
phosphoimaging. Nuclease activity of SsoXPF and ApeXPF was monitored using a 3’-
flap DNA substrate. SsoPCNA heterotrimer was used for stimulation of ApeXPF 
nuclease activity. Time points were: 10 sec (SsoXPF + SsoPCNA); 10 min (ApeXPF); 1, 
3, 10 min (ApeXPF + SsoPCNA). 
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 XPF-mutants were generated using the QuikChange Mutagenesis Kit (Stratagene) 
and respective mutant proteins (Figure 6.11) were purified as described for the wildtype 
XPF protein (see Material and Methods). The mutations and the whole protein mass were 
confirmed by mass spectrometry. 
 
 
 
 
 
 
 
 
Figure 6.11: SDS-PAGE of purified XPF mutants 
The gel shows mutant XPF proteins after purification. M, Mark12 Standard Marker 
(Invitrogen); XPF mutants: 1, S56A; 2, R61A; 3, F63A; 4, Q65A; 5, Y108A; 6, wildtype. 
 
6.6 CHARACTERISATION OF THE CATALYTIC CORE OF SSOXPF/ APEXPF 
USING MUTAGENESIS 
 The XPF mutant and the wildtype proteins were characterised by their ability to 
process different DNA substrates. DNA constructs containing a 3’ single stranded flap or 
nick are preferrentially cleaved by SsoXPF, while a splayed duplex DNA substrate is 
cleaved with lower rates (Roberts & White (2005a)). Initially, a 3’-flap and a splayed 
duplex substrate were used for endonuclease assays, as they are the preferred substrates 
for human Mus81/ Eme1 and XPF/ ERCC1, respectively. The nicked duplex was used to 
confirm data obtained for the 3’-flap substrate. Firstly, all assays were carried out using 1 
µM protein. To confirm the data under more realistic single turnover conditions, another 
set of experiments was performed using 7 µM SsoXPF protein. The Y108A mutant was 
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not further characterised as it showed wildtype activity in initial nuclease assays. 
Experiments were carried out as described in Material and Methods.  
 Single substrate reactions of enzymatic catalysis can be easily described with 
Equation 6.1, where k1/-1 and k2/-2 are equilibrium rate constants and kcat, the catalytic 
constant that describes the catalytic step of product formation. Under conditions where 
the enzyme (E) is in excess over the substrate (S) the enzyme-substrate (ES) complex is 
favored and the catalytic constant kcat can be obtained directly. Cleavage products of 
SsoXPF were separated on a denaturing polyacrylamide gel, visualized by 
phosphoimaging and quantified (Image Gauge Software). The mean ratio of total DNA 
counts (cut + uncut) to uncut counts was used to determine kcat. kcat was directly obtained 
by linear regression (ln (total DNA/ uncut) versus time) using the equation y = mx, where 
m corresponds to kcat. 
 
 
 
 
 Representative gels for XPF mutants and wildtype nuclease activity with different 
DNA substrates are shown in Figure 6.13 and the quantification results are presented in 
Table 6.1 and Table 6.2. Previous results of a preference of SsoXPF for 3’-flaps and 
nicked duplexes were confirmed, indicating different modes of DNA binding (Roberts & 
White (2005a)). As explained in earlier sections, for stable protein-DNA binding it seems 
important that both the regions downstream and upstream of the incision site are double 
stranded (see also Figure 6.8A). Single stranded DNA in the downstream region, as 
present in a splayed duplex substrate, reduces the stability of the complex and therefore 
the enzymatic activity. 
 A reduction in activity was observed for all mutants, ranging from modest (S56A, 
F63A) to very severe effects (R61A, Q65A). In the crystal structure of ApeXPF the 
equivalent residues of SsoXPF-R61 (ApeXPF-R77) and Q65 (ApeXPF-Q81) were found 
to be located just outside the catalytic cleft (Figure 6.8) and a substrate recognition role 
was attributed to them. This would explain the severe effects a mutation to alanine had on 
catalysis. There was also a difference in the reduction of the incision rates between 3’-
E + S 
k1 
k-1 
ES EP 
kcat k2 
k-2 
E + P (Equation 6.1) 
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flap and splayed duplex. While the wildtype showed approximately 10-fold reduction, the 
R61A and Q65A mutants showed 280-fold and 80-fold reduction, respectively (Table 
6.1), confirming a role in DNA substrate recognition for these residues. The hydrophobic 
cleft is centered around F63 (ApeXPF-F79; Figure 6.12), however, mutation of this 
residue to alanine has only mild effects on the nuclease activity, suggesting that loss of 
only one hydrophobic residue can be tolerated. The reduction of the catalytic rates 
between 3’-flap versus splayed duplex is similar to the wildtype. The residue SsoXPF-
S56 (ApeXPF-S72) is also located at the entrance to the hydrophobic cleft, but mutation 
to an alanine showed relatively mild effects on catalysis of a 3’-flap DNA substrate, in 
contrast to R61A or Q65A. However, a 100-fold reduction in endonuclease activity was 
observed when using a splayed duplex DNA construct instead of a 3’-flap, suggesting an 
involvement of S56 in DNA substrate recognition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.12: The hydrophobic cleft of the nuclease domain of ApeXPF 
The hydrophobic cleft, centered around F79, could accommodate ssDNA. The 
hydrophobic residues may intercalate between bases, while positively charged residues 
could interact with the DNA backbone (adapted from Newman et al. (2005)). 
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Figure 6.13: Nuclease activity of XPF mutants and wildtype on different DNA 
substrates 
Selected examples of denaturing polyacryamide gels showing incision products of XPF 
mutants and wildtype on different DNA substrates. (A) splayed duplex, (B) 3’-flap and 
(C) nicked duplex. A schematic of the DNA constructs is shown left of the gel images. 
The different XPF proteins are indicated across the top of each gel. Time points were 5, 
10, 15, 20, 30 min (S56A, R61A, Q65A); 1, 2, 3, 4, 5 min (F63A); 0.5, 1, 1.5, 2, 3 min 
(wildtype) for splayed duplex substrates. For 3’-flaps and nicked duplexes the time points 
were as follows 20, 40, 60 sec (S56A, F63A); 60, 120, 180 sec (R61A, Q65A); 10, 20, 30 
sec (wildtype). 
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Table 6.1: Reaction rates of SsoXPF mutants and wildtype (7 µM) on splayed 
duplex, nicked duplex and 3'-flap DNA substrates 
Mutation in 
SsoXPF 
Equivalent 
residue in 
ApeXPF 
Splayed duplex 
kcat ± s.e. (min-1 
x 103)* 
Nicked duplex 
kcat ± s.e. (min-1 
x 103)* 
3’-flap kcat ± 
s.e. (min-1 x 
103)* 
WT - 720 ± 49 9760 ± 1570 7200 ± 880 
S56A S72 33 ± 1 1730 ± 120 3120 ± 210 
R61A R77 3 ± 0.1 510 ± 13 840 ± 23 
F63A F79 277 ± 27 3190 ± 260 4730 ± 88 
Q65A Q81 3.3 ± 0.4 230 ± 10 260 ± 11 
 
Table 6.2: Reaction rates of SsoXPF mutants and wildtype (1 µM) on splayed 
duplex, nicked duplex and 3'-flap DNA substrates 
Mutation in 
SsoXPF 
Equivalent 
residue in 
ApeXPF 
Splayed duplex 
kcat ± s.e. (min-1 
x 103)** 
Nicked duplex 
kcat ± s.e. (min-1 
x 103)* 
3’-flap kcat ± 
s.e. (min-1 x 
103)** 
WT - 260 ± 47 5900 ± 400 2380 ± 230 
S56A S72 2.1 ± 0.5 1155 ± 35 810 ± 50 
R61A R77 0.3 ± 0.1 230 ±1 380 ± 7 
F63A F79 35 ± 11 2350 ± 106 1520 ± 220 
Q65A Q81 0.7 ± 0.2 170 ± 15 160 ± 11 
Table 6.1 and Table 6.2 show kcat of SsoXPF mutants and wildtype using different DNA 
substrates and protein concentrations. Sso, S. solfataricus; Ape, A. pernix; s.e., standard 
error; * data from a single experiment; ** data from triplicate experiments. 
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6.7 SUMMARY AND CONCLUSIONS 
 This chapter described the purification of the C-terminal HhH2 domain of S. 
solfataricus XPF. When this project was initiated it was known that the isolated nuclease 
domain as well as the whole XPF protein forms a homodimer (Roberts (2004)). Although 
not likely to be the case, it still needed to be proven that the HhH2 domains of XPF also 
dimerise. Glutaraldehyde cross-linking experiments confirmed this. 
 The HhH2 motif is found in a variety of DNA binding proteins and facilitates non-
sequence specific DNA binding (Doherty et al. (1996)). Different DNA constructs were 
tested, including a 3’-flap, the preferred substrate for SsoXPF endonuclease activity. The 
HhH2 domains showed very weak DNA binding, with an apparent KD of around 20-25 
µM for a 3’-flap. Splayed duplexes were bound with KDs of 15  µM. Double and ssDNA 
was bound as well, with apparent KDs which were much higher. PCNA was shown not to 
have an influence on DNA binding. The observed weak DNA binding affinity could arise 
from improper folding of the isolated HhH2 domains, from missing interdomain 
interactions with the nuclease domain or from the absence of other binding partners.  
 Subsequently, wildtype XPF was tested, but no DNA binding could be observed. 
On the contrary, when the mutant SsoXPF-D52A, which is deficient in nuclease activity 
was used, DNA binding was observed in gelshift experiments. Apparent KDs were similar 
to those of the isolated HhH2 domains. The reason why DNA binding could be observed 
only for the mutant and not for the WT is not clear. One possibility is that the mutant 
obtains a slightly different structure enabling a stronger interaction with DNA. PCNA did 
not have any influence on D52A-DNA binding, matching the results obtained for the 
HhH2 domains. This suggests that PCNA does not contribute in loading the enzyme onto 
the DNA, but it helps to keep it attached to the site of DNA damage repair (Dionne et al. 
(2003)). Binding to PCNA via its C-terminal interaction motif stimulates the nuclease 
activity of XPF, which seems not to be necessary for the initial step of DNA binding and 
substrate coordination.  
 With the solved crystal structure of ApeXPF, Newman et al. (2005) proposed that 
the two HhH2 domains of each monomer engage the DNA substrate downstream and 
upstream of a lesion (Figure 6.4A). This results in large domain movement and the 
coordination of one of the nuclease domains relative to the 3’ single DNA strand, which 
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will become subject to incision. It showed that the enzyme kinks the DNA around 90 ˚, 
which is thermodynamically easier if there is a lesion present in one of the DNA strands. 
The ssDNA enters a hydrophobic cleft within the nuclease domain of one of the XPF 
monomers (Figure 6.12). This hydrophobic cleft contains several conserved residues, 
which are thought to interact with the DNA and help to coordinate this strand to the 
active site which is located on the bottom of the hydrophobic cleft. Mutagenesis studies 
carried out on the XPF homologue from S. solfataricus showed that these residues are 
indeed important for the endonuclease activity. How they are involved in ssDNA binding 
has yet to be investigated by crystal structures of XPF for example in complex with 
longer and 3’-flapped DNA constructs, as the published structure was in complex with 
dsDNA (Newman et al. (2005)). 
7 CONCLUSIONS AND FUTURE WORK 
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 This PhD thesis described the characterisation of XPD from S. acidocaldarius. It 
showed that SacXPD, like its human homologue, functions as a 5’3’ monomeric SF2 
DNA helicase. In contrast to eukarya, SacXPD does not appear to be associated with a 
higher multimeric protein complex. Helicase activity was detected in the presence of ATP 
and Mg2+ (Mn2+) without the need for an additional binding partner. Gel filtration 
experiments have also shown that the active form of SacXPD is a monomer, as no higher 
complexes were observed upon binding to ssDNA. Therefore, the mechanism of action 
for XPD should follow the Inchworm model (Velankar et al. (1998)). Respective ssDNA 
and dsDNA binding domains of XPD still have to be located, using mutagenesis for 
example. A possible domain model was proposed in Chapter 5. It would be useful to 
obtain crystal structures of XPD in complex with ATP and ADP bound to a 5’ overhang 
DNA substrate. More work will also be carried out on the DNA substrate specificity of 
XPD. Although SacXPD is a homologue of human XPD, it does not necessarily imply 
that it has an identical function in NER. In addition, as shown for XPF for example, XP 
proteins tend to participate in different DNA processing pathways.  
 SacXPD is the first described example of a helicase containing an iron-sulphur 
(FeS) cluster. A number of different methods were applied to investigate the nature of the 
FeS cluster, revealing that in solution XPD has a [3Fe-4S]0 cluster bound. The EPR 
spectrum obtained showed a weak but significant signal for the oxidised form (1+) of the 
cluster. It was suggested that the FeS cluster is buried within the enzyme and is not easily 
accessible for oxidants. In contrast, helicase experiments showed a high sensitivity of 
XPD to even very low concentrations of the oxidant ferricyanide. This may be caused by 
conformational changes the enzyme undergoes while unwinding DNA. These changes 
could expose the FeS cluster to solvents, resulting in oxidation and subsequent enzyme 
inactivation. It will be necessary to optimise EPR experiments to obtain stronger signals 
for wildtype XPD and to clarify existing data. It would also be useful to obtain an EPR 
signal for the C102S mutant, which coordinated a stable FeS cluster. Despite several 
attempts, the FeS cluster of the C102S mutant could not be oxidised in solution and no 
EPR spectrum could be recorded. A successful EPR experiment would fully prove that 
the wildtype and C102S mutant bound exactly the same type of FeS cluster and that 
cysteine 102 is not involved in FeS cluster coordination in the wildtype protein. 
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 The FeS cluster is located between the Walker A and B boxes and it has been 
shown to be essential for helicase activity. It was also shown that the FeS cluster is not 
necessary for ATP hydrolysis, DNA binding or general structural stability of the protein. 
Tryptic digestion experiments showed different digestion patterns for wildtype XPD and 
a mutant without the FeS cluster, indicating a local structural role. Sequence alignments 
revealed the presence of the FeS cluster domain in other helicases, including E. coli DinG 
and hXPD. Preliminary experimental data on DinG suggested the presence of a FeS 
cluster (R. D. Camerini-Otero, personal communication). As for the human helicases, the 
discovery of the FeS cluster opens completely new insights into the human pathology. 
Two human mutations found in TTD (hXPD-R112H) and Fanconi anemia (FancJ-
A349P) patients were successfully introduced into SacXPD. These mutations destabilise 
the FeS cluster and subsequently abolish the helicase activity. The presence of the cluster 
was also confirmed in vivo in S. cerevisiae Rad3p, the orthologue of hXPD. The function 
of the FeS cluster has still to be investigated. A likely function may be to help stabilise a 
loop or hairpin structure, which supports the engagement of one of the single DNA 
strands during DNA duplex unwinding. This could actively distort the ss/ ds fork, 
facilitating base pair disruption during translocation. A possible model is shown in Fig 
7.1. 
 The ATPase activity of SacXPD was stimulated by ssDNA, however, no 
stimulation was observed with dsDNA. All of the mutants, apart from those with 
mutations in one of the conserved helicase motifs (K35A, F38C, G447D, C523R), 
showed ssDNA dependent ATPase activity similar or slightly higher than the wildtype. 
Mutations that affected the coordination or stability of the FeS cluster showed an 
uncoupling of helicase and ATPase activity. The KM for ATP hydrolysis was measured to 
be 0.35 to 0.36 mM ATP for the wildtype enzyme and representative mutants, while 
maximum rates of ATP hydrolysis were slightly higher for mutants compared to the 
wildtype. 
 Translocation could not be fully proven, but it is assumed that the FeS cluster is not 
necessary for ssDNA tracking. One possible way to test translocation would be to use two 
oligonucleotides of identical sequence and different lengths and compare their KM by 
measuring the ATPase activity using different concentrations of oligonucleotides. The 
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same oligonucleotides containing a central blocking lesion would then be used in 
subsequent experiments. The presence of the blocking lesion should reduce the ATPase 
activity and increase the KM (Raney & Benkovic (1995)).  
 
 
 
 
 
 
 
 
 
 
 
Fig 7.1: Hypothetical model of XPD duplex DNA unwinding and the function of the 
FeS cluster 
The figure shows a schematic of XPD duplex DNA unwinding. Single and double 
stranded DNA binding domains are shown in yellow. The FeS cluster supports a loop or 
hairpin structure (in brown, left), which clamps the single DNA strand of the loading 
strand and kinks it around 90 ˚. In this way, the ss/ ds fork ahead is actively distorted, 
facilitating duplex unwinding. Furthermore, this prevents reannealing of the two single 
DNA strands. In mutants that do not coordinate a FeS cluster (right), the DNA is still 
unwound with very low rates, probably similar to XPB. Since the loading strand is not 
bend away from the complementary strand, this leads to reannealing and formation of the 
duplex DNA.  
 
 XPD was shown not to stall on a fluorescein lesion in either the loading or 
displaced strand, although slightly lower DNA unwinding rates were detected when the 
lesion was on the loading strand. Further experiments using different DNA substrates will 
need to be carried out to investigate if XPD interacts directly with the bases of the 
loading strand or rather with the sugar-phosphate backbone, as proposed for SF2 
helicases (Singleton & Wigley (2002)). These DNA substrates can also be used to probe 
if XPD stalls at a lesion in one of the DNA strands. If XPD recognises a lesion while 
FeS cluster 
domain 
XPD with 
FeS cluster 
XPD without 
FeS cluster 
dsDNA 
ssDNA 
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unwinding DNA and stalls, this could imply a mechanism for the regulation of XPD and 
positioning other proteins (e.g. XPG/ FEN1) during DNA repair. 
 Interactions of XPD with other proteins during DNA repair are likely to occur, 
however, no interactions could be detected for XPD. This could be caused by weak 
binding affinities of XPD to other proteins (e.g. in the case of transient interactions) or 
that interactions were not detected under the conditions or methods used. If XPD takes 
part in NER, interactions with XPB and XPG/ FEN1 would be anticipated. Further 
experiments investigating protein-protein interactions of XPD are likely to involve 
different experimental conditions and/ or XPD constructs (e.g. GST-, His-tag). In another 
approach, fractionating S. acidocaldarius cell lysate by gel filtration chromatography and 
detection of fractions containing XPD via antibodies could lead to the identification of 
interacting proteins in a possible complex (Richard et al. (2004)). It is also possible that 
binding to DNA induces conformational changes in XPD that lead to exposure of a new 
protein-binding surface. Pull-down experiments in the presence of an appropriate DNA 
substrate could also reveal XPD binding partners. 
 XPD binding to DNA appeared weak, which is not unusual for DNA repair 
enzymes (Reardon & Sancar (2005)). It is possible that XPD does not interact strongly 
with DNA as this could hinder translocation. It seemed, that bubble DNA substrates were 
bound preferentially compared to a 5’-overhang DNA substrate. This could imply that 
SacXPD specifically recognises structures similar to an emerging repair bubble indicating 
its involvement in DNA repair. But these data are only preliminary and experiments have 
to be continued, preferentially using fluorescence based in-solution assays. The same 
applies for DNA binding studies using single and double stranded DNA in the presence 
of ATP-γS and ADP, respectively. According to the binding model for monomeric 
helicases, binding of ATP should decrease the affinity for ssDNA and increase that for 
dsDNA, while ADP is supposed to increase ssDNA and decrease dsDNA binding 
affinities (Velankar et al. (1999)).  
 This work showed how an archaeal enzyme can help to unravel completely new 
features of eukaryotic proteins. The discovery of the FeS cluster in S. acidocaldarius 
XPD and the presence of the FeS cluster domain in several human helicases contribute to 
our understanding of the development of different human diseases, including cancer.
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APPENDIX 1: OLIGONUCLEOTIDE SEQUENCES 
Table 1: Mutagenesis oligonucleotide primer 
Name Sequence 5’ to 3’ 
XPF-S56A GATCTAGTAAATGCAGTTTTTGACAAAAGG 
XPF-S56A-r CCTTTTGCTAAAAACTGCATTTACTAGATC 
XPF-R61A GTTTTTGACAAAGCGTTTTTTGACCAA 
XPF-R61A-r TTGGTCAAAAAACGCTTTGTCAAAAAC 
XPF-F63A GACAAAAGGTTTGCTGACCAAATTAGC 
XPF-F63A-r GCTAATTTGGTCAGCAAACCTTTTGTC 
XPF-Q65A AGGTTTTTTGACGCAATTAGCAGGCTT 
XPF-Q65A-r AAGCCTGCAATTGCGTCAAAAAACCT 
XPF-Y108A GCTACAATTGATGCTGATGTTAAAGTG 
XPF-Y108A-r CACTTTAACATCAGCATCAATTGTAGC 
XPD-K35A CACTGGTAGTGGGGCGACTCTATTTTC 
XPD-K35A-r GAAAATAGAGTCGCCCCACTACCAGTG 
XPD-T56A CCGAAAGTATTGTTCGTAGTCAGAGCACATAATGAG 
XPD-T56A-r CTCATTATGTGCTCTGACTACGAACAATACTTTCGG 
XPD-K84H CTTTTCTTGTAGGTCACCCCTCATCATGTTT 
XPD-K84H-r AAACATGATGAGGGGTGACCTACAAGAAAAG 
XPD-C88S CCCTCATCATCTTTATACGCTGAGAAGGG 
XPD-C88S-r CCCTTCTCAGCGTATAAAGATGATGAGGG 
XPD-C102S GAGCGAAGATATTCCATCCAAATATTGTGAGC 
XPD-C102S-r GCTCACAATATTTGGATGGAATATCTTCGCTC 
XPD-C105S CCATGCAAATATTCCGAGCTTAAAGGCTCT 
XPD-C105S-r AGAGCCTTTAAGCTCGGAATATTTGCATGG 
XPD-F136P GACGGACTTCAGGATAAACCCTGCCCCTACTACTCA 
XPD-F136P-r TGAGTAGTAGGGGCAGGGTTTATCCTGAAGTCCGTC 
XPD-C137S CTTCAGGATAAATTCTCCCCCTACTACTC 
XPD-C137S-r GAGTAGTAGGGGGAGAATTTATCCTGAAG 
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XPD-Y139F AAATTCTGCCCCTTCTACTCATTACTC 
XPD-Y139F-r GAGTAATGAGTAGAAGGGGCAGAATTT 
XPD-Y140F AAATTCTGCCCCTACTTCTCATTACTC 
XPD-Y140F-r GAGTAATGAGAAGTAGGGGCAAGAATTT 
XPD- 
Y139A/Y140A 
AAATTCTGCCCCGCCGCCTCATTACTC 
XPD- 
Y139A/Y140A -r 
GAGTAATGAGGCGGCGGGGCAGAATTT 
XPD- 
Y157A/Y159A 
CGTTATAGCCCTAACTGCTCCAGCTTTCTTTATAGATCG 
XPD- 
Y157A/Y159A -r 
CGATCTATAAAGAAAGCTGGAGCAGTTAGGGCTATAACG 
Rad3 K48A CCTTCAGGAACAGGTGCAACGGTCTCATTAC 
Rad3 K48A-r GTAATGAGACCGTTGCACCTGTTCCTGAAGG 
Rad3 R111H CTTGGCTTGACATCACACAAAAATTTGTGTTTGC 
Rad3 R111H-r GCAAACACAAATTTTTGTGTGATGTCAAGCCAAG 
Rad3 C115S CAAGAAAAAATTTGAGTTTGCATCCCGAAGTG 
Rad3 C115S-r CACTTCGGGATGCAAACTCAAATTTTTTCTTG 
Rad3 
Y208A/Y210A 
CTCTTTGTAACATTATTATTGCTTCTGCCCATTATCTATTA
GATCCTA 
Rad3 
Y208A/Y210A-r 
TAGGATCTAATAGATAATGGGCAGAAGCAATAATAATGT
TACAAAGAG 
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Table 2: Oligonucleotides for DNA substrates 
Name Sequence 5’ to 3’ 
B1-25 CCTCGAGGGATCCGTCCTAGCAAGC 
B25comp GCTTGCTAGGACGGATCCCTCGAGG 
B50 CCTCGAGGGATCCGTCCTAGCAAGCCGCTGCTACCGGAAGCTTCT
GGACC 
B50 comp GGTCCAGAAGCTTCCGGTAGCAGCGGCTTGCTAGGACGGATCCCT
CGAGG 
R26-50 TCTCAACTGCAGTCTAGACTCGAGC 
T 6 TTTTTTGCTTGCTAGGACGGATCCCTCGAGG 
T 9 TTTTTTTTTGCTTGCTAGGACGGATCCCTCGAGG 
T12 TTTTTTTTTTTTGCTTGCTAGGACGGATCCCTCGAGG 
T15 TTTTTTTTTTTTTTTGCTTGCTAGGACGGATCCCTCGAGG 
T20 TTTTTTTTTTTTTTTTTTTTGCTTGCTAGGACGGATCCCTCGAGG 
X26-50 GCTTGCTAGGACGGATCCCTCGAGG 
X50 GCTCGAGTCTAGACTGCAGTTGAGAGCTTGCTAGGACGGATCCCT
CGAGG 
60mer 
Fluor 
CAGCGGCTTGCTAGTACGGA[Fl~dT]CCCTCGAGGCCGCAGGTACT
CGTGAATTCCGCTATTCGG 
60mer CAGCGGCTTGCTAGTACGGATCCCTCGAGGCCGCAGGTACTCGTG
AATTCCGCTATTCGG 
45mer 
Fluor 
CCGAATAGCGGAATTCACGAGTACCTGCGGCCTCGAGGGA[Fl~dT]
CCGT 
45mer CCGAATAGCGGAATTCACGAGTACCTGCGGCCTCGAGGGATCCGT 
Bubble4 GGTCCAGAAGCTTCCGGTAGCAGACCGTTGCTAGGACGGATCCCT
CGAGG 
Bubble10 GGTCCAGAAGCTTCCGGTAGGCTACCGCACCTAGGACGGATCCCT
CGAGG 
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Table 3: Oligonucleotides for length dependent ATPase assays 
Name Sequence 5’ to 3’ 
6nt GGCGCG 
14nt GTACCAGCATGAAC 
25nt GCTTGCTAGGACGGATCCCTCGAGG 
50nt GCTCGAGTCTAGACTGCAGTTGAGAGCTTGCTAGGACGGATCCCTCGA
GG 
70nt GGTCCAGAAGCTTCCGGTAGCAGCGGCTTGCTAGGACGGATCCCTCGA
GGCCGCAGGTACTCGTGAATTC 
100nt GCTCGAGTCTAGACTGCAGTTGAGAGGTCCAGAAGCTTCCGGTAGCAG
CGGCTTGCTAGGACGGATCCCTCGAGGCGTCGAGGAATTCAACCACCG
CTCC 
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APPENDIX 2: ITC-DATA 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: ITC data of XPD binding to a 6mer oligonucleotide 
The figure only shows the raw ITC data of XPD binding to a 6 nt dT oligonucleotide. No 
DNA binding was observed at 25 ˚C, hence data not further processed. 
 
Table 4: Summary of XPD-DNA binding data obtained by ITC 
 T20 T14 
Chi2 34870.6 15881.6 
Binding sites (N) 0.3915±0.01314 0.4810±0.0419 
Binding constant (K) 4.441E5±2.918E4 l mol-1 1.936E5±1.959E4 l mol-1 
KD 2.5±0.3 µM 5.2±0.5 µM 
Change in Enthalpy (ΔH) -2.339E4±993.3 cal mol-1 -1.596E4±1722 cal mol-1 
Change in Entropy (ΔS) -52.6 cal mol-1 K-1 -29.34 cal mol-1 K-1 
Table 4 shows protein-DNA binding data obtained by ITC. Experiments were carried out 
at 25 ˚C and binding of XPD to a 14 nt or 20 nt dT oligonucleotide was investigated. 
 
 
 
T6 (raw data) 
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Figure 2: ITC data of XPD binding to a 20mer oligonucleotide 
The figure shows processed ITC data after baseline correction (-1600 cal mole-1) of XPD 
(10.6 µM) binding to a 20 nt dT oligonucleotide (100.9 µM). Experiments were carried 
out at 25 ˚C. No DNA binding was observed at 45 ˚C. Data were fitted to a one site of 
binding model using MicroCalTM ORIGIN software, assuming XPD binds DNA in a 1:1 
ratio. The results are summarised in Table 4. 
 
 
 
T20 
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Figure 3: ITC data of XPD binding to a 14mer oligonucleotide 
The figure shows processed ITC data after baseline correction (-1500 cal mole-1) of XPD 
(10.6 µM) binding to a 14 nt dT oligonucleotide (99.1 µM). Experiments were carried out 
at 25 ˚C. No DNA binding was observed at 50 ˚C. Data were fitted to a one site of 
binding model using MicroCalTM ORIGIN software, assuming XPD binds DNA in a 1:1 
ratio. The results are summarised in Table 4. 
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